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Abstract
After a concussion there is a complex cascade of events, termed the neurometabolic
cascade, that includes changes in ion flux, neurotransmission, and cellular energetics.
How this pathophysiological process translates into cognitive deficits remains poorly
understood. Magnetic resonance spectroscopy (MRS) provides a non-invasive technique
that allows for the quantification of brain metabolites that are involved in these processes,
including glutamate and glutamine, which are involved in neurotransmission. Moreover,
female athletes are underrepresented in studies on concussion, limiting our knowledge and
understanding of sex differences. The overall goal of this thesis was to examine metabolite
changes using MRS in female athletes before and after concussion, with the added goal of
quantifying glutamate and glutamine separately. The second objective was to replicate
metabolite changes in an animal model of concussion, to position future studies to probe
the reasons for these changes, and to explore whether these changes represent potential
therapeutic targets.
MRS was acquired from the prefrontal WM of female athletes (contact and noncontact sports) and sedentary women at 3T to explore metabolite differences between
groups and changes after concussion. In addition, an animal model of repeated closed
head impacts was studied at 9.4T, in an effort to replicate the findings observed in
humans.
In the contact athlete cohort, reduced glutamine and glutamine/total creatine (Gln/Cr)
were found following concussion, and after a season of play in non-concussed athletes. In
the non-contact athlete cohort, metabolite levels did not change over the course of a
season, and they did not differ from age matched sedentary women, except for a small
difference in myo-inositol. Most interestingly, glutamine levels were significantly
elevated in contact athletes compared to sedentary and non-contact groups, suggesting that
sub-concussive impacts may have a long-term effect on brain metabolite levels.
Furthermore, the large difference in glutamine levels between contact and non-contact
athletes has implications in study design in regards to control groups versus test-retest
paradigm.
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In the final study, we used a murine model (C57BL6) of repeated closed head injury
to investigate metabolite level changes post-injury. Elevated Gln/Cr was observed 10weeks post-injury, suggesting that the model may be appropriate to study sub-concussive
injury.
Together, these studies suggest that there exists a cumulative effect on the brain from
sub-concussive impacts in contact sports, that manifests as elevated glutamine levels.
Moreover, concussion in the same cohort of athletes results in reduced glutamine levels.
Further work aimed at replicating these findings in animal models will be crucial to
understanding the effects of cumulative impacts and concussion.
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Lay Summary
After a concussion there is a complex cascade of events, termed the neurometabolic cascade,
that includes changes in ion flux, neurotransmission, and cellular energetics. How this
process translates into cognitive deficits remains poorly understood. Magnetic resonance
spectroscopy (MRS) provides a non-invasive technique that allows for the quantification of
brain metabolites that are involved in these processes, including glutamate and glutamine,
which are involved in neurotransmission. Moreover, female athletes are underrepresented in
studies on concussion, limiting our knowledge and understanding of sex differences. The
overall goal of this thesis was to examine metabolite changes using MRS in female athletes
before and after concussion, with the added goal of quantifying glutamate and glutamine
separately. The second objective was to replicate metabolite changes in an animal model of
concussion, to position future studies to probe the reasons for these changes, and to explore
whether these changes represent potential therapeutic targets.
MRS was acquired from the prefrontal white matter of female athletes (contact and
non-contact sports) and sedentary women to explore metabolite differences between groups
and changes after concussion. In the non-contact athlete cohort, metabolite levels did not
change over the course of a season, and they did not differ from age matched sedentary
women, except for a small difference in myo-inositol. Most interestingly, glutamine levels
were significantly elevated in these contact athletes compared to sedentary and non-contact
groups, suggesting that sub-concussive impacts may have a long-term effect on brain
metabolite levels. Moreover, reduced glutamine levels were found following concussion in
the contact cohort.
In the final study, we used a mouse model of repeated closed head injury to
investigate metabolite level changes post-injury. Elevated Glutamine/Creatine was observed
10-weeks post-injury, suggesting that the model may be appropriate to study sub-concussive
injury.
Together, these studies suggest that there exists a cumulative effect on the brain from
sub-concussive impacts in contact sports, that manifests as elevated glutamine levels.
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Moreover, concussion in the same cohort of athletes results in reduced glutamine levels.
Further work aimed at replicating these findings in animal models will be crucial to
understanding the effects of cumulative impacts and concussion.
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Introduction

1.1

Prevalence and Clinical Definition

Traumatic brain injury (TBI) imposes a healthcare burden of $60 billion annually in the
United States alone1 and an estimated 57 million people worldwide have been hospitalized
with one or more TBIs2. The severity of TBIs is typically classified as mild, moderate, to
severe, with “concussion” and “mild TBI” often being used interchangeably3. Furthermore,
the National Collegiate Athletic Association Injury Surveillance Program has reported the
concussion rate among student-athletes in 25 different sports to be 4.47 per 10,000 AthleteExposures (defined as one athlete participating in one practice or competition) overall, with
some sports (e.g. hockey, football, wrestling) as high as 20 concussions per 10,000 Athlete
Exposures4. Additionally, Hirschhorn et al. (2018)5 found that the most commonly injured
body part among emergency transport incidents (ETIs) in both collegiate and high school
players to be the head and face, followed by the neck, with concussion as a frequent
diagnosis at both levels. Although concussions can occur in many situations, including
motor vehicle accidents, domestic violence, and slips and falls, athletes participating in
contact sports have a high risk of sustaining a concussion due to the nature of the activity1.
Concussion can be defined as a complex pathophysiological process affecting the
brain, induced by traumatic biomechanical forces that may be caused by a direct blow to
the head, face, neck, or elsewhere on the body with an impulsive force transmitted to the
head6,7. Traditionally, concussion is considered a subset of traumatic brain injury (TBI) and
is less severe than impacts that cause cranial fractures and intracranial hemorrhage.
Clinical symptoms can include physical, cognitive, emotional, and sleep disturbances.
Onset of symptoms is typically rapid, short-lived, and the mechanism of impairment is
usually a functional disturbance rather than structural injury. Additionally, brain loading
patterns of stress and strain vary throughout the brain depending on factors including
external forces, geometry, tissue properties and bony architecture of the skull, such that
clinical symptoms may vary from person to person6.
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Although an athletic trainer is often the first health care provider on the scene to
provide initial care5, diagnosis of concussion is made through clinical assessment by a
sport medicine physician based on mechanism of injury and symptomatology8. In sports,
this diagnosis is often made with the aid of clinical tests such as the Sport Concussion
Assessment Tool (SCAT) or Immediate Post-Concussion Assessment and Cognitive
Testing (ImPACT). The SCAT is a standardized tool that integrates the Glasgow Coma
Scale (GCS) and Maddocks score9. The GCS assesses visual, verbal and motor response on
a 15-point scale, with concussed athlete’s scoring 14-15, and more severe TBI’s scoring
lower, while the Maddocks score consists of simple questions such as “Who scored last in
this match” to assess short-term memory. Furthermore, the SCAT requires the athlete to
rank 22 different symptoms (including headache, neck pain, nausea, dizziness, blurred
vision, etc.) on a scale of 0-6, followed by questions and tasks that specifically assess
orientation, immediate memory, concentration and balance. The ImPACT is a
computerized test that also assesses 22 symptoms (on a 7-point scale) and employs
neurocognitive tests that evaluate verbal and visual memory, processing speed, reaction
time and impulse control10. However, these assessments are limited since they are
subjective, and rely on athletes to voluntarily report symptoms that are often delayed.
Additionally, athletes with musculoskeletal injuries have been found to have impaired
neurocognitive test results similar to those of concussed athletes, demonstrating the lack of
specificity to concussion11. Furthermore, the proper testing environment needed for these
tests in addition to the training required to properly review the results (e.g. ideally by a
neuropsychologist), are impractical for schools and organizations12. Therefore, an objective
biomarker that could be diagnostic and/or prognostic is greatly needed for concussion,
especially in sports where the decision to remove the athlete and return to play is time
sensitive.

1.2

Concussion and Clinical Practice

1.2.1 Motivation and Overview
After a concussion there is a complex cascade of events, termed the neurometabolic
cascade, that includes changes in ion flux, neurotransmission, and cellular energetics13.
Although magnetic resonance spectroscopy provides a technique that is able to measure
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several different metabolites that may be associated with this process, glutamate and
glutamine are hardly ever reported separately, because their signals overlap and are
confounded by macromolecules, reducing quantification precision and reliability14.
However, it is important to quantify these metabolites separately due to their involvement
in neurotransmission, and several metabolic pathways is the central theme throughout this
thesis.
In order to appreciate the complex pathophysiological process of concussion, this
section begins by introducing the basics of the central nervous system, including
neurotransmission, the metabolic demands of the brain, and traumatic brain injury, before
describing the biochemical changes associated with the neurometabolic cascade. Then an
overview of medical imaging in concussion follows, before describing the basics of
magnetic resonance and the metabolites that are measurable by magnetic resonance
spectroscopy, and their relevance to concussion.
This thesis then uses magnetic resonance spectroscopy to explore metabolite
changes in the prefrontal white matter of female contact athletes before and after
concussion, with the added goal of quantifying glutamate and glutamine separately. With
the findings from these female human studies, an animal model of repeated closed head
impacts is developed to replicate these findings, to position future studies to probe the
reasons for these changes, and how to use these changes as potential therapeutic targets.

1.2.2 Concussion Management and Recovery
Every concussion is unique and it is therefore necessary to have an individualized approach
to concussion management and return to play as well as return to learn. First and foremost,
it is important that the athlete is removed from play and not allowed to return to play the
same day. Studies have shown that athletes that return to play the same day are at greater
risk of having a recovery period longer than 21 days15. While it is recommended that
athletes reduce their physical and cognitive activity acutely after a concussion, studies have
shown that some physical activity is beneficial, so long as it does not exacerbate
symptoms12. Alternatively, it has been suggested that subthreshold aerobic exercise
(progressive exercise to the point of symptom exacerbation) may improve patient outcomes
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after concussion and post-concussion syndrome, by aiding in the restoration of autonomic
function16.
Return to play is usually accomplished by following the graduated stepwise
program updated by the Berlin Concussion in Sport Group6, which starts with (1)
symptom-limited activity, then moves the athlete into (2) light aerobic exercise, (3) sportspecific exercise, (4) non-contact training drills, (5) full-contact practice, and last (6) return
to sport. If at any of these stages symptoms are triggered, the athlete falls back to the
previous step. Ideally, the progression through these stages is monitored by a health care
provider or athletic trainer12. Depending on the nature of the injury, athletes may have also
experienced cervical strain, vestibular injuries or oculomotor dysfunction (resulting in
prolonged dizziness or balance deficits), which would likely require physical therapy and
rehabilitation during the recovery stage as well.
There are no current medications that treat concussion specifically, however, the
recommendation of medications is common among primary care, emergency department,
and sports medicine physicians12 to treat sleep disturbances and somatic, emotional, or
cognitive symptoms17. Acetaminophen and nonsteroidal anti-inflammatory medications are
the most commonly used12. Melatonin, an endogenous hormone produced by the pineal
gland from serotonin, can be prescribed for sleep disturbances, as well as Trazodone, a
serotonin reuptake inhibitor. Antidepressants such as amitriptyline are commonly used to
treat posttraumatic headaches as well as more severe emotional disturbances17.

1.2.3 Female Concussion
Estrogens and androgens can influence neuronal and glial structure and function in the
brain, due to the distribution of receptors throughout the cerebral cortex and other brain
regions18, providing a neurobiological foundation for potential sex differences in brain
injury. How these neurobiological differences influence brain injury following concussion,
however, is not well understood. Females tend to report a greater number of symptoms,
present with a different collection of symptoms, and take longer to recover19. It has been
proposed that these disparities could be due to the neck musculature and head/neck
stability, making females more susceptible to injury20. It has also been suggested that
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changes in hormonal levels in females, due to the menstrual cycle, can impact recovery
outcomes20. For example, the reduction of progesterone after concussion may impact
recovery outcomes, with a greater reduction reflecting worse outcome20.
Even though sex may be a risk factor for concussion or influence injury severity,
there exists a disparity between male and female studies in the concussion and TBI
literature. Males have dominated the majority of TBI cases, with greater hospitalization
rates that were attributed to differences in societal roles and risk-taking behavior20.
Furthermore, the majority of studies on concussion have been male dominated due to the
high rates of concussions in American football19. However, females actually suffer more
concussions in sports where males and females compete equally, such as soccer or
basketball (9.5% versus 6.4%)19. Therefore, it is clear that more studies focused on female
concussion are greatly needed, to better understand the clinical significance of sex
differences in concussion.

1.3

The Human Brain

1.3.1 Basics of the Central Nervous System: Key Components
Understanding the neurobiological effects of concussion requires a brief introduction to the
central nervous system. The nervous system can be divided into two broad cell types: nerve
cells, or neurons, and glial cells18. Neurons and glia contain the same organelles found in
all cells, however the localization of organelles and general morphology of these cell types
differ. Generally, neurons are composed of a cell body, axons, and dendrites. Dendrites,
which can be highly branched, are the primary location for synaptic input from the axon
terminals of other neurons18, while an axon is an extension of the cell body that carries
electrical signals known as action potentials18.
Neurons are specialized cells for electrical signaling over long distances18. These
signals transition from one neuron to the next through synapses, or synaptic transmission.
A synapse consists of a presynaptic and postsynaptic neuron, and usually there is no
physical continuity between these two components, but rather an elegant transmission of
molecules from the presynaptic neuron to receptors on the postsynaptic cell through
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extracellular space known as the synaptic cleft. The number of synaptic inputs to a given
neuron vary throughout the nervous system from 1 to 100,00018.
Glia, like neurons, have complex processes extending from their cell bodies, but
do not serve the same purposes as axons and dendrites. They do not participate directly in
synaptic transmission or electrical signalling but provide supportive functions that are
imperative to maintaining the neurons signalling abilities, in addition to providing a
scaffold during neurodevelopment and aiding neurons after injury18. In the mature brain,
glia can be further subdivided into astrocytes, oligodendrocytes, and microglia. Astrocytes
help maintain the chemical environment for neuronal signalling, oligodendrocytes produce
and maintain the lipid-rich myelin around axons (Schwann cells in the periphery), and
microglia are immune cells involved in regulating neuronal development, innate immune
response and wound healing21.
Together, an ensemble of neurons (and surrounding glia) are organized into neural
circuits, which process specific information, setting the foundation for sensation,
perception, movement, and behavior18. The basic constituents of a neural circuit are
afferent neurons, efferent neurons, and interneurons. Afferent neurons carry information
from the periphery to the central nervous system while efferent neurons carry information
away, and interneurons act locally within the circuit, evident by their short axons18. Neural
circuits that process similar types of information make up a neural system. Neural systems
can be broadly divided into sensory systems (visual, auditory), motor systems, and
associational systems18. Nerves cells are further organized in the brain into regions rich in
neuronal cell bodies called gray matter and regions rich in axons called white matter. The
segregation of the brain into gray and white matter is a ubiquitous feature of the vertebrate
anatomy22. In the human brain, there are approximately 32.8 billion total cells in gray
matter with a glial to neuron ratio of about 3:2, whereas of the 44.4 billion cells in white
matter the majority are glial cells23.

1.3.2 Neurotransmission
As a function of cortical firing rate, the amount of glutamate that is packaged into vesicles,
released, and then recycled through glial cells is proportional across species24. The intricate
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activity of neurotransmitters and their receptors are the basis for nerve cell
communication18. Neurons generate electrical signals based on the flow of ions across their
plasma membranes. When at rest, neurons generate a constant voltage across their
membrane, called the resting membrane potential, typically -40 to -90 mV18. The resting
membrane potential is primarily due to the selective permeability of potassium ions (K+)
caused by K+-permeable membrane channels, resulting in more K+ inside the neuron than
outside18. Electrical signals produced by neurons are caused by responses to stimuli, which
then change the resting membrane potential, resulting in an action potential. During an
action potential the membrane becomes transiently permeable to sodium (Na+) by the
opening of Na+ channels, allowing Na+ influx, causing the membrane potential to
depolarize. This rise in Na+ permeability is followed by a transient rise in membrane K+
permeability by the opening of K+ channels, allowing K+ efflux, repolarizing the neuronal
membrane18. The Na+-K+ ATPase restores the resting membrane potential by actively
moving Na+ out, and K+ into the cell. Local depolarization causes neighbouring Na+
channels to open and continue the generation of the action potential. Myelination of an
axon further speeds up action potential conduction by acting as an electrical insulator18.
While action potentials allow the transmission of a signal along an axon,
communication from one neuron to the next is made possible by synapses, the functional
contact between neurons. There are two general classes of synapses in the human brain:
electrical and chemical. In electrical synapses, the presynaptic and postsynaptic neurons
are actually linked by gap junctions, and ionic current is allowed to flow passively through
the pores created by these gap junctions18. However, the majority of synapses throughout
the central nervous system are not electrical, but chemical. In chemical synapses,
neurotransmitters are packaged into membrane-bound organelles called synaptic vesicles
within the presynaptic terminal. The arrival of an action potential leads to the opening of
calcium (Ca2+) channels causing a rapid influx of Ca2+. The rapid influx of Ca2+ allows the
synaptic vesicles to fuse with the plasma membrane, releasing the neurotransmitters into
the synaptic cleft. The neurotransmitters diffuse across the synaptic cleft to where they
bind to their receptors on the postsynaptic neuron causing channels to open or close,
depending on the nature of the neurotransmitter and receptor, resulting in an increased or
decreased probability that the neuron will fire an action potential.
7

Although there are over 100 different neurotransmitters in the human brain, the
main excitatory neurotransmitter in the brain is glutamate, and the main inhibitory
neurotransmitter is !-aminobutyric acid (GABA)18. Glutamate is a nonessential amino acid
that does not cross the blood brain barrier, and therefore must be synthesized in the brain
from local precursors. These precursors include tricarboxylic acid (TCA) cycle
intermediates ("-ketoglutarate), and predominantly glutamine by the mitochondrial
enzyme glutaminase18. Glutamate is then packaged into synaptic vesicles by vesicular
glutamate transporters. Once released into the synaptic cleft, glutamate is rapidly removed
by excitatory amino acid transporters (EAATs, a family of Na+-dependent co-transporters),
present on some presynaptic terminals and primarily on glial cells, specifically astrocytes18.
Once in the astrocyte, glutamate is converted to glutamine by glutamine synthetase25.
Glutamine is then transported back to the neuron, where it can be converted to glutamate.
The sequence of these events is better known as the glutamate-glutamine cycle, see Figure
1.1. GABA on the other hand, while most commonly found in local circuit interneurons, is
primarily synthesized from glutamate by the glutamic acid decarboxylase (GAD) enzyme
and can also be synthesized from glutamine and pyruvate18. GABA is then similarly
packaged into vesicles, released into the synaptic cleft, and removed by Na+-dependent cotransporters found on neurons and astrocytes. GABA is then converted to succinate by
GABA transaminase and succinic semialdehyde dehydrogenase (SSADH), a TCA cycle
intermediate18. These tightly coupled glutamatergic and GABAergic systems are better
known as the GABA-glutamate-glutamine cycle, and is depicted in Figure 1.1.
Glutamatergic neurotransmission is excitatory due to the postsynaptic receptors
that glutamate binds. There are metabotropic glutamate receptors (mGluR) that can excite
or inhibit, and therefore are actually quite varied in their physiological roles18. However,
the vast majority of glutamate receptors are ionotropic receptors (AMPA, NMDA, and
Kainate) that always produce excitatory responses due to the influx of Na+ and K+, and
sometimes Ca2+, when activated18. Activation of these receptors can also result in
excitotoxicity, the ability of prolonged glutamate synaptic transmission to destroy neurons.
Evidence of excitotoxicity causing neuronal damage after brain injury has been observed
during studies of ischemia and epilepsy18,26. GABAergic neurotransmission on the other
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hand, is inhibitory because activation of these receptors causes an influx of Cl-, which
hyperpolarizes the membrane and therefore transiently inhibits an action potential18.

Figure 1.1: Illustration of the GABA-Glutamate-Glutamine Cycle. Glutamate is packaged
into synaptic vesicles and released into the synaptic cleft. Glutamate is rapidly removed by
excitatory amino acid transporters, present on some presynaptic terminals and primarily on
glial cells, specifically astrocytes. Once in the astrocyte, glutamate is converted to
glutamine by glutamine synthetase. Glutamine is then transported back to the neuron,
where it can be converted to glutamate. The sequence of these events is better known as the
glutamate-glutamine cycle. GABA on the other hand, is primarily synthesized from
glutamate by the glutamic acid decarboxylase (GAD) enzyme and can also be synthesized
from glutamine and pyruvate. GABA is then similarly packaged into vesicles, released into
the synaptic cleft, and removed by Na+-dependent co-transporters found on neurons and
astrocytes. GABA is then converted to succinate by GABA transaminase and succinic
semialdehyde dehydrogenase (SSADH), a TCA cycle intermediate. These tightly coupled
glutamatergic and GABAergic systems are better known as the GABA-glutamateglutamine cycle.
9

1.3.3 Metabolic demands of the human brain
The principal nutrients that support biosynthesis in mammalian cells are glucose and
glutamine27. Although the regulation of glutamine through signalling pathways is still
being elucidated27, the brain utilizes 20% of the body’s total glucose and oxygen to
generate ATP to fuel physiologic functions28. Glucose is also a key substrate in forming the
second messenger inositol, as well as glutamate and GABA for neurotransmission, as
discussed earlier29. It is generally accepted that glucose is the obligatory energy substrate
for the brain30,31, and crosses the blood brain barrier through glucose transporters, primarily
GLUT1. Even though neurons possess the glucose transporter, GLUT3, several studies
suggest that glucose is mostly consumed by glial cells while neurons depend on glucose
metabolites released from the glia32. Further studies have suggested other useful energy
substrates for the brain, including lactate and acetate32. In astrocytes, after glycolysis,
pyruvate can easily be converted into lactate, and is potentially a major source to support
axonal function33. Although controversial, it has also been proposed that this lactate is
transported to neurons where it serves as the primary metabolic fuel, known as the
astrocyte-neuron lactate shuttle hypothesis32,34. Acetate, which can be metabolized to
acetyl CoA to enter the TCA cycle, has been shown to be metabolized in vitro to glutamate
and aspartate by neurons, and to glutamine by astrocytes35. In vivo studies have found
acetate to be rapidly incorporated into glutamine, GABA, glutamate, and aspartate, with
the greatest amount metabolized to glutamine32. The role of other substrates over glucose is
particularly important in pathological conditions where glucose supply is disrupted or
limited.
The human brain is highly energy demanding, as ATP is consumed through nonsignaling and signaling processes in the brain36. Non-signaling processes include
housekeeping mechanisms and maintaining the resting potential, while signaling processes
include the neural firing rate, action potential conduction, synaptic transmission,
neurotransmitter recycling, and calcium activity24. The calculated average neuronal firing
rate in the resting awake human is approximately 1.15Hz, much lower than the rat
(approximately 4.3Hz)24. Experimental studies have observed brain energy metabolism
from glucose oxidation to correlate with signaling processes37,38. Several studies
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investigating energy budgets did not include glial activity39,40, even though it has been
reported that astrocytes and oligodendrocytes have active calcium responses to spiking
processes41,42. It has been reported that the nonsignaling costs of glial cells are three times
higher than neurons, and nearly half of glial metabolism is due to calcium signaling24.
Furthermore, Yu et al. (2018)24 estimated energy budgets for gray matter by taking into
account neuronal and glial energy demands, and validated their findings with in vivo PET
and 13C magnetic resonance spectroscopy (MRS). They found that 70% and 30% of the
energy demand in gray matter is related to signaling and non-signaling processes
respectively, while in white matter the cost is approximately 20% and 80%. These results
matched well with other studies, for example, a recent in vivo 13C-MRS study in rat and
human brain suggested 70-75% and 25-30% of the energy in the awake state supports
signaling and nonsignaling functions respectively in gray matter43. The main difference
between gray and white matter energy demand stems from the cost of neuronal signaling in
the cerebral cortex, and the higher biosynthesis turnover demands in white matter24.

1.3.4 Traumatic Brain Injury
Traumatic brain injury (TBI) begins not as a disease but as an event that causes traumatic
impact to the brain44. The primary injury is the result of immediate mechanical damage
from direct or indirect contact to the brain. This damage can be due to, for example,
acquired brain injury, a stroke, an aneurysm, hemorrhaging, or axonal shearing. Next,
secondary injury evolves over minutes to days after the primary injury due to a cascade of
metabolic, cellular and molecular events3. These include glutamate excitotoxicity,
disrupted calcium homeostasis, mitochondrial dysfunction, increased free radicals,
inflammation, and diffuse axonal injury (DAI)3.
More specifically, when the brain is damaged, damage-associated molecular
patterns (DAMPs) are passively released by injured cells. DAMPs, which can include
proteins, ATP, and DNA, bind pattern recognition receptors (PRR) on microglia and
astrocytes to initiate innate immune activation45 through the production of cytokines and
chemokines3. These molecules will further activate other receptors that in turn initiate
inflammatory signaling cascades and the recruitment of immune cells (leukocytes) to the
site of damage3,45. Studies have shown leukocyte recruitment to contribute to the
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development of BBB breakdown, edema formation, and potentially contribute to secondary
damage3. As a result, several studies have investigated the therapeutic potential of blocking
leukocyte migration and adhesion in animal models of TBI46,47. However, the extent to
which leukocyte recruitment is harmful to brain parenchyma remains controversial.
Taken together, it appears that TBI is a multimodal disease process with primary
and secondary injury mechanisms that cause structural and functional damage. These
deficits include cognitive, behavioral, emotional and physical, resulting in diminished
quality of life3. These deficits can include communication problems, mood disorders, and
cognitive impairment even six months after mild TBI3. Post traumatic seizures, although
more prevalent following severe TBI, can follow mild and moderate TBIs3. Furthermore,
the vast majority of studies done of TBI in the literature have examined severe or
penetrating TBI, leaving mild TBI less well characterized.

1.4

Concussion

1.4.1 The Neurometabolic Cascade
During a concussive injury, the brain may experience linear and rotational accelerations,
with dynamic shear, tensile, and compressive strains within the tissue48. As depicted in
Figure 1.2, these stresses can result in mechanoporation, leading to altered ion flux,
including calcium influx, and glutamate release immediately after injury13,49,50. Glutamate
release can interact with immune receptors and trigger a series of events resulting in
synaptic injury and cellular damage51. Higher intracellular calcium can lead to
phosphorylation of neurofilaments, resulting in loss of axonal structural integrity13,52, and
interruption of axonal transport48, producing diffuse axonal injury (DAI). Subsequently, the
shift in intracellular and extracellular ions requires ATP ionic pumps to restore balance,
leading to an acute depletion of intracellular energy reserves13,53. Additionally, this
increased demand for energy is accompanied by reduced cerebral blood flow54, further
prolonging the mismatch between energy demand and supply. This reduced cerebral blood
flow has been sustained for up to 2 weeks post-concussion55. Furthermore, the
sequestration of calcium into mitochondria can result in mitochondrial dysfunction,
worsening the cellular energy crisis13. The extent to which these events are sustained
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appears to vary, from calcium influx lasting 3-5 days, to reduced cerebral blood flow as
long as 7-14 days13.
Fluorodeoxyglucose (FDG) PET and single photon emission computed
tomography (SPECT) studies have characterized changes in glucose and oxygen
consumption, and cerebral blood flow (CBF) after concussion and TBI56. Generally,
hypermetabolism has been found acutely after concussion, followed by reduced glucose
metabolism in various brain regions. Additionally, a reduced cerebral metabolic rate of
oxygen has been observed, indicating diminished oxidative metabolism57,58. Although
global CBF often appears unchanged, reduced regional CBF has been found in several
studies (ranging from frontal and temporal cortex to cerebellum and brainstem), which is
consistent with functional deficits in attention, working memory, verbal fluency, and
processing speed56.
Activation and infiltration of microglia have been well documented in TBI59,60,
and more recent studies suggest that inflammation is also triggered in concussion61,62.
Madathil et al., (2018)62 observed robust microglial activation after single and repeated
impacts using a rodent closed-head concussive impact injury model, that resolved by 72
hours after a single impact but persisted in rodents with repeated impacts. Even though
these inflammatory processes are currently being studied in concussion and TBI, their role
in injury severity is largely unknown. Additionally, techniques such as carbon-13 (13C) and
phosphorus-31 (31P) NMR spectroscopy may be useful in identifying shifts in cerebral
metabolism, intracellular pH, free magnesium, and cellular bioenergetic status63 after
concussion. In fact, Bartnik and colleagues (2007)64 found reduced glutamine labeling up
to 24-hrs post-injury in a fluid percussion injury rodent model using 13C NMR, suggesting
reduced oxidative metabolism after injury. Additionally, Cernak and colleagues (2004)63
found a decline in free magnesium and reduced bioenergetic status 4-hours after an impactacceleration induced severe diffuse axonal injury in rats using 31P NMR, suggesting
increased energy demand in response to attempts to restore ionic balance. These studies
can provide insights into neuronal and glial energetics after injury, due to the location of
specific metabolic enzymes, such as glutamine synthetase, which is exclusively found in
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glial cells65. By combining these findings on inflammation, cerebral energetics, and other
disturbances after concussion, it is possible to build a more detailed picture of the
metabolic changes post-concussion and move towards identifying an objective biomarker
for diagnosis and prognosis.

1.4.2 From Clinical Practice to Areas of Active Research: A Historical
Perspective of Imaging Concussion
Although the notion of closed head injury dates as far back as Ancient Greek medicine, the
entity of concussion was first described as an abnormal transient physiologic state without
gross brain lesions by the Arabic physician, Rhazes around 900 AD66,67. It wasn’t until
1280 that concussion was first discussed as a separate entity from penetrating brain wounds
by the modern physician Lanfrancus67,68. Over the next few centuries, the clinical
description would be further refined and the term concussion would come into widespread
use. Following the development of the microscope in 1694, the focus shifted to a
pathophysiological approach to understanding the well documented clinical entity of
concussion through animal models and case reports67,69,70, resulting in several new
physiologic theories focusing on functional rather than structural injuries. This led to two
broad schools of thought: structural versus functional brain injury, which have both led to
several hypotheses and studies aimed at exploring diffuse axonal injury, mechanoporation,
and subsequent events following concussion.
It wouldn’t be until 1895, with the discovery of the x-ray, that the era of medical
imaging would commence, from the introduction of nuclear medicine and PET in the
1950’s, to the advent of CT and MRI in the 1970’s71. CT and MRI became commonly used
in hospitals throughout the 80’s and 90’s, with CT traditionally used to rule out a more
serious TBI injury such as structural lesions, fractures or intracranial hemorrhages72. In the
clinical setting, CT is beneficial due to low cost and greater speed compared to an MRI,
but convention structural neuroimaging by CT and MRI is rather insensitive to
concussion72. From the end of the 1980’s into the 21st century, fluorodeoxyglucose (FDG)
PET and single photon emission computed tomography (SPECT) studies characterized
changes in glucose and oxygen consumption, and cerebral blood flow (CBF) after
concussion and TBI56. More recently, over the last two decades,
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Figure 1.2: Flow Chart of the Neurometabolic Cascade after Concussion
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thanks to the advancement of novel ligands, PET has been used to explore activated
microglia and tauopathies after concussion and TBI to investigate neuroinflammation and
neurodegenerative changes.
Alongside the advancement of concussion with PET imaging, several different
MRI techniques that were developed throughout the 1990’s were also investigated,
including arterial spin labeling (ASL), diffusion tensor imaging (DTI), and functional MRI
(fMRI). ASL is a perfusion technique that allows the assessment of CBF73. Similar to what
was found with PET, some ASL studies observed regional decreases in CBF55,74 that were
associated with changes in processing speed, learning and memory, executive function and
verbal fluency74. Furthermore, studies have found reduced regional CBF to persist in
athletes that take longer to recover75. However, other studies have found significantly
elevated regional CBF76. These discrepancies are likely due to the heterogenous nature of
the injury, timing of data acquisition relative to the concussion, and the specific brain
region.
The MRI technique, diffusion tensor imaging (DTI), is a type of diffusion
weighted imaging that quantifies an elliptical diffusion tensor within a voxel. Radial (RD)
and axial diffusivity (AD) describe the magnitude of diffusion along the radial and long
axes of the ellipsoid, respectively. The mean diffusivity (MD) represents the average
magnitude of water diffusion, while fractional anisotropy (FA), describes the directionality
of water diffusion on a scale of 0 (isotropic) to 1 (maximum anisotropy). Human studies
using DTI have found an acute period of high FA with low RD, followed by decreases and
increases in FA and RD respectively77,78, while other studies have found the exact
opposite79. Changes in AD and MD have also been observed80. Alterations in these
diffusion parameters may reflect neuronal swelling, edema77,81, or axonal pathology80.
Furthermore, decreased FA in frontal and temporal regions relative to healthy controls has
been observed several months to years following concussion, indicating a loss of myelin
and potentially degenerative changes81,82. However, a study by Ilvesmaki et al., (2014)83
found no differences in DTI metrics between mTBI patients and healthy controls. Future
research directions include the application of multi-compartmental models of diffusion and
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multi-shell imaging. More information on these techniques can be found in Delouche et al.,
201684.
Early fMRI studies found hyperactivation in frontoparietal brain regions in
concussed patients relative to healthy controls under moderate processing loads, and
hypoactivation for lower processing loads85,86. Hypoactivation in the dorsolateral prefrontal
cortex and other brain regions during working memory tasks has also been reported after
concussion in several studies87–90, as well as associations between hypoactivation and
clinical measures such as symptom severity91. Furthermore, studies have found different
areas of activation and/or hypoactivation depending on the mode of injury91. To date,
several resting state (RS) fMRI studies have also found changes in connectivity in the
default mode network (DMN), intrinsic connectivity networks (ICN), and other networks
using seed-based approaches or independent component analysis (ICA)91,92.

1.5

Magnetic Resonance Spectroscopy

Magnetic resonance spectroscopy (MRS) is a magnetic resonance-based method that can
be used to detect and quantify specific metabolites in a brain region of interest. Quantifying
metabolite changes following concussion could aid in identifying altered
neurotransmission from the secondary chemical cascade of ion flux that occurs after
receiving a hit to the head.13 In this section, the basic principles of MRS are outlined,
followed by the acquisition and post-processing of MRS data, and finally a description of
the metabolites that can be measured and their relevance to concussion, in humans and
animal models.

1.5.1 Magnetic Resonance Principles
NMR is the study of the magnetic properties and energies of nuclei. In NMR, only nuclei
with nonzero nuclear spin are detectable (For example; 1H, 31P, 13C)93. This is because
nuclei with a nonzero spin quantum number have a nonzero spin angular momentum
! = #$,
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(Eq. 1.1)

where L is the spin angular momentum, # is the gyromagnetic ratio, an intrinsic property of
each nuclei (1H # = 42.58 MHz/T), and ! is the magnetic moment. The spin angular
momentum (L) is quantized and given by94
&

$ = '( )*(* + 1),

(Eq. 1.2)

where h is Planck’s constant and I is the spin quantum number, which can only be an
integral or half-integral. By substituting (Eq. 1.1) into (Eq. 1.2) we show that the magnetic
moment is also quantized:
&

! = # '( )*(* + 1).

(Eq. 1.3)

Nuclear magnetic resonance occurs when a nucleus with a magnetic moment, ! , is placed
in an external magnetic field (B0). The magnetic field will exert a torque on the magnetic
moment, leading to precession of the nucleus about B0. The frequency of this precession is
known as the Larmor frequency (v) and is given by:
2

0 = 1'( 3 45 .

(Eq. 1.4)

It is convention that the z-direction is set along B0, and a magnetic moment in a magnetic
field will have potential energy (E) given by:
6 = −!8 49 .

(Eq. 1.5)

In quantum mechanics the direction of angular momentum is specified by the quantum
number, m, which can have I(I+1) values given by I, I-1, I-2, …, -I. The component of the
magnetic moment in the z direction is given by:
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&

!8 = # 1'( 3 :,

(Eq. 1.6)

where !8 is the component of the magnetic moment in the z direction. By substituting (Eq.
1.6) into (Eq. 1.5) we show that the energy levels are also quantized:
&

6 = −# '( :49 .

(Eq. 1.7)

In a magnetic field, for a 1H of spin I=1/2 94, there are only two energy levels (m = -1/2 and
+1/2), and the energy difference (∆6) is given by:
&

∆6 = # 1'( 3 49 .

(Eq. 1.8)

The two spin states m= +1/2 (parallel to B0), and m= -1/2 (antiparallel to B0) are referred to
as the = and > spin states respectively. In a macroscopic sample there are many spins that
distribute themselves among these two orientations according to the Boltzmann Equation94.
Due to energy differences between these spin states, as shown by Equation 1.8, there will
also be a difference in the population of these spin states, given by:
@

?@A C = D

∆EH
FG

B

=D

&IH
FG ,

(Eq. 1.9)

where n is the number of spins the low energy state (=) and high energy state (>), k is the
Boltzmann constant and T is the absolute temperature.
The total net magnetic moment, the magnetization (M), of a macroscopic sample
is the sum over all the individual magnetic moments, !. Due to the population difference in
z, there will be a net component of M parallel with B0 along the +z axis, known as the
longitudinal magnetization, M0. At thermal equilibrium, the amplitude of this
magnetization is given by:
2& ' @K

J9 = 1'( 3 1MFGL 3,
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(Eq. 1.10)

where N = NO + NP , the total number of 1H nuclear spins in the macroscopic sample.
MRI scanners are designed to detect magnetization that is perpendicular to the
main magnetic field (in the transverse plane). However, at thermal equilibrium the spins
have no phase coherence in the transverse plane, and the net longitudinal magnetization,
M0, is a static vector94. Therefore, the net magnetization must be rotated onto the transverse
plane for detection. This is achieved by applying a second magnetic field, B1, in the
transverse plane, oscillating in the radio frequency (RF) MHz range. While this RF pulse
(B1) is applied, the magnetization will precess about B0 and B1, resulting in a rotation of
the magnetization towards the transverse plane. If the B1 field is applied long enough, M0
will be excited onto the transverse plane (90º excitation) or even inverted to the -z axis
(180º excitation). Following the RF pulse, M0 will only experience B0 and will precess
around it at the Larmor frequency, v, inducing an electromotive force (emf) in the receiver
coil, giving rise to the detected NMR signal. This signal is an alternating current with
frequency equal to the Larmor frequency, that decays exponentially due to transverse and
longitudinal relaxation. The Fourier Transform of this signal produces a Lorentzian
lineshape in the frequency domain94.

1.5.2 Chemical Shift and J-Coupling
If the frequency of nuclear spins were solely determined by Equation 1.4, then in vivo 1H
MRS would have little value, since every 1H nucleus in all metabolites would precess at
the same frequency, determined by their identical gyromagnetic ratios. Fortunately, this is
not the case. In fact, in addition to the gyromagnetic ratio and magnetic field, the resonance
frequency of a given nucleus depends on the chemical environment of the nucleus, also
known as the chemical shift. The chemical shift arises because electrons surrounding the
nucleus effectively shield the nucleus from the external magnetic field, ultimately reducing
the magnetic field that is experienced by the nucleus94. The effective magnetic field (Beff)
experience by the nucleus is given by:
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4QRR = 49 (1 − S),

(Eq. 1.11)

where S is the shielding coefficient in units of parts per million (ppm), and is independent
of B0. Therefore, within the same molecule, each 1H that is in a different chemical
environment will precess at a slightly different frequency, resulting in a distribution of
resonance frequencies, which produces a fingerprint for the given metabolite.
Chemical shifts are generally not expressed in units of Hz, since this would make
them dependent on the magnetic field strength. Alternatively, chemical shifts (T) are
expressed in terms of ppm defined as:

T=

RURVWX
RVWX

× 10[ ,

(Eq. 1.12)

where f is the frequency of the nucleus under investigation and fref is the frequency of a
reference compound. Proton MRS commonly uses sodium 3-trimethylsilyl-propionic acid
(TSP) as a chemical shift reference94.
In addition to the chemical shift phenomenon, nuclei with magnetic moments can
influence each other through electrons in covalent bonds, resulting in more complex
spectral patterns, known as spin-spin coupling or J-coupling. J-coupling results in slight
frequency shifts, that appears as splitting of the peaks. For example, in the case of
glutamine, there is a single methine proton and 4 methylene protons, in a total of 3
different chemical environments (Figure 1.3A). Without J-coupling, this would produce 3
different peaks resonating at slightly different frequencies due to the chemical shift (Figure
1.3B). However, in reality a peak is split according to the spin orientation of the nonidentical spin (or spins) it is coupled to. In the example of glutamine, the methine proton
(2CH) is split into three sub-peaks with relative areas in a 1:2:1 ratio (Figure 1.3C) because
the spins of the coupled 3CH2 protons have three possible spin configurations, resulting in
different energy states: (up, up) one way, (up, down) two ways, and (down, down) one
way. In general, a coupled nucleus will be split by n magnetically equivalent nuclei into
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n+1 peaks, and the amplitudes of these peaks are given by Pascal’s triangle (1:1, 1:2:1,
1:3:3:1, etc.)94. The frequency difference between these peaks is given by the scalar
coupling constant (Hz), and is independent of the applied external magnetic field.
Furthermore, the scalar coupling constant rapidly decreases with increasing number of
chemical bonds and can typically be ignored for four or more bonds.
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Figure 1.3: (A) Structure of Glutamine molecule, with MRS visible protons in red (B)
MRS spectrum of glutamine according to chemical shift, and (C) splitting of glutamine
methine group according to J-coupling

1.5.3

1

H MRS Acquisition

Single voxel acquisition is the magnetic resonance spectroscopy technique used in this
thesis. To acquire MRS data from a specific region of the brain, a voxel is placed in the
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region of interest by an MRI technician using sagittal, axial, and coronal images to guide
the voxel placement (see Figure 1.4). Saturation bands are placed near the boundaries of
the voxel to reduce signal from the surrounding tissue. The signal detected by the MR
scanner is localized to the voxel by using gradients that selectively excite three orthogonal
planes, where the intersection of these planes defines the voxel of interest. This is achieved
by using the Point Resolved Spectroscopy Sequence (PRESS), which uses a slice-selective
excitation (90º) combined with two slice-selective refocusing pulses (180º). Signal from
outside the voxel of interest is either not excited (by the 90º pulse), or not refocused (by the
180º pulse). Furthermore, most MRS studies of sport concussion have utilized a short echo
time (TE < 50 ms), which makes metabolite quantification more challenging due to the
overlapping broad macromolecule resonances that are most prominent within the 2-4 ppm
region of the spectrum. To avoid this complication, a long echo time (TE = 135 ms) was
chosen for the work presented in this thesis.
The most abundant compound in mammalian tissue is water, and as a result the
NMR signal is dominated by the water resonance at 4.7 ppm94. This becomes problematic
when trying to detect metabolites with concentrations that are 10 000 times lower than that
of water. Therefore, to properly resolve the metabolite signals it is important that the water
signal is suppressed during acquisition. This is often achieved by chemical shift selective
(CHESS) water suppression, which uses a frequency selective RF pulse to excite the water
followed by strong crusher gradients to dephase the magnetization in the transverse plane,
ideally leaving the metabolite resonances unperturbed.
Although the above techniques are used for the majority of this thesis, different
acquisition methodology is used in Chapter 4. Specifically, MRS spectroscopy data were
acquired on an Agilent 9.4 Tesla small-bore MRI scanner (Santa Clara, CA, USA).
Magnetic resonance spectroscopy was acquired using Localization by Adiabatic Selective
Refocusing (LASER), a localization method that uses adiabatic excitation and refocusing
RF pulses. This sequence, excites the entire sample with a nonselective adiabatic half
passage pulse (90º), followed by three pairs of adiabatic full passage (AFP, 180º) pulses in
the presence of magnetic field gradients to achieve slice-selective refocusing. Pairs of AFP
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are used to refocus the phase that accumulates across the slice when a single AFP is
applied along with a slice select gradient.
Water suppression was achieved by variable pulse powers and optimized
relaxation delays (VAPOR), which uses seven frequency selective RF pulses interspersed
with optimized T1 recovery delays. Moreover, a short echo time of TE = 18 ms was used,
which required the addition of an extra step to remove macromolecule signals, before the
spectrum could be fitted. This was achieved by acquiring a macromolecule only spectra
interleaved with the acquisition of the full spectrum using a single-inversion preparation
pulse. This subject specific macromolecule spectrum was then subtracted from the full
spectrum, leaving behind only the metabolites.
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Figure 1.4: (A) From left to right; axial, sagittal, and coronal views of a T1-weighted
anatomical image with the spectroscopy voxel overlaid in green in the prefrontal region.
(B) Spectrum acquired (green) from the voxel in A, reconstructed spectrum (red), the
residual after fitting (blue), and the individual prior knowledge components of the
spectrum shown in black. Glc = Glucose; Myo = Myo-inositol; Glu = Glutamate; Gln =
Glutamine; Cr = Creatine; Cho = Choline; NAA = N-acetyl aspartate; ppm = parts per
million.

1.5.4

1

H MRS Post Processing

Lineshape distortions can be induced from time dependent, spatially dependent, and time
and spatially dependent B0 inhomogeneities. Popular methods to correct the lineshape use a
reference signal, which is typically the unsuppressed water signal from the MRS voxel.
The two methods employed in this thesis are QUALITY (QUAntification improvement by
converting Lineshapes to the lorentzian TYpe) deconvolution95 and ECC (Eddy Current
Correction)96. QUALITY deconvolution divides the time-domain signal by the
unsuppressed water time-domain signal, and effectively removes spectral distortions and
restores the Lorentzian lineshape. However, the T2 of water is shorter than the T2 of most
metabolites, resulting in division by near-zero water signals towards the end of the timedomain signal. By employing ECC towards the end portion of the time-domain signal, a
subtraction of just the phases of the two signals, the division of near-zero values can be
avoided. This combined spectroscopic lineshape correction is known as QUECC97, and is
the technique used in this thesis. Once the lineshapes are restored, the spectrum is then
fitted to a prior knowledge template. Spectra were reconstructed using linear combinations
of metabolite lineshapes obtained from spectra of in vitro metabolites solutions that were
acquired under controlled temperature and pH.
The concentration of a metabolite is determined from the area of the resonance
peak(s) because the area is directly proportional to the number of nuclei resonating at that
frequency. In order to calculate the absolute tissue concentration of the metabolites from
the measured signals, several assumptions must be made. First, we must assume that water
densities and signal relaxation times of GM, WM, and CSF in the voxel can be reliably
estimated and do not change significantly among groups98. Second, we assume that volume
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fractions are accurately measured, and this is done in this thesis by segmentation of the T1Weighted MPRAGE anatomical image (for Chapter 4, the animal study, a 2D fast spinecho anatomical image was segmented for tissue/CSF partial volume correction). Third, we
assume the relative proton density of water, compared to that of pure water to be 0.82, 0.73
and 1.0 for GM, WM, and CSF, respectively. The relative proton density of metabolites in
GM, WM and CSF are not known and therefore assumed to be 1.
The fully relaxed signal (S) from water or any metabolite in the spectroscopy
voxel will be proportional to the number of moles (n) of the molecule in the voxel:

\]W^_`_VWb_cWd
\efL_VWb_cWd

=

@]W^_`
@efg

.

(Eq. 1.13)

Provided that the metabolite(s) and water come from the same volume of the voxel, we can
solve for the metabolite concentration (M):
[J ] =

\]W^_`_VWb_cWd
\efL_VWb_cWd

[j' k].

(Eq. 1.14)

Note that to obtain the fully relaxed signal described above, we must correct for T1 and T2
relaxation lmGn mGf o, number of signal averages (NA), number of protons (p), and any
gain/scaling factors (G):

[J ] =

\]W^_` /lrsn rsf ]W^_` o(tu)(v)(w)
\efL / lrsn rsf x_^WVo(tu)(v)(w)

[j' k].

(Eq. 1.15)

To correct the water signal for T1 and T2 related signal loss, we directly apply the
following to our signal:
(Eq. 1.16)
UGr/GnÄ olD UGE/GfÄ o

mGn mGf yz{Q| = }w~ =w~ l1 − D
+ }Å~ =Å~ l1 − D UGr/GnÇÄ olD UGE/GfÇÄ o
+ }É\Ñ =É\Ñ l1 − D UGr/GnÖÜá olD UGE/GfÖÜá o,
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which describes relaxation of the transverse magnetization, where fx denotes the volume
fraction of x = GM, WM, or CSF in the spectroscopic voxel, =à denotes the relative proton
density, and TR/TE represent the repetition and echo time of the spectroscopy experiment
(2000/135 ms for human experiments, and 3250/18.9 ms for mouse experiments in this
thesis). To correct the metabolite signal for T1 and T2 related signal loss, a similar approach
is taken, except that no correction is applied for the CSF compartment, because metabolites
are assumed to be exclusively found in tissue:
(Eq. 1.17)
mGn mGf âQ{zä =

}w~
l1 − D UGr/GnÄ olD UGE/GfÄ o
}w~ + }Å~

+

}Å~
l1 − D UGr/GnÇÄ olD UGE/GfÇÄ o.
}w~ + }Å~

Since the relative proton densities of metabolites are assumed to be 1, they are omitted
from the equation. By substituting (Eq. 1.16) and (Eq. 1.17) into (Eq. 1.15), the final
equation for the corrected metabolite concentration with respect to the entire volume of the
voxel is as follows:
(Eq. 1.18)
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Finally, Equation 1.18 can be multiplied by (}w~ + }Å~ )Uñ to determine the concentration
of the metabolite in brain tissue alone, and this is how the absolute concentrations are
reported in this thesis.
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1.5.5

1

H MRS Metabolites and findings in Concussion Studies

There are several metabolites of interest that are measurable by in vivo 1H MRS. Table 1.1
outlines these metabolites, including their main functions within the brain and relevance to
concussion. Briefly, the main metabolites found in human 1H MRS include N-acetyl
aspartate (NAA), total choline (Cho), total creatine (Cr), glutamate (Glu), glutamine (Gln),
and myo-inositol (Myo). Several different changes in these metabolites, as well as different
directions in these changes, have been observed after sport concussion. This section
outlines the main function of each of these metabolites, and introduces the current findings
in sport concussion (Table 1.2) and the timing of these changes (Table 1.3).
The MRS creatine peak incorporates signals from both creatine and
phosphocreatine (total creatine), which is used as a marker of energy metabolism, due to
their primary role as an intracellular buffer for ATP99,100. Creatine is primarily synthesized
in the liver and transported to the brain99, although it is also suggested that the brain is able
to endogenously synthesize its own creatine100. Furthermore, creatine plays an important
role in energy metabolism through interconversion to the high energy phosphorylated
analogue, phosphocreatine (PCr)100. The N-phosphoryl group is transferred from PCr to
ADP, yielding ATP100. Moreover, creatine and PCr allow for the shuttle of high-energy
phosphates from mitochondria to sites of utilization in the cytoplasm100. Therefore, the Cr
measured by MRS may be sensitive to the energy supply and demand mismatch that can
occur after a concussive injury. The MRS signal of total creatine (Cr) produces two
singlets at 3.03 and 3.93 ppm94. In human studies, no change in Cr has been observed after
concussion, however elevated Cr has been reported in the motor cortex of contact athletes
at the beginning of season compared to non-contact athletes, followed by reduced Cr
during the season101. Moreover, creatine is commonly used as the denominator when
calculating metabolite ratios in the MRS literature. Therefore, to compare to the literature,
metabolite ratios are reported in this thesis in addition to absolute quantification, as already
discussed.
NAA is one of the highest concentrated free amino acids in the brain102, and is
commonly regarded as a marker of neuronal health and integrity, as it is synthesized in
neurons and its spatial distribution in GM has been shown to be correlated with the density
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of neuronal cells99. Although the exact function of NAA is not fully understood, it is
implicated in acetyl-CoA and aspartate storage, a source for lipid synthesis in
oligodendrocytes, a potential osmolyte, and involved in NAAG synthesis103,104. NAA is
synthesized in the mitochondria of neurons from acetyl coenzyme A and aspartate, where it
is then transported along axons to oligodendrocytes, except for a small amount that is
converted with glutamate to NAAG102. In oligodendrocytes, NAA is catabolized to
aspartate and acetate, where the acetate can then be used in the synthesis of fatty acids,
such as myelin102,103. Studies of diseases in which there is a loss of neurons or axons, such
as infarctions, brain tumors, and multiple sclerosis, have presented with decreased NAA105.
The NAA MRS signal is composed of a singlet at 2.01 ppm, as well as smaller resonances
at 2.49, 2.67, and 4.38 ppm94. In the case of concussion and TBI, a decrease in NAA has
the potential to aid in the assessment of irreversible and temporary neuronal damage99. In
human studies, mostly decreases in NAA and NAA/Cr have been reported106–110, with a
single study reporting elevated NAA/Cr111 in the WM of the frontal lobes.
The choline signal is made up of choline, glycerophosphocholine and
phosphocholine. Choline is an essential nutrient that is involved in neurotransmitter
synthesis (acetylcholine), lipid transport (lipoproteins), and cell membrane signaling
(phospholipids)112. The majority of choline, however, is converted to phosphatidylcholine,
the predominant phospholipid in cell membranes112. The most prominent signal produced
from total choline is at 3.2 ppm94. Quantification of the MRS choline peak can be used to
infer changes in membrane turnover rate such as demyelination after injury113, likely due to
the degradation of myelin phospholipids114. Elevated Cho/Cr115 has been observed after
sport concussion, as well as reduced Cho80. Additionally, changes in Cho have been
observed in retired athletes116–118.
Mentioned previously, glutamate is a nonessential amino acid that is synthesized
in the brain from local TCA cycle precursors (=-ketoglutarate), but predominantly from
glutamine18. Glutamate is an excitatory neurotransmitter, and up to 90% of neurons excrete
glutamate during neurotransmission99. Moreover, there is evidence of glutamatergic
signaling in the white matter as well119, although the role of WM signaling is less well
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understood. In regards to the spectral pattern of glutamate, it is complex with a resonance
at 3.75 ppm and multiplets from 2.04-2.35 ppm94.
As demonstrated in Figure 1.1, glutamine is important in recycling
neurotransmitters, as part of the tightly coupled GABA-glutamate-glutamine cycle.
Additionally, glutamine is involved in brain nitrogen homeostasis120, and there is also
evidence suggesting that the metabolite is immunomodulatory in models of infection and
trauma121. Glutamine is structurally similar to glutamate, resulting in a resonance at 3.76
ppm, and multiplets from 2.12-2.46 ppm (Figure 1.3)94. In more severe head injuries,
studies have shown glutamine synthetase (GS) activity, the enzyme that converts glutamate
to glutamine, to be reduced due to increased oxidative stress, and that this inhibition in GS
can lead to reduced glutamine122,123, suggesting that glutamine levels could change postconcussion. However, most studies to date do not differentiate between glutamate and
glutamine, but instead report the sum of these metabolites as Glx. In human studies of sport
concussion, reductions in Glx/Cr have been observed108,109, as well as increases124.
Myo-inositol is a simple isomer of glucose that is synthesized in the brain from
glucose-6-phosphate125. Myo-inositol was initially found in astrocytes and assumed to be a
useful marker of glial proliferation35,125. However, myo-inositol is also involved in many
biochemical and signaling pathways including synthesis of inositol-containing
phospholipids and as a component of the secondary messenger system, the
phosphoinositide pathway125, which has been shown to be activated immediately following
experimental rodent TBI126. Myo-inositol has resonances at 3.52, 3.61, and 4.05 ppm, as
well as a resonance at 3.27 ppm that is obscured by the Cho resonance. An increase109 and
decrease127 in Myo/Cr has been reported 6 months post-concussion, as well as elevated
Myo in retired athletes116,118.
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1
Table
1.1:
ofMRS
Hvisible
MRSmetabolites
visible metabolites
Table
1.1:Summary
Summary of 1H

Metabolite
N -acetyl aspartate (NAA)

Choline (Cho)
Glycerophosphocholine
(GPC), Phosphocholine (PC)
and a small amount of
choline itself

Function
Marker of neuronal health and integrity
(Bittsansky et al., 2012 )
Storage substance for acetyl-CoA and
aspartate, regulator of protein
synthesis, source of acetyl group for
lipid synthesis, catabolic product of
NAAG, and osmolyte (Moffett and
Namboodiri 2006 )
Neurotransmitter synthesis
(acetylcholine), cell-membrane
signaling (phospholipids) and lipid
transport (lipoproteins)

Where it is synthesized
Synthesized in the mitochondria of Neurons
(Bittsansky et al., 2012 )
Exogenous sources of NAA do not cross the
blood brain barrier, but NAA can be exported
out of the brain via astrocytes (can be
detected in blood and urine) (Karaman et al.,
2011; Prokesch et al., 2016 )

Relevance to Concussion
Is a sensitive tool to assess irreversible and
temporary neuronal damage. (Bittsansky
et al., 2012 )

Other Notes
Studies of diseases in which there is a loss of neurons or
axons (infarctions, brain tumors, multiple sclerosis)
confirm a decrease in NAA (Barker and Lin 2006 ).

Has been found to decrease after several
studies of concussion (see Table 1.2 )

Decreases in NAA also reflect neuronal dysfunction,
which can be reversible, opposed to neuronal death
(Bittsansky et al., 2012 )

Essential Nutrient; can be acquired from diet
(crosses blood brain barrier) and de novo
synthesis from phosphatidylethanolamine

Can detect changes in memrane turnover
rate, such as demyelination after injury
(Davie et al., 1993)
Elevated levels have been found in retired
athletes with a history of concussion (see
Table 1.2 )

Active demyelination causes an increase in tCho (Davie
et al., 1993 ); likely due to the degradation of myelin
phospholipids to GPC, or as a result of inflammation
(Brenner et al., 1993 ).

May be sensitive to energy supply and
Since creatine is synthesized in the liver, its brain
demand mismatch seen after a concussive concentration would decrease during liver damage
injury
(Barker and Lin 2006 ).

Major fate of choline is conversion to
phosphatidylcholine, the predominant
phospholipid in cell membranes (Zeisel
et al., 2009)

Creatine (Cr)
Creatine and
Phosphocreatine

Phosphorylated to phosphocreatine
which can be used as energy storage
and can create ATP from ADP without
oxygen consumption (Bittsansky et al.,
2012 )

Synthesized in Liver and transported to the
brain (Bittsansky et al., 2012 )

Glutamate (Glu)

Is an excitatory neurotransmitter
Up to 90% of neurons excrete
glutamate during their excitation.
(Bittsansky et al., 2012 )

Synthesized predominantly from glutamine,
Could detect changes in the glutamatebut also from TCA cycle intermediates (Purves glutamine cycle, as a result of altered
et al., 2012 )
neurotransmission

Glutamine (Gln)

Most abundant amino acid in the CNS. Synthesized in astrocytes from glutamate and Could detect changes in the glutamateServes as a precursor to glutamate and ammonia (Albrecht et al., 2019 )
glutamine cycle, as a result of altered
as energy fuel (Albrecht et al., 2019 )
neurotransmission

GABA

Main inhibitory neurotransmitter in the Synthesized predominantly from glutamate,
brain (Purves et al., 2012 )
but can also be synthesized from glutamine
and pyruvate (Purves et al., 2012 )

Myo -Inositol (Myo)

Glial marker, osmolyte, synthesis of
inositol-containing phospholipids, and
component of phosphoinositide
pathway (Kim et al., 2005 )

Increased GABA/Cr has been observed 2
Studies investigating GABA after concussion tend to
weeks post-concussion in the frontal
specifically use MEGA-PRESS (see Table 1.2 )
region of the brain (Friedman et al., 2017 )

Synthesized in brain de novo from glucose-6- Believed to represent glial proliferation
phosphate and transported from blood (Kim et (Harris et al., 2012 )
al., 2005 )
Phosphoinositide pathways have been
implicated in TBI studies (Lyeth et al.,
1996; Chen et al., 2012 )
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Most studies to date do not differentiate between
glutamate and glutamine, but instead report the sum of
these metabolites as Glx
At 3 T, glutamate and glutamine can be reliably
separated (Provencher 1993; Srinivasan et al., 2005)

Primary source of myo -insoitol in neurons is from
recycling of phosphoinositide pathway constituents (Kim
et al., 2005 )

Table
1.2: Review of MRS in Sport Concussions
Table 1.2: Review of MRS in Sport Concussions
Lab
London, UK

ROI
Right Lentiform Nucleus

Type of MRS
1.5 T STEAM (TR/TE/TM =
2270/270/12 ms)

Study Designs
Followed Ex-Boxers with Parkinsonian syndrome
(n=3), idiopathic Parkinson's Disease (n=6), Age
Matched Controls (n=6)
Catania and Rome, Italy WM of Frontal Lobes (Bilateral) 3 T PRESS (TR/TE = 2000/144 Mixed Concussed Athletes (n=13) scanned at 3, 15
ms)
and 30 DPI were compared to age-matched control
*Vagnozzi et al. 2010 used 1.5 volunteers (not specified as athletes or not)
and 3 T (one centre used CSI
Concussed Athletes (n=40) scanned at 3, 15, 22, and
with TE = 135 ms instead)
30 DPI, and heathy control subjects (n=30)

Concussed Athletes (n=11) sanned at 3, 15, 30, 45
DPI, and healthy control subjects (n=11)

Montreal, Canada

Bilateral DLPFC, Hippocampus, 3 T PRESS (TR/TE = 1500/30
M1
ms)
Bilateral DLPFC and M1

Corpus Callosum

Bilateral DLPFC, M1,
Hippocampus
Dominant M1

Pennsylvania, USA

Corpus Callosum

Ohio, USA

Anterior cingulate gyrucs, Left
DLPFC and Thalamus
Corpus Callosum and Parietal
WM

Loma Linda, California

Main Finding
↓ [NAA] in ex-boxers vs.
Controls

References
Davie et al. 1995 J of Neurology,
Neurosurgery, and Psychiatry

M/F

Mixed; Skiing, soccer,
kickboxing, rugby

↓ NAA/Cr at 3 and 15 DPI
Compared to controls

Vagnozzi et al. 2008 Neurosurgery

M/F

Mixed; soccer, rugby,
horse riding, boxing,
basketball, kickboxing,
skiing, bike riding

↓ NAA/Cr and /Cho at 3 and Vagnozzi et al. 2010 Brain
15 DPI Compared to controls
*Values did not differ across
MRI centres

M/F

Mixed; Soccer, Skiing,
Boxing, Baskteball,
Rugby, Kickboxing

↑NAA/Cr at 3 and 15 DPI;
Vagnozzi et al. 2013 J Head Trauma Rehabil
↓NAA/Cr at 30 DPI;
↓NAA/Cho at 3, 15, 30 DPI;
↑Cho/Cr 3, 15 DPI
↓Glu/Cr and NAA/Cr 1-6 DPI Henry et al. 2010 J Neurotrauma

Concussed (n=12) to non-concussed (n=12) athletes M
scanned 1-6 DPI
Concussed football players (n=10) and non-concussed M
(n=10) athletes scanned 1-6 DPI and at 6-months

Mixed
American Football

Varsity Hockey

↓Glu/Cr (M1) , NAA/Cr
Henry et al. 2011 BMC Neurology
(M1&DLPFC) 1-6 DPI
↑Myo/Cr (M1)
↓NAA/Cr in non-concussed Chamard et al. 2012 Neurosurg Focus
female athletes Post-Season

Mixed

↓Myo/Cr Hippocampus and Chamard et al. 2013 Brain Injury
M1 (7 Months)

Mixed

↓Glu; Concussed group had De Beaumont et al. 2013 BMC Neurology
exacerbated declines in Glu
compared to control
↑Myo , ↓Cho (L MTL)
Tremblay e al. 2013 Cerebral Cortex
↑Cho (R PFC)

Former athletes who sustained their last sports
M
concussion >3 decades (n=15) prior to testing were
compared with those with no history of TBI (n=15)
Female concussed athletes (n=11) and female
F
control athletes (n=10) were scanned 7-10 DPI and at
6 months

Hockey or Football

Mixed

↑Glx/Cr in concussed 6
Chamard et al. 2014 J Neurotrauma
months in DLPFC (trend) and
M1
↓NAA/Cr 6 months in
controls athletes

3 T MEGA-PRESS (Edit off
spectra summed to look at
other metabolites)
3 T MEGA-PRESS, TE=68 ms
(Edit off spectra summed to
look at other metabolites)
3D CSI (TR/TE=1510/135 ms;
NA=1)

Football players with a concussion history (n=16) and M
football players without (n=14) were scanned at a
single session
Nonathletes (n=24), contact athletes (n=24), nonM/F
contact athletes (n=24) came in for a single session

Football

No changes but GABA and
Tremblay et al. 2014 Clin Neurophysiol
Glx not correlated in
experimental group
↑Myo in contact (M1) ↓Glx Lefebvre et al. 2018 J Neurotrauma
in contact (DLPFC)

3 T PRESS (TR/TE=3000/144
ms)
3 T MRSI 9 x 8 x 6 cm volume
covering corpus callosum and
midbrain; PRESS
(TR/TE=1700/144 ms, NA = 1)

Concussed pediatrics subjects and control group (not M/F
specified as athletes)
Concussed pediatric subjects (n = 15) and control
M/F
group (n = 15, not specified if athletes)

Bilateral DLPFC, M1,
Hippocampus

Left M1 and PFC

Sport
Ex-Boxers

*Chamard 2012 used TE=35 ms Hockey players were scanned pre- and postseason; M/F
concussed athletes were scanned 72hrs, 2 weeks and
2 months post injury
Female athletes with concussion (n=10) and control F
female athletes (n=10) were scanned 7 months postconcussion
De Beaumont 2013 used
Former university-level athletes (ages 51-75) with
M
TR=1200 ms
and without a history of concussion

Bilateral PFC and MTL

Left M1

Sex
M

Concussed Athletes (n=28) and athletes with no
history of concussion (n=20) were scanned with a
week to 3 weeks of injury (were scanned 1, 2 or >3
weeks post injury)

M/F

Contact (Rugby,
Soccer); Non-contact
(Swimming)
Mixed

Mixed; soccer, footbal,
wrestling
Mixed; soccer, football,
softball

↓NAA/Cr and /Cho in genu Johnson et al. 2012 J Neurotrauma
(Greatest alterations
observed in those recovering
from 1st concussion)
no changes in NAA at any of Maugans et al. 2012 Pediatrics
the time points in any ROIs
↓NAA/Cr and /Cho in corpus Bartnik-Olson et al. 2014 J Neurotrauma
callosum and in parietal WM
region

DPI, days post injury; DLPFC, dorsolateral prefrontal cortex; M1, motr cortex; PFC, prefrontal cortex; MTL, medial temporal lobe; AC, anterior commissure; PC, posterior commisure; PCG,
posterior cingulate gyrus; ACG, anterior cingulate gyrus
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Table 1.2: Review of MRS in Sport Concussions Continued
Table 1.2: Review of MRS in Sport Concussions Continued
Lab
Indiana, USA

ROI
DLPFC, M1

Type of MRS
Study Designs
Sex
3 T PRESS (TR/TE=1500/30 ms) Contact (n=34) and non-contact (n=10) athletes were M
scanned prior to and during their active season

Sport
Contact (High School
Football); Non-contact
(swimming, track and
field, tennis)
Collision (Male
Football, Female
Soccer);
Non-contact (crosscountry, swimming,
track and field,
basketball, softball)

Main Finding
↑Myo (DLPFC), Glx and Cr
(M1) in contact at baseline;
↓Glx and Cho (M1), Cr
(DLPFC & M1)
Males:
↓Glx/Cr, ↑Cho/Cr (DLPFC)
during season
Females:
↑Glx/Cr (M1) in season and
post-season

References
Poole et al. 2014 and 2015 Developmental
Neuropsychology

M

Mixed Martial Arts
Fighters

↓NAA at 1 year follow up

Mayer et al. 2015 J Neurotrauma

M

Football

↑Cho, Glx, Phenylalanine,
Fucose

Lin et al. 2015 Alzheimer's Research &
Therapy

M

Soccer

↑Cho/Cr, Myo/Cr

Koerte et al. 2015 J Neurotrauma

M/F

Varsity Hockey

↓NAA (M/F), ↓Cho (M/F
trend)

Panchal et al. 2018 Frontier in Neurolgy

M

NFL Football

↓NAA (PWM)

M/F

Physical education,
↑GABA/Cr (Frontal),
weight lifting, football, ↓GABA/Cr (PCG, trend)
soccer, lacrosse,
ultimate frisbee,
skateboarding

Alosco et al. 2019 Brain Imaging and
Behavior
Friedman et al. 2017 American Academy of
Neurology

Collision athletes were scanned at pre-season, twice M/F
during the season, and at post-season (4-8 weeks)
and 20-24 weeks post-season; Non-contact athletes
were scanned twice during their season, 5-18 weeks
apart

New Mexico, USA

Above Lateral Ventricles,
Parallel to AC&PC

Boston, USA

PCG

Corpus Callosum (Splenium)

3 T PRESS (TR/TE=1500/40 ms) MMA Fighters were scanned in season and at a 1
year follow up; Healthy controls were scanned in
season and at 3-6 months follow up
3 T L-COSY
Former NFL athletes (n=5) and male healthy controls
(professionals with no history of concussion, n=5)
were examined
3 T PRESS (TR/TE=2000/30 ms) Retired soccer players (no history of concussion)
were examined in comparison to age matched
controls (non-contact)
3T PRESS (TR/TE=2000/35 ms) Pre- and post-season scans of male and female
(Same Dataset at Chamard et varsity ice hocey athletes
al. 2012)
3T PRESS (TR/TE=2000/35 ms) Retired NFL Players, symptomatic vs asymptomatic

Seattle, USA

ACG and PCG, Left Parietal WM
PCG, Frontal Lobe
3 T MEGA-PRESS, TE=68 ms

Newcastle, Australia

PCG, Parietal WM

Toronto, Canada

London, Canada

Pediatric sport concussion compared to healthy
controls (admitted to emergency for non-head
related injuries)

Bari et al. 2018 Brain Imaging and Behavior

3 T PRESS (TR/TE=2000/40 ms) Retired Rugby Players and Matched Controls (No
M
Rugby
↓Glutathione (PCG)
Gardner et al. 2017 Int J Sports Med
History of contact play or concussion)
Left and Right Motor Cortex
3 T STEAM (TR/TE/TM =
Non-contact, contact, and collision athletes recruited M/F
Mixed
↓NAA/Cr in collision
Churchill et al. 2017 Frontiers in Neurology
(Values averged together)
2000/30/10 ms)
from varsity teams (n = 65) were scanned during
compared to non-contact
preseason
Prefrontal White Matter
3 T PRESS (TR/TE=2000/135
Concussed Hockey players recruited from the banting M
Hockey
↓Cho 3 months after
Manning et al. 2017 Neuroloy
ms)
division (n = 17) were scanned 24-72 hours and 3
concussion compared to
months post-concussion, compared to non-concussed
controls
hockey players (n=26)
DPI, days post injury; DLPFC, dorsolateral prefrontal cortex; M1, motr cortex; PFC, prefrontal cortex; MTL, medial temporal lobe; AC, anterior commissure; PC, posterior commisure; PCG,
posterior cingulate gyrus; ACG, anterior cingulate gyrus
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TableTable
1.3:
ofTimepoints
MRS Timepoints
in Sport Concussions
1.3: Review
Review of MRS
in Sport Concussions
Reference
Davie et al. 1995 J of Neurology,
Neurosurgery, and Psychiatry
Vagnozzi et al. 2008 Neurosurgery

In Seaon
-

NonConcussed Group / Control Group
During
Off Season
Retired
Non Athletes
IPD and Age matched

-

-

-

-

Vagnozzi et al. 2010 Brain

-

-

-

-

Vagnozzi et al. 2013 J Head Trauma
Rehabil

-

-

-

-

Henry et al. 2010 J Neurotrauma

-

No History of
Concussion

-

Henry et al. 2011 BMC Neurology

-

Nonconcussed
Athletes

Pre-Season

-

Chamard et al. 2013 Brain Injury

-

Female Athlete
Control Group

De Beaumont et al. 2013 BMC
Neurology
Tremblay e al. 2013 Cerebral Cortex

-

Baseline
-

24-72 Hours
-

"Control
Volunteers"
"Control
Volunteers"
"Control
Volunteers"

-

-

-

-

(18 months
later)

-

-

-

↓NAA/Cr
(Females)
Post-Season
-

-

-

Pre-Season

-

-

-

-

-

-

-

-

-

-

-

Mixed
Athletes
No History of
TBI

-

Chamard et al. 2014 J Neurotrauma

-

↓NAA/Cr (2nd
scan; 6 months)

-

-

Tremblay et al. 2014 Clin Neurophysiol

-

-

Lefebvre et al. 2018 J Neurotrauma

-

Johnson et al. 2012 J Neurotrauma

-

Glx and GABA do
not correlate in
experimental
group
↑Myo in contact
(M1)
↓Glx in contact
(DLPFC)
Normal Volunteer
Student-Athletes
with no mTBI
History

Maugans et al. 2012 Pediatrics

-

Bartnik-Olson et al. 2014 J
Neurotrauma

-

Chamard et al. 2012 Neurosurg Focus

2 Weeks
-

3 Months
-

6 Months
-

Retired
↓[NAA]

(30 DPI)

-

-

-

-

(22 and 30
DPI)
↑NAA/Cr,
Cho/Cr
(30 DPI)

-

-

-

-

(45 DPI)

-

-

-

-

-

-

-

-

-

-

-

↑Myo/Cr
(M1)

-

-

(2 months)

-

-

-

-

-

-

-

↓Myo/Cr
(M1 and
Hippo)
(7 Months)

-

-

-

-

-

-

-

↓Glu

-

-

-

-

-

-

-

-

-

-

(9 DPI)

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-athletes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

"Healthy
Controls"

-

(24-72
Hours)

(2 Weeks)

-

-

-

-

-

-

"Healthy
Controls"

-

-

-

-

↓NAA/Cr
↓NAA/Cr
(3 DPI)
(15 DPI)
↓NAA/Cr
↓NAA/Cr
(3 DPI)
(15 DPI)
↑NAA/Cr,
↑NAA/Cr,
Cho/Cr
Cho/Cr
↓NAA/Cho ↓NAA/Cho
(3 DPI)
(15 DPI)
↓Glu/Cr (M1),
↓NAA/Cr (M1&DLPFC)
(1-6 DPI)
↓Glu/Cr (M1),
↓NAA/Cr (M1&DLPFC)
(1-6 DPI)
(72 Hours)
(2 weeks)

Concussed Group
1 Month
2 Months
-

↓NAA/Cr, /Cho
(1-3 Weeks Post Injury)

(1 Month or Greater)
-

↑Myo , ↓Cho
(L MTL)
↑Cho (R PFC)
↑Glx/Cr to 9
DPI
(6 months)
-

↓NAA/Cr, /Cho
(2-12 months post-injury)

IPD, idiopathic parkinson' disease; DPI, days post injury; Hippo, hippocampus; DLPFC, dorsolateral prefrontal cortex; M1, motr cortex; PFC, prefrontal cortex; MTL, medial temporal lobe; AC, anterior commissure; PC, posterior
commisure; PCG, posterior cingulate gyrus; ACG, anterior cingulate gyrus; F, female; M, male
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Table 1.3: Review of MRS Timepoints in Sport Concussions Continued
Table 1.3: Review of MRS Timepoints in Sport Concussions Continued

Reference
Poole et al. 2014 and 2015
Developmental Neuropsychology

NonConcussed Group / Control Group
In Seaon
During
Off Season
Retired
↑Myo
↓Glx and Cho
(DLPFC), Glx (M1), Cr (DLPFC &
and Cr (M1) in
M1)
contact

Bari et al. 2018 Brain Imaging and
Behavior

Pre-Season

Mayer et al. 2015 J Neurotrauma

Baseline

Non Athletes
-

Baseline
-

24-72 Hours
-

2 Weeks
-

Concussed Group
1 Month
2 Months
-

3 Months
-

6 Months
-

Retired
-

↓Glx/Cr, ↑Cho/Cr ↑Glx/Cr (F,
(M, DLPFC)
M1)
↑Glx/Cr (F, M1)

-

-

-

-

-

-

-

-

-

-

-

-

Healthy Controls
(no changes)

-

-

-

-

-

-

-

-

-

-

Healthy Controls
(No History of
concussion)

-

-

-

-

-

-

-

↑Cho, Glx

Lin et al. 2015 Alzheimer's Research &
Therapy

-

↓NAA (2 Scans, 1
year apart) from
baseline
-

Koerte et al. 2015 J Neurotrauma

-

-

-

-

Retired (NonContact)

-

-

-

-

-

-

-

↑Cho/Cr,
Myo/Cr

Pre-Season

-

↓NAA
(M/F), ↓Cho
(M/F trend)

-

-

-

-

-

-

-

-

-

-

Alosco et al. 2019 Brain Imaging and
Behavior

-

-

-

-

-

-

-

-

-

-

-

↓NAA (PWM)

Friedman et al. 2017 American
Academy of Neurology

-

-

-

-

Asymptomatic
Retired NFL
Players
Admitted to
emerg for nonhead related
injuries

-

-

↑GABA/Cr
(Frontal),
↓GABA/Cr
(PCG, trend)
(12 DPI)

-

-

-

-

-

Gardner et al. 2017 Int J Sports Med

-

-

-

-

-

-

-

-

-

-

-

↓Glutathione
(PCG)

↓NAA/Cr in
collision vs noncontact
-

-

-

-

No History of
contact play or
concussion
-

-

-

-

-

-

-

-

-

Male Hockey
Control Group

-

-

-

-

(24-72 hrs
DPI)

-

-

-

↓Cho

-

-

Panchal et al. 2018 Frontier in
Neurolgy

Churchill et al. 2017 Frontiers in
Neurology
Manning et al. 2017 Neuroloy

IPD, idiopathic parkinson' disease; DPI, days post injury; Hippo, hippocampus; DLPFC, dorsolateral prefrontal cortex; M1, motr cortex; PFC, prefrontal cortex; MTL, medial temporal lobe; AC, anterior commissure; PC, posterior
commisure; PCG, posterior cingulate gyrus; ACG, anterior cingulate gyrus; F, female; M, male
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The spectroscopy acquired from mice in this thesis (Chapter 4) additionally quantifies
taurine (Tau), lactate (Lac), and glutathione (GSH). Tables 1.4, 1.5, and 1.6 highlight
single and repetitive closed head impact MRS findings from the literature, as well as the
timing of these findings. The exact function of taurine is not known but it has been
proposed to be an osmoregulator, play a role in modulating neurotransmission94, and cell
volume regulation128. Taurine has two triplets at 3.25 and 3.42 ppm, with the former
overlapping with the total choline peak94. Animal models have found elevated Tau129, and
reduced Tau/Cr128. Lactate is the end product of anaerobic glycolysis94, and has been
shown to increase in more severe cases of TBI, due to hypoxic/ischemic conditions130,131.
The lactate signal gives rise to a doublet resonance at 1.31 ppm and a quartet at 4.10
ppm94. Finally, glutathione is an antioxidant that is primarily located in astrocytes and its
singlet at 3.77 ppm overlaps with glutamate. Reduced GSH has been observed in retired
athletes with a history of concussion132.
Moreover, Pascual et al. (2007)129 observed elevated Tau, Glu, GABA, NAA,
Myo, and Cr after injury using a weight drop model. Although, this study had a high
mortality rate, indicating more severe injury than concussion. However, a later study by
Singh et al. (2017)130 also found elevated Glu, Myo, and Cr in a milder weight drop model.
Additionally, Singh et al. (2017)130 and Lyons et al. (2018)133 both observed reduced NAA,
Cr, and Cho, while only Singh et al. (2017) found reduced Gln and GABA. Another study
found reduced Tau/Cr128, and reduced NAA/Cr107 in male rats after using a weight drop
model. Moreover, even fewer studies to date have investigated the effects of repeated head
injury134,135. Therefore, investigating concussion or the effects of repetitive impacts with
MRS in animal models, remains relatively unexplored. Investigating repetitive CHI will
help to delineate how the timing between impact and concussion history may affect an
individual’s metabolic profile.
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Table
1.4:Review
Review
of Single
and Repetitive
Closed
Impact MRS Studies
Table 1.4:
of Single
and Repetitive
Closed Head
ImpactHead
MRS Studies
Single:

Reference
Pascual et al. (2007)
J Neurotruma

ROI
Whole Brain, ex vivo

MRS / Study Design
Divided rats into sham, 4 hours, 1, 2,
and 3 Days post impact
8.4 T, ex vivo NMR

Signoretti et al. (2009)
Mol Cell Biochem

Whole Brain, ex vivo

Using HPLC* at 2, 6, 24, 48, and 120
M, Rats
hours post mTBI (n=6 in each group),
compared to sham control
(*High-performance liquid
chromatograhy on deproteinized whole
brain extracts)

Weight Drop Model
↓ Cr and NAA at 2, 6, 24, and 48 hours in
450g/1m
mTBI group
Impact: Central portion of the
skull

Schnieder et al. (2015)
J Neurotrauma

Tissue Punches, ex
vivo
(PFC, Hippocampus,
Amygdala)

Divded mice into sham or mTBI groups M, Mice
and were sacrificed before (naïve) or
after a fear conditioning paradigm
MRS: 11.7 T High-resolution magic
angle spinning MRS

Closed Head Impactor
(5mm diameter tip; 5 m/s, 1
mm depth, 100 ms dwell
time)
Impact: Midpoint between
lambda and bregma

↑GABA/Cr in PFC at days 8 in mTBI
↓GABA/Cr in dorsal hippocampus and
↑Glu/Cr in ventral hippocampus at 25days
Changes may be reflective of dysregulated
excitatory and inhibitory neurotransmission
(overlearning of conditioned fear and
delayed extinction)

Singh et al. (2016)
NMR in Biomedicine

Cortex
(1.7 x 4 x 3 mm)
Hippocampus
(2 x 4 x 3 mm)

Divided rats into sham, mTBI + repeat
anesthesia, and mTBI no anesthesia
MRS: 7 T PRESS (TR/TE=2500/20 ms,
NA=512)

M, Rats

Weight Drop Model
450g/25cm
Impact: Sagittal midway of
brain

↓Tau/Cr in cortex 5 days post mTBI with or
without anesthesia compared to control.
↓Glu/Cr in Injury combined with anesthesia
in rat cortex

Singh et al. (2017)
NMR in Biomedicine

Hippocampus
(2 x 4 x 3 mm)

Divided rats into mild and moderate
injuries (baseline imaging) for in vivo
MRS: same as Singh et al. 2016
(Also divided another group of rats in
control, mild and moderate for in vitro
MRS)

M, Rats

Weight Drop Model
450g/25cm (mild) and
450g/50cm (moderate)
Impact: Sagittal midway of
brain

↑Cho, Myo (Hippo) in moderate injury, no
changes in mTBI using in vivo MRS (several
changes observed using in vitro, see Table
1.5 )

Lyons et al. (2018)
J Neurotrauma

Bilateral dorsal
hippocampus
(2 x 5.23 x 1.2 mm)

Divided mice into sham, 3 and 28 days
post injury
MRS: 7 T PRESS (TR/TE=1500/135 ms,
NA=400); 2nd experiment used LASER
(TR/TE=2500/21 ms, NA=200)

M/F Mice

Closed Head Impactor (5mm
flat steel tip; 5m/s, 1mm
depth, 100 ms dwell time)
Impact: Midline impact
(mediolateral 0mm,
anteroposterior 1.5mm)

↓NAA, Cr, Cho at 3 Day post injury
compared to sham

ROI
Whole Brain, ex vivo

MRS / Study Design
2 Repetitive impacts at 3 or 5 days
apart (Group 1 and 2), single mild
(Group 3), single severe (Group 4) and
sham (Group 5)
(Using HPLC)

Sex, Animal
M, Rats

Impact
Weight Drop Model
450g/1m (mild);
450g/2m (severe)
Impact: Midline between
bregma and lambda

Main Finding
↓NAA in all groups compared to sham
(Reductions in 3-rmTBI and severe TBI were
lower than sham mild/5day)

Hippocampi
(2 x 2 x 2 mm)

Divided rat into sham, single mTBI, and M, Rats
rmTBI
7 T, PRESS (TR/TE=1800/40ms,
NA=576)

Closed Head Impactor Model:
4 ms, 1 mm depth, 50 ms
duration
Impact: 1.8mm caudal to
bregma, 3mm left of midline

rmTBI Group:
↓NAA/Cr (contra. & ips.; vs sham & mTBI),
↓Cho/Cr & Lip/Cr (ips.) ↑Myo/Cr (contra. &
ips.)
mTBI Group:
↓NAA/Cr (ips.), ↑Myo/Cr (contra. & ips.)

Repetitive: Reference
Vagnozzi et al. (2005)
Neurosurgery

Fidan et al. (2018)
ASN Neuro

Sex, Animal
M, Rats

Impact
Weight Drop Model
450g/2m
(High Mortality Rate)

Main Finding
3 Time course Patterns:
(1) ↑Tau, Threonine, Gly at 24hrs
(2) ↑Glu, GABA, Ala 24-48 hrs,
(3) ↑NAA, Myo, Cr at 48 hrs

Tau, taurine; Gly, glycine; Glu, glutamate; Ala, alanine; NAA, N-acetyl aspartate; Myo, myo-inositol; Cr, creatine; mTBI, mild traumatic brain injury; rmTBI, repeated mTBI; PFC, prefrontal cortex; Hippo,
hippocampus; contra, contralateral; ips, ipsilateral
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Table 1.5: MRS Imaging Timepoints in Single Closed Head Injuries

Table 1.5: MRS Imaging Timepoints in Single Closed Head Injuries
Reference
Pascual et al. (2007)
J Neurotruma

Groups
Sham (n=4)

Imaging Timepoints
2 Days
3 Days
-

Before CHI
-

2 Hours
-

3 Hours
-

4 Hours
-

1 Day
-

5 Days
-

1 Week
-

2 Weeks
-

1 Month
-

-

-

-

(9 Hours)

↑Tau,Thr,
Gly, Glu,
GABA, Ala

↑Glu,
GABA, Ala,
NAA, Myo,
Cr

(3 days)

-

-

-

-

Signoretti et al. (2009) Sham (n=6)
Mol Cell Biochem

-

-

-

-

(Sacrificed)

-

-

-

-

-

-

Head Injured (n=6 at
each time)
Schnieder et al. (2015) Sham (n=12/10)
J Neurotrauma

-

↓NAA, Cr

-

-

-

-

↓NAA, Cr
(6 Hours)
-

↓NAA, Cr

↓NAA, Cr

-

(120 Hours)

-

-

-

-

-

-

-

Head Injured (n =
10/6)

-

-

-

-

-

-

-

-

Sham Anesthesia
(n=7)
mTBI + Anesthesia
(n=7)
mTBI Only
(n=7)
in vivo mTBI

/

-

-

/

/

-

/

/

-

-

-

/

-

-

/

/

-

/

-

-

-

-

-

-

-

-

-

-

-

-

-

Yes

-

-

(4 Hours)

(Day 1)

-

-

↓Tau/Cr
(Cortex)
↓Tau/Cr
(Cortex)
(Day 5)

-

-

-

in vivo moTBI

Yes

-

-

(4 Hours)

(Day 1)

-

-

-

-

-

in vitro sham

-

-

-

-

-

-

-

↑Cho, Myo
(Hippo)
-

-

-

-

in vitro mTBI

-

-

-

↓BCAA,
Gln ↑Cr,
Glu, Myo,
Tau

↓BCAA,
Gln, Succ
↑Cr, Glu,
Myo, Tau

-

-

↓BCAA,
Gln, Suc

-

-

-

in vitro moTBI

-

-

-

↓NAA,
Succ
↑Acetate

↓BCAA,
NAA, Succ,
Glu
↑Myo,
GABA

-

-

↓BCAA,
GABA
↑Cr, Glu,
Myo, Tau,
Lac

-

-

-

Sham (n=13)

-

-

-

-

-

-

-

-

-

-

-

mTBI (n=15)

-

-

-

-

-

-

↓NAA, Cr,
Cho

-

-

-

(28 Days)

Head Injured (n=4 at
each time)

Singh et al. (2016)
NMR in Biomedicine

Singh et al. (2017)
NMR in Biomedicine
(n=5 at each
timepoint)

Lyons et al. (2018)
J Neurotrauma

n=12
Fear
n=10
Sacrificed Conditionin Sacrificed
(Naïve)
g Days 1424
↑GABA/Cr
↓GABA/Cr in
in PFC
dhippo,
(Naïve)
↑Glu/Cr in
vhippo

/ Timing of sham, if specified in study
- Groups not assessed at this timepoint
Ala, alanine; BCAA, branched chain amino acids; CHI, closed head impact; Cho, choline; Cr, creatine; Gln, glutamine; Glu, glutamate; Gly, glycine; dhippo, dorsal
hippocampus; vhippo, ventral hippocampus; mTBI, mild traumatic brain injury; moTBI, moderate TBI; Myo, myo -inositol; NAA, N -acetyl aspartate; PFC, prefrontal
cortex; Tau, taurine; Thr, theronine
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Table 1.6:
MRS
Timepoints
in Repetitive
ClosedClosed
Head Injuries
Table
1.5:Imaging
MRS Imaging
Timepoints
in Single
Head Injuries Continued
Reference
Vagnozzi et al.
(2005)
Neurosurgery

Fidan et al.
(2018)
ASN Neuro

Groups
Sham
(n=6)

Day 0
/

Day 1

Hit Paradigm
Day 2
Day 3
/

Day 4

Day 5

Before CHI
-

Imaging Paradigm
2 Days
(2 Days)

1 Week
-

Single Mild
(n=6)
Single Severe
(n=6)

-

↓NAA

-

-

-

rmTBI 3
(n=6)

-

rmTBI 5
(n=6)
Sham
(n=8)

-

↓NAA
(to sham and
mild/5day)
↓NAA
(to sham and
mild/5day)
↓NAA

-

-

-

-

-

-

-

↓NAA/Cr (ips.),
↑Myo/Cr (contra. &
ips.)
↓NAA/Cr (contra. &
ips.; vs sham & mTBI),
↓Cho/Cr & Lip/Cr
(ips.)
↑Myo/Cr (contra. &
ips.)

mTBI
(n=9)

/

/

/

/

/

rmTBI
(n=10)

-

-

/ Timing of sham, if specified in study
Timing of closed head impacts
contra, contralateral; Cho, choline; Cr, creatine; ips, ipsilateral; Lip, lipids; Myo, myo -inositol; NAA, N -acetyl aspartate; rmTBI, repeated mild traumatic
brain injury
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1.5.6 Animal Models of TBI and Concussion
As previously discussed, the effect of concussion on the brain has been largely studied
using MRS in athletes participating in contact sports, and various changes in metabolites
have been observed. The large variability in metabolite findings across the literature is
likely due to the heterogeneous nature of concussion (e.g. impact site, force of impact,
timing of imaging post impact, concussion history, sex, diet, etc.)136. Animal models can be
utilized to minimize many confounding variables, allowing exploration of the mechanisms
and relevance of specific metabolite changes after concussion137.
To date, the majority of MRS animal models have studied moderate to severe
traumatic brain injuries using fluid percussion injury138–140, controlled cortical impact141–
144

, or blast injuries145,146, rather than mild TBI or concussion. Few animal studies to date

have investigated a closed head impact (CHI) model of concussion, and these are
summarized in Table 1.4 and Table 1.5. The majority of these single CHIs have used a
weight drop model of 450g107,128–130 with drop heights from 25-100 cm characterized as
mild injuries, and >100 cm as moderate to severe, with high mortality rates. Closed-head
controlled cortical impact models have also been used with 5mm diameter tips at 5-4 m/s at
a depth of 1 mm being characterized as mild133,134,147.

1.6

Thesis overview and objectives

This introductory chapter provided an overview of concussion and the human brain,
including the neurometabolic cascade of events that occur at the molecular level following
a concussion. Next, the main principles of in-vivo magnetic resonance spectroscopy were
provided, including the acquisition and data analysis, followed by descriptions of the
different brain metabolites measured by this technique, and their relevance in concussion.
The overall objective of this thesis was to use MRS to explore metabolite changes in the
prefrontal white matter of female contact athletes before and after concussion, then to
replicate these findings in an animal model of concussion, to position future studies to
probe the reasons for these changes, and how to use these changes as potential therapeutic
targets.
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Chapter 2 addresses the first objective by studying a team of female varsity rugby
athletes over 5 seasons, collecting data at the beginning and end of season, as well as 24-72
hours, 3 months, and 6 months post-concussion. This study found a reduction in glutamine
levels in female rugby athletes after concussion, and after a season of play.
Chapter 3 further explores the nature of this glutamine change by studying noncontact athletes and sedentary women, in comparison to contact athletes. This study
demonstrated that glutamine changes, among other metabolite changes, exist in contact
athletes likely as a result of the accumulation of sub-concussive impacts.
Chapter 4 translates these findings to an animal model that investigates metabolite
changes in mice after repeated head injury, and similarly finds changes glutamine that
suggest that the model used might be appropriate as a model of sub-concussive injury.
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Chapter 2

2

Reduced brain glutamine in female varsity rugby
athletes after concussion and in non-concussed
athletes after a season of play

Permission to reuse this article has been obtained. Please see Appendix B.
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Rugby Athletes after Concussion and in Non-Concussed Athletes after a Season of Play. Human Brain
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*Dr. Kathryn Y. Manning analyzed the DTI data and contributed to those written sections.

The purpose of this study was to use non-invasive proton magnetic resonance
spectroscopy (MRS) and diffusion tensor imaging (DTI) to monitor changes in prefrontal
white matter metabolite levels and tissue microstructure in female rugby players with and
without concussion (ages 18-23, n = 64). Evaluations including clinical tests and 3T
MRI were performed at the beginning of a season (in-season) and followed up at the end
of the season (off-season). Concussed athletes were additionally evaluated 24-72 hours
(n = 14), three months (n = 11), and six months (n = 8) post-concussion. Reduced
glutamine at 24-72 hours and three months post-concussion, and reduced
glutamine/creatine at three months post-concussion were observed. In non-concussed
athletes (n = 46) both glutamine and glutamine/creatine were lower in the off-season
compared to in-season. Within the MRS voxel, an increase in fractional anisotropy (FA)
and decrease in radial diffusivity (RD) were also observed in the non-concussed athletes,
and correlated with changes in glutamine and glutamine/creatine. Decreases in glutamine
and glutamine/creatine suggest reduced oxidative metabolism. Changes in FA and RD
may indicate neuroinflammation or re-myelination. The observed changes did not
correlate with clinical test scores suggesting these imaging metrics may be more sensitive
to brain injury and could aid in assessing recovery of brain injury from concussion.
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2.1 Introduction
A concussion is a brain injury caused by forces applied to the head or another part of the
body, causing the brain to experience rapid rotational and translational accelerations 1.
Momentum from such forces can cause axonal stretching, cell membrane disruption,
dysregulation in ion fluxes and uncontrolled neurotransmitter release 2,3ultimately leading
to mitochondrial oxidative dysfunction 4, inflammation and edema 5.
The National Collegiate Athletic Association Injury Surveillance Program has
reported the concussion rate among student-athletes in 25 different sports to be 4.47 per
10,000 Athlete-Exposures (defined as one athlete participating in one practice or
competition) overall, with some sports as high as 20 concussions per 10,000 Athlete
Exposures 6. It is likely that the true incidence is even higher as many concussions are not
reported 6. Although concussions can occur in many situations, including motor vehicle
accidents, domestic violence, and slips and falls, athletes participating in contact sports
have a high risk of sustaining a concussion due to the nature of the activity.
Currently, concussion diagnosis in sport is made clinically through assessment by
a physician 7 based on symptomatology, often with the aid of the Sport Concussion
Assessment Tool III (SCAT3) 8. Such assessments are limited since they rely on athletes
to voluntarily report symptoms that are often delayed. The difficulty in identifying when
a concussion is sustained during a sporting event, and making the decision to remove the
athlete from the event increases an athlete’s risk for sustaining multiple concussions in a
short period of time. Multiple concussions can induce second impact syndrome, which
has been associated with rapid brain swelling, herniation and, in severe cases, death 9.
Repetitive head trauma in sports may also be linked to chronic traumatic encephalopathy,
a neurodegenerative disease characterized by a specific distribution of phosphorylated tau
in the brain 10. Chronic traumatic encephalopathy has been found in individuals that have
sustained multiple concussions 10 as well as in individuals without a history of concussion
11

.
Axons are vulnerable to biomechanical stretching, which in concussion can lead

to undulations and beading 12. However, this diffuse axonal injury (DAI) is not easily
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discernable with conventional CT or MRI 12. Diffusion tensor imaging (DTI) provides a
means of detecting DAI 13. Along with DAI, a secondary chemical cascade of ion flux
and altered neurotransmission follows, which can result in mitochondrial dysfunction and
altered metabolism 13. These events have the potential to manifest as a decrease in Nacetyl aspartate (NAA), an amino acid marker of neuronal integrity and mitochondrial
function measured by proton (1H) magnetic resonance spectroscopy (MRS) 14. MRS can
also measure choline (Cho), creatine (Cr), glutamate (Glu), glutamine (Gln), and myoinositol (Myo). Metabolites such as glutamate and glutamine may also be altered
following concussion since both are involved in neurotransmission and oxidative
metabolism 15,16.
Over the past decade the effect of concussion on the brain has been studied by
MRS in athletes participating in various sports including football 17, boxing 18, hockey 19
and others 20,21. These studies have shown changes in metabolite levels (primarily
decreases in NAA/Cr) in multiple brain regions, in both white and grey matter. Brain
regions studied have included the motor cortex 22, dorsolateral prefrontal cortex 17,23,
corpus callosum 24, and the white matter of the frontal lobes 25. However, the majority of
previous studies were cross-sectional, comparing concussed groups to control groups
rather than longitudinally examining athletes prior to and after concussion. In addition,
control groups were often athletes from other contact sports. Interestingly, several recent
studies have reported metabolite changes in the brains of non-concussed athletes
participating in contact sports suggesting such athletes are not ideal controls. For
example, Chamard and colleagues (2012)26 found decreased NAA/Cr in the corpus
callosum in females without concussion after a season of hockey. Furthermore, Poole
and colleagues (2014)23 investigated changes in metabolite levels in grey matter in the
motor cortex and dorsolateral prefrontal cortex in high school football players without
concussions throughout a single season. Decreases in choline and creatine, and an
increase in the sum of glutamate and glutamine (Glx) were found in the motor cortex (1-3
months into the season). Decreases in creatine and myo-inositol were subsequently found
in the dorsolateral prefrontal cortex. These studies underscore the importance of utilizing
pre-concussion scans in athletes to better assess metabolic changes post-concussion.
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Additionally, most studies to date have focused on male athletes. Therefore,
studies in female athletes are urgently needed. The objective of the current prospective
cohort study was to measure changes in prefrontal white matter metabolite levels using a
rigorous MRS protocol in female varsity rugby players after a season of play and up to
six months following concussion. Based on previous literature, it was predicted that Nacetyl aspartate would decrease after a season of play in the non-concussed players.
Immediately post-concussion it was hypothesized that N-acetyl aspartate would decrease,
and partially recover by six months. It was also hypothesized that decreased N-acetyl
aspartate would be associated with altered tissue diffusion after concussion, but not after
a season of play in the non-concussed players. Additionally, it was predicted that
changes in the imaging measures would persists beyond clinical assessments.

2.2 Materials and Methods
2.2.1

Participants

This study was approved by the University of Western Ontario’s Health Sciences
Research Ethics Board. Informed consent was obtained from each player prior to the
start of each season. All participants in this study were university level athletes (21 ± 1.5
years old) recruited from a women’s varsity rugby team over the course of four seasons.
Forty-eight athletes participated in this study, 24 athletes played a single season, 14
played two consecutive seasons, nine played three consecutive seasons, and one played
two seasons, interspersed with a season of no play.
The rugby season ran from September to the end of October, with training
beginning at the end of August. August through September is referred to as the in-season
time point throughout the study, and January through March is referred to as the offseason. There was an average of 14.5 games in a full rugby season, with four contact
practices per week throughout the season. From October to April players continued to
participate in tournaments and a weekly practice. For the detailed training schedule from
August to April, please see Table 1. There were 20 documented concussions in 15
different athletes over the four seasons the team was followed. Only an athlete’s first
concussion was used in the analysis. Athletes were evaluated for a potential concussion
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when self-reporting symptoms, or symptoms were noticed by the trainers, and a similar
protocol for return to play was followed as outlined in McCrory et al. (2017)27.
Participants included in the non-concussed group were concussion free for at least 10
months prior to their in-season scan, and were not diagnosed with a concussion while
participating in this study. Participants with data from multiple seasons were treated as
separate data sets. Each athlete was evaluated at the beginning of the season (in-season),
and followed up at the end of season (off-season), after their last tournament (160 ± 39
days). Athletes that were concussed, and available to participate were additionally
evaluated 24-72 hours post-concussion, and then again at three and six months postconcussion. Not all concussed athletes attended their scheduled visits or were available to
participate at each follow-up time point if they had moved away. Please see
Supplementary Table 2.1 for the complete concussion timeline on these 15 athletes. Each
evaluation consisted of two clinical assessments, magnetic resonance imaging and MRS,
and blood collection (data to be reported elsewhere). In total, we acquired 63 spectra at
the beginning of season, 56 at the end of season (49 paired sets), 14 at 24-72hours postconcussion, 11 at three-months post-concussion, and eight at six-months post-concussion.
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Table 2.1: Rugby Players Training Schedule

August

September-October

November

December-April

Contact Practices

Weight Training

Light Practice

Games

1 session=2hrs

1 session=2hrs

2/day

Notes

-

-

3-4

4/week

1/week

-

1/week

Regular Season

-

-

-

1/day*

*National Championships (4 days)

1/week

3-4/week

3-4/week

1/month†

2-Week Pre-Season Training Camp

Contact practices focus on technical skill,
light contact compared to regular season
†

1 day tournament per month (January-

March)
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2.2.2

Clinical Scores

Two standard clinical tests were used in this study. The first was the Sport Concussion
Assessment Tool III (SCAT3)8. The SCAT3 is a standardized tool used for evaluating
injured athletes (age 13 and older) on the sidelines. For the complete SCAT3 tests and
procedures please see SCAT3 (2013). Briefly, it integrates the Glasgow coma scale
(GCS) with the Maddocks Score, and includes a brief cognitive and physical evaluation.
The GCS assesses an athlete’s visual, verbal, and motor responses on a 15-point scale,
with concussed individuals usually scoring around 14-15, and lower scores requiring
medical attention. The Maddocks score consists of five simple questions to assess shortterm memory. The cognitive and physical evaluation consists of questions to assess the
athlete’s orientation, concentration, balance and coordination, as well as short-term
memory. The SCAT3 also documents the athlete’s background information (medication,
concussion history, etc.), as well as scores 22 different symptoms the athlete may be
experiencing on a scale of 0 to 6, with a symptom severity score out of 132 (maximum
points multiplied by number of symptoms). The second clinical test employed was the
Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT)28. ImPACT is
a computerized concussion evaluation system used by clinicians, and consists of four
different sections. The first section asks for the athlete’s demographic information and
medical history. The second section records concussion history, current medication, and
rates 22 symptoms on a 7-point scale. The third section consists of neurocognitive tests
to evaluate the athlete, and the final section displays the athlete’s results. The results are
broken into six different composites, verbal memory, visual memory, processing speed,
reaction time, impulse control, and total symptoms.

2.2.3

Magnetic resonance imaging acquisition

Siemens 3 T Magnetom Tim Trio and Prisma Fit MRI Scanners (Erlangen, Germany),
both using a 32 channel head coil, were used for data acquisition. Anatomical images
were acquired using a sagittal T1-weighted magnetization-prepared rapid acquisition
gradient echo sequence (TE/TR=2.94/2300 ms, flip angle=9o, matrix size 256 x 256,
FOV=256 mm x 240 mm, number of slices=160, slice thickness=1.22 mm). A rapid T2-
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weighted FLAIR image was acquired to guide the placement of a 6 cm3 (2 cm x 2 cm x
1.5 cm) voxel in the prefrontal white matter region of the brain (Fig. 1A) for the
acquisition of the spectroscopy data (slices=50, TE/TR=139/15000 ms, slice thickness=3
mm, turbo factor=38, matrix size 256 x 256, FOV=256 mm, inversion time=2850 ms).
Water suppressed (number of acquisitions = 192) and unsuppressed (number of
acquisitions = 8) spectroscopy data were acquired using the PRESS (point resolved
spectroscopy) pulse sequence (TE/TR = 135/2000 ms, dwell time = 833 µs, number of
points = 1024). A long echo-time was chosen in the current study to reduce the error
associated with quantification of the macromolecule baseline at shorter echo times.
Improper quantification of the macromolecule baseline can greatly bias the measurement
of glutamate and glutamine. A spin-echo echo-planar diffusion tensor imaging sequence
(TE/TR = 79/7200 ms, matrix size = 98 x 98, FOV = 200 mm x 200 mm, number of
slices = 64, slice thickness = 2 mm, b1 = 0, b2 = 1000 s/mm2, gradient directions = 64,
IPAT acceleration factor = 3) was used to examine tissue microstructure.

2.2.4

Magnetic resonance spectroscopy analysis

Spectra were processed and analyzed as previously described 29,30. Spectra with a signal
to noise ratio (SNR) less than 50 or water linewidth greater than 12 Hz were not included
in the analysis. Signal to noise ratio was measured as the NAA peak height divided by
the standard deviation of the noise. Briefly, spectra were lineshape corrected by
combined QUALITY (Quantification improvement by converting lineshapes to the
lorentzian type) deconvolution and eddy current correction 31 then fitted in the time
domain using a Levenberg-Marquardt minimization routine 29 using prior knowledge of
metabolic lineshapes (Fig. 1B). Analysis software created in our laboratory in the IDL
(version 5.4 Research Systems Inc., Boulder, CO, USA) programming language was used
to model the spectra using prior knowledge acquired from in vitro spectra obtained from
aqueous solutions of metabolites at pH=7.0 prior to the study 29. In the current study, we
report absolute metabolite levels using unsuppressed water from the voxel as an internal
standard as previously described in detail 29,30. The calculation of absolute metabolite
levels incorporated a correction to account for tissue partial volume (grey matter (GM),
white matter (WM) and cerebrospinal fluid (CSF) voxel fractions) obtained by
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segmenting the T1-weighted anatomical images using the FMRIB (Functional MRI of the
Brain) Software Library (FSL) tools (FMRIB, Oxford). The metabolite levels were also
corrected for T1 and T2 relaxation related signal loss. The same relaxation time constants
were used in all groups and were obtained from the literature from measurements made at
3 T. To allow for comparison to other studies, and to eliminate the uncertainty associated
with partial volume correction from influencing the results, metabolite ratios relative to
Cr were also calculated. The reproducibility of voxel placement within subjects, between
time points was assessed by calculating the relative fraction of gray matter, white matter
and CSF in the voxels, and by registering the follow-up anatomical images to the baseline
images to quantify the voxel overlap using the Dice index 32.
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Gln
Cr
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NAA
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Figure 2.1: (A) From left to right; axial, sagittal, and coronal views of a T1-weighted
anatomical image with the spectroscopy voxel overlaid in green in the prefrontal region.
(B) Spectrum acquired (green) from the voxel in A, reconstructed spectrum (red), the
residual after fitting (blue), and the individual prior knowledge components of the
spectrum shown below in black. Glc = Glucose; Myo = Myo-inositol; Glu = Glutamate;
Gln = Glutamine; Cr = Creatine; Cho = Choline; NAA = N-acetyl aspartate; ppm = parts
per million.

2.2.5

Diffusion tensor imaging analysis

Raw DTI data were eddy-current corrected and conservatively brain extracted using FSL
tools (FMRIB, Oxford). A diffusion tensor was fitted at each voxel to create maps of
fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial
diffusivity (AD). These maps were then registered and transformed to standard space
using the standard Montreal Neurological Institute (MNI) 2 mm atlas 33. The MRS voxel
varied slightly from person to person and from scan to scan. To ensure alignment to the
preprocessed and registered DTI data, a slightly smaller volume (1cm × 1cm × 1cm)
located in MNI space at x = 36, y = 68 and z = 51 that only included WM (GM and CSF
masked) was used for analysis (Supplementary Fig. 1). The alignment with the MRS
voxel and DTI volume was visually inspected for all datasets. The FA, MD, RD, and AD
values were extracted from this voxel and correlated with the MRS-derived metabolite
levels.

2.2.6

Statistical analyses

All statistical analyses were performed using GraphPad Prism version 6.0 for Mac OS X
(GraphPad Software, San Diego California USA). Metabolite levels were compared
between the in-season and off-season in the non-concussed group (n=49) using a repeated
measures two-tailed Student’s t-test with an alpha value of 0.05. In the concussed group,
data were not available for all athletes at all time points, eliminating the possibility of a
repeated measures ANOVA. Alternatively, a one-way ANOVA was used to compare
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each metabolite across all time points. Metabolites that changed over time were further
examined to determine differences between the in-season and the 24-72 hours postconcussion (N=14), in-season and the three-months post-concussion follow up (N=11),
and in-season and the six-months post-concussion follow up (N=8) using t-tests with
Tukey’s multiple comparisons correction. Additionally, the metabolites that changed
over time were also examined using a repeated measures two-tailed Student’s t-test with
an alpha value of 0.05 in all available athletes to confirm differences between the
mentioned time points.
The association between metabolite changes and clinical scores (i.e. SCAT3 and
ImPACT), as well as between metabolite changes and DTI were examined with twotailed Spearman correlations. An alpha value of 0.05 was used. Additionally, the effect
of concussion history was assessed at the in-season time point using a two-tailed
Student’s t-test with an alpha value of 0.05. Athletes with no concussion history (Never
concussed) were compared to those with a concussion history (Ever concussed). Finally,
metabolite changes across two consecutive seasons (four time points, first and second inseason and off-season scans) were evaluated using a repeated measures ANOVA in nonconcussed athletes (N=7 using absolute metabolite levels, N=8 using metabolite ratios).
Metabolites that changed over time were then further examined using Tukey’s multiple
comparisons test with an alpha value of 0.05 to determine differences between an
athlete’s first in-season, first off-season, second in-season and second off-season time
points.

2.3 Results
2.3.1

Concussion history

In the non-concussed group (n = 47), 28 reported no prior concussion history, 12
individuals reported having 1-2 prior concussions, 1 reported having 3 prior concussions,
and 6 individuals did not provide a concussion history. In the concussed group, three
reported no prior concussions, seven reported having 1-2 prior concussions, and one did
not provide a concussion history. At the in-season time point no significant differences
were found in any metabolite concentrations or DTI metrics between athletes with and
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without a previous history of concussion. Supplementary Figure 2.2 compares imaging
metrics as a function of concussion history for NAA (p = 0.47), Gln (p = 0.11), FA (p =
0.07) and RD (p = 0.18) values.

2.3.2

Quality assurance measures

The spectroscopy voxel was placed in the prefrontal region with mean (± standard
deviation) tissue content: GM 20% ± 8%, WM 77% ± 9%, and CSF 3% ± 2%. The tissue
composition of the voxel did not significantly change within subjects between time
points. The voxel overlap between in-season and follow-up scans was 46% on average
using the Dice similarity coefficient 32. For all in-season spectra (n = 54), the average
full-width at half maximum of the water peak was 6.7 Hz and the average signal to noise
ratio was 92. Additionally, all spectra were visually inspected prior to statistical analyses
for artefacts. No spectra were eliminated from the analysis due to artefacts or insufficient
quality (SNR<50 or water linewidth > 12 Hz). Cramér-Rao Lower Bounds (CRLB) were
calculated for all metabolites but not used to eliminate spectra to avoid bias selection 34.
For all in-season spectra (n = 54), the average CRLB for N-acetyl aspartate, choline,
creatine, glutamate, glutamine, and myo-inositol were 0.65%, 1.4%, 1.4%, 4.6%, 35.5%
and 7.9% respectively.

2.3.3

Participants

A total of N = 49 paired metabolite ratio data sets were collected in the non-concussed
group. Absolute quantification could not be performed on two athletes due to missing
data, leaving N = 47 paired data sets. One additional individual ended the scan prior to
the acquisition of the DTI, leaving a total of N = 46 paired DTI data sets. Absolute
quantification could not be performed on one 24-72 hours post-concussion data set due to
incomplete data acquisition, leaving N = 13 data sets for that time point.

2.3.4

Clinical Data

The complete results of the SCAT3 and ImPACT will be reported in a subsequent
manuscript focused on resting state fMRI changes in the rugby players. In the subset of
46 non-concussed rugby players with complete imaging data in the study, ImPACT
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verbal memory (p = 0.046), ImPACT visual motor speed (p = 0.0003), and SCAT3
concentration (p = 0.047) all increased in the off-season compared to in-season. In the
concussed group the SCAT3 symptom score (p < 0.0001) and symptom severity score (p
= 0.0008) were higher 24 hours post-concussion compared to the in-season and returned
to the in-season values at 3 months post-concussion (Supplementary Figure 2.3).

2.3.5

MRI data

No changes in N-acetyl aspartate were found in the concussed group (Figure 2.2A) or
non-concussed group (Figure 2.2B). However, glutamine was significantly lower in the
concussed group (Figure 2.2C, F = 3.52, p = 0.02), with a 52% decrease in the mean
observed 24-72 hours post-concussion (p = 0.04) and a 56% decrease 3 months postconcussion (p = 0.03) compared to the initial in-season level. The repeated measures ttest using the subset of subjects with both baseline and post-concussion data yielded the
same changes in glutamine 24-72 hours post-concussion (N = 6, p = 0.02) and 3 months
post-concussion (N = 5, p = 0.03). A 21% decrease in glutamine was also observed in
the non-concussed group in the off-season compared to the in-season (Figure 2.2D, p =
0.01). When examining metabolite ratios, a change in the Gln/Cr ratio was also found in
the concussed group (Figure 2.2E, F = 3.45, p = 0.03), with a 58% decrease observed 3
months post-concussion (p = 0.03) relative to the initial in-season value. The repeated
measures t-test using the subset of subjects with both baseline and post-concussion data
showed a 48% decrease in Gln/Cr 24-72 hours post-concussion (N = 6, p = 0.04) and the
same reduction 3 months post-concussion (N = 5, p = 0.04). A 25% decrease in Gln/Cr
in the non-concussed group was observed in the off-season compared to in-season
(Figure 2.2F, p = 0.005). No other metabolite changes were found.
No significant changes in FA within the MRS region of interest (ROI) were found
in the concussed group (Figure 2.3A), however a small 3.8% increase was observed
within the voxel in the non-concussed group in the off-season compared to the in-season
(Figure 2.3B, p = 0.01). No significant changes in RD were found in the concussed
group (Figure 2.3C), although a small 2.1% decrease in RD was observed in the nonconcussed group in the off-season compared to the in-season (Fig. 3D, p = 0.048). No
other significant changes were observed.
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In a sub-set of athletes that played two consecutive seasons, Gln was significantly
altered (Supplementary Figure 2.4A, F = 4.7, p = 0.047), with a 60% decrease in the
mean observed at the second off-season in comparison to the first in-season (p = 0.03)
and a 54% decrease in the mean observed at the second off-season in comparison to the
first off-season (p = 0.02). Additionally, Gln/Cr was significantly altered
(Supplementary Figure 2.4B, F = 4.8, p = 0.04), with a 54% decrease in the mean
observed at the second off-season in comparison to the first in-season (p = 0.002) and
first off-season (p = 0.02). Within the ROI, FA significantly changed (Supplementary
Figure 2.4C, F = 6.4, p = 0.02) with an increase observed at the second off-season
relative to the first in-season (p = 0.006). Similarly, RD significantly changed
(Supplementary Figure 2.4D, F = 5.1, p = 0.04) with an increase observed at the second
off-season relative to the first in-season (p = 0.015).
In the non-concussed group, a negative correlation was found between the change
in Gln/Cr and the change in FA (Figure 2.4A, p = 0.01, r = -0.39) within the ROI.
Additionally, a positive correlation was observed between the change in Gln/Cr and the
change in RD (Figure 2.4B, p = 0.002, r = 0.45). Similar correlations were observed
between Gln and FA (p = 0.008, r = -0.38, not shown), and Gln and RD (p = 0.002, r =
0.44, not shown) within the ROI. No correlations were found between changes in
metabolite levels and clinical measures.
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Figure 2.2: Bar graphs showing the mean concentration of N-acetyl aspartate (NAA),
glutamine (Gln) and the glutamine/creatine ratio (Gln/Cr) in the concussed and nonconcussed groups. Standard error of the mean (SEM) is represented by vertical bars.
NAA levels did not change in the concussed (A) or non-concussed group (B). Gln levels
(C) decreased in the concussed group (F = 3.52, p = .02) by 52% at 24-72 hours (p = .04)
and by 56% at 3 months (p = .03). Gln levels in the non-concussed group (D) decreased
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by 21% (p = .01). Gln/Cr (E) decreased in the concussed group (F = 3.45, p = .03) by
58% at 3 months (p = .03), and in the non-concussed group (F) by 25% (p = .005).

Figure 2.3: Bar graphs showing the mean Fractional Anisotropy (FA) and Radial
Diffusivity (RD) values in the concussed and non-concussed groups found within the
spectroscopy voxel. Standard error of the mean (SEM) is represented by vertical bars.
Mean FA values in the concussed group (A) did not change (F = 1.41, p = .26), but
increased (B) in the non-concussed group (p = .01). RD values in the concussed group
(C) did not change (F = 0.14, p = .93), but decreased (D) in the non-concussed group (p =
.05).
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Figure 2.4: Correlations between the change in Gln/Cr and the (A) change in FA (p = .01,
r = -.39), and (B) change in RD (p = .002, r = .45), plotted with 95% confidence bands.

2.4 Discussion
The purpose of this study was to examine white matter metabolite levels using MRS in
female rugby players after a season of play and following concussion. Based on previous
studies, it was originally hypothesized that NAA would decrease in both groups, however
no changes in NAA were found. Rather, reduced Gln and Gln/Cr were observed in both
the concussed and non-concussed groups. Within the same ROI, FA increased and RD
decreased in the non-concussed group, and both changes correlated with the change in
Gln and Gln/Cr. These trends were also observed in the sub-set of athletes that played
two consecutive seasons concussion free.

2.4.1

N-acetyl aspartate and previous studies

In the current study, levels of NAA and Myo remained stable across all time points in
both groups. This result was unexpected since previous studies have shown changes in
these metabolites 35,36. The lack of change observed in the current study may be due to a
number of factors including differences in concussion severity between the current study
and previous reports 36, differences in the age and sex of study participants 21,23, and
differences in the timing and location of measurements. For example, a previous report
examining more severe cases of traumatic brain injury 37, indicates that decreased NAA
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and increased Myo may be indicative of a more severe head injury. Additionally, other
studies have examined different regions of the brain 19,36 or voxels primarily in the grey
matter 22. Increases in Myo have also been reported within the first two weeks of brain
injury 37. Such changes may have been missed in the current study because we did not
examine the same time points post-concussion. Changes in Myo, Cho, Cr and Glx have
also been reported in males and in different age cohorts 21,23 compared to the current
cohort. The methodological differences between studies makes it difficult to draw
conclusions between potential sex differences in regards to concussion 38. However, a
meta-analysis by Dougan et al. (2014)39 presented evidence that more severe deficits in
neuropsychological functioning were seen acutely post-concussion (1-10 days) in female
athletes in comparison to males. Alternatively, the study by Reynolds et al. (2017)40
found no differences in the number or severity of head impacts between males and
females in collegiate soccer. Taken together, these studies suggest that potential sex
related differences are likely due to a range of physiological and metabolic differences,
and not necessarily differences in the number or severity of head impacts 38.

2.4.2

Reduced glutamine and Gln/Cr

A large and significant reduction in Gln and Gln/Cr was found in both concussed athletes
and non-concussed athletes in the off-season. The absolute Cr concentration did not
significantly change, implying the decrease in Gln/Cr was due to the decrease in Gln. To
our knowledge, no other human study has found significant changes in Gln postconcussion, since most 1H-MRS studies do not quantify Gln alone, but instead quantify
the sum of Glu and Gln as Glx. Past studies have found increases 35,37 and decreases 23 in
Glx that could have been caused by changes in Gln. In the current study a decrease in
Gln/Cr was observed, but Glu/Cr and Glx/Cr remained stable. The decrease in Gln and
Gln/Cr observed in the days and months post-concussion in the current study is consistent
with studies of rodent models using Carbon-13 spectroscopy that have found reduced Gln
levels up to 24-hours post-injury 41. A previous cross-sectional study of 13-14 year old
hockey players using the same methodology as the current study also found a statistical
trend towards reduced glutamine levels in the concussed athletes three months after
concussion 42. Since Gln is a by-product of glucose metabolism these results suggest that
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the reduction in Gln may be the result of reduced glucose metabolism 41. Another
possible explanation for the observed change is that concussion and repetitive subconcussive hits over the course of the season could alter oxidative metabolism in the
brain, causing a shift in the glutamate-glutamine cycle, a major pathway for Gln in the
brain. Specifically, the release of Glu and increased oxidation of Glu through the
tricarboxylic acid cycle post-concussion 43 may decrease the amount of Glu that is
converted to Gln, causing an overall decrease in Gln.

2.4.3

Non-concussed brain changes

In the non-concussed group, we also found a significant increase in FA and decrease in
RD in the off season. These results suggest alterations in the white matter microstructure
within the MRS ROI. Similar changes have been associated with neuroinflammation 44,
as well as re-myelination 45. However, neuroinflammation seems an unlikely explanation
since no significant increase in Myo, a marker of increased glial cell activity, was
observed.
Past studies have suggested that similar changes in DTI metrics may be the result
of sub-concussive hits or undiagnosed concussions 46,47. Additionally, a study by
McAllister and Colleagues (2013)48 that measured the effect of head impacts on
diffusivity measures in athletes in contact versus non-contact sports found significant
group differences in MD and FA, as well as a relationship between the magnitude and
timing of head impacts and changes in white matter diffusion measures in various brain
regions. Another study by Chamard and Colleagues (2012)26 examined female varsity
hockey players and found a decrease in NAA/Cr in the corpus callosum in non-concussed
players and also attributed these changes to sub-concussive impacts. Furthermore, there
have been several studies that have examined non-contact athletes, and found no changes
in 1H MRS or brain structure over time in athletes 23,49. To our knowledge, no other study
has examined associations between DTI and 1H MRS measures within the same tissue
region. Although small, significant correlations were found between the change in
Gln/Cr and the change in FA and RD, as well as between the change in Gln and change
in FA and RD. Additionally, the same changes in Gln, FA and RD were observed in the
sub-set of athletes that played two consecutive seasons, further suggesting a relationship
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between these metrics. These correlations suggest a potential relationship between
alterations in metabolite levels and white matter integrity. Remyelination during the offseason is consistent with the observations of decreased Gln, increased FA, and decreased
RD. The metabolic demand in oligodendrocytes increases during myelin synthesis 50.
Remyelination in the off-season could produce a shift in oxidative metabolism to favor
lipid formation 50, leading to an overall decrease in the Gln substrate. Therefore,
different mechanisms may be responsible for the decrease in Gln observed in the nonconcussed and concussed groups. In the concussed group, the reductions in Gln with no
change in DTI metrics suggests altered oxidative metabolism as described above.
Whereas in the non-concussed athletes, the association between the change in Gln/Cr and
the change in FA and RD over the course of a season are consistent with changes in
tissue microstructure suggesting a remyelinating recovery process.

2.4.4

Clinical correlations

Consistent with previous studies 51 concussed players reported significantly more
symptoms 24-72 hours post-concussion compared to in-season. At 3 months postconcussion these symptoms had recovered while the reduction in Gln and Gln/Cr
persisted. This persistent reduction in Gln suggests that metabolic tissue changes due to
concussion extend well beyond clinical recovery. It is possible that the recovery of Gln
levels was delayed because the athletes continued to participate in contact sports.
Examination of Gln levels in non-concussed athletes that played multiple seasons
demonstrated a partial recovery between seasons suggesting Gln levels can recover. We
found no association between Gln or Gln/Cr levels and clinical measures consistent with
Mayer and colleagues (2015)52 who found no association longitudinally between
decreased NAA, and self-reported symptoms in MMA Fighters. Additionally, Sasaki and
colleagues (2014)44, who reported similar DTI findings to this study in hockey players,
also reported no association with ImPACT or SCAT2 scores. However other studies have
reported associations 22,46 between MRI and clinical data. It should be noted that in
contrast to the concussed group, the non-concussed group had increased verbal memory,
visual motor speed, and concentration scores in the presence of MRI changes. Although
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the MRI changes correlated with each other, these metrics also did not correlate with the
clinical changes.

2.4.5

Limitations and strengths

There are several limitations to the current study. For one, the placement of the voxel
was performed manually at the time of the scan, limiting the reproducibility of voxel
placement within subjects. However, the tissue partial volume did not differ, and the
voxel was well within the prefrontal region. The effect of small shifts in voxel position is
likely minimal since the affected white matter likely extends beyond the voxel. Although
the athletes studied are at a greater risk of head injury, the number and magnitude of
impacts throughout the season were not directly monitored, making it difficult to relate
the observed changes directly to impact severity. Recording impacts in future studies
will facilitate comparisons between studies. Additionally, in the non-concussed group
the time between the off-season scan and the last game played was on average 97 (± 25)
days. However, weekly contact practices continued up to, and past, the off-season scan
(Table 2.1), making it difficult to attribute changes to neuroinflammation or a recovery
mechanism. There are also many WM tracts that overlap in the prefrontal region of the
brain, limiting the interpretation of the DTI changes found within the ROI. Additionally,
athlete compliance for attending concussion follow up scans was moderate, making it
difficult to achieve high power in the concussed group. Due to the resultant low sample
size, the reduced glutamine must be considered exploratory at this point. However,
further research efforts directed at validating reduced glutamine post-concussion is
warranted. Greater conspicuity may be achieved with a larger sample size, and use of
spectral editing or ultra high-field MRI 53. There was also no explicit control group in this
study. A future study is now needed with the same experimental design to investigate
what changes may be found in female athletes from a non-contact sport or non-athletes.
Such a study will help elucidate the mechanism behind the unexpected metabolite and
microstructure changes observed in the non-concussed group. Additionally, future work
should include a similar study design with male rugby athletes to better elude to how
differences in sex may affect outcome from concussion.
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There are many strengths to this current study. First, we chose to study the
prefrontal white matter bordering the cortex because past studies have shown this region
to be susceptible to changes following concussion 22,23. In addition, Bayly and colleagues
(2005)1 found that regions bordering grey and white matter experience the greatest shear
forces during mild acceleration due to differences in tissue stiffness. Pre-concussion
scans were also used. Repeated measures additionally detected the small change in
Gln/Cr at 24-72 hours post-concussion in the concussed group. Since these metrics can
vary greatly from subject to subject, an individual’s pre-concussion measures can help
identify small changes regardless of the inter-subject variability. Without the concussed
athletes in-season data for comparison, the changes in the concussed group would not
have been observed when compared against the non-concussed athletes in-season levels.
For a biomarker to be clinically relevant for making the decision to return an athlete to
play it must be sensitive to the structural, metabolic, or functional changes in the brain
due to a concussion independent of symptoms. This highlights the importance of having
pre-concussion measures before the start of a sports season, for self-comparison, rather
than simply a comparison to an age matched control group.

2.5 Conclusion
To conclude, reduced Gln and Gln/Cr were found in the prefrontal region of the brain
following concussion and in the off-season in non-concussed female varsity athletes.
Within the same tissue region, increases in FA and decreases in RD were found in the
non-concussed athletes. The decrease in Gln and Gln/Cr may suggest a reduction in
oxidative metabolism, and the changes in FA and RD suggest neuroinflammation or remyelination, both of which have been previously reported in concussion. The absence of
any correlations with the clinical data in the presence of changes in metabolite levels and
DTI measures demonstrates the insensitivity of current symptomatic diagnosis and
emphasizes the need for alternative methods.
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2.7

Supplemental Material

Supplementary Figure 1. From left to right; sagittal, coronal, and axial views of the mask used
in MNI space at x = 36, y = 68 and z = 51 to extract FA, MD, RD, and AD values.

Supplementary Figure 2.1: From left to right; sagittal, coronal, and axial views of the
mask used in MNI space at x = 36, y = 68 and z = 51 to extract FA, MD, RD, and AD
values
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Supplementary Figure 2.
(A) N-acetyl aspartate (P=0.47) and (B) glutamine (P=0.11), (C) fractional anisotropy (P=0.07), and (D)
Supplementary
Figure 2.2: (A) N-acetyl aspartate (p = 0.47) and (B) glutamine (p =
radial diffusivity (P=0.18) of Never concussed and Ever concussed players at the in-season time point.
Standard
of the mean
(SEM) is represented
vertical
0.11),
(C)error
fractional
anisotropy
(p = 0.07),byand
(D)bars.
radial diffusivity (p = 0.18) of Never

concussed and Ever concussed players at the in-season time point. Standard error of the
mean (SEM) is represented by vertical bars.
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Supplementary Figure 3.
Bar graphs showing the mean SCAT3 Symptom Score and SCAT3 Symptom Severity Score in the concussed
Supplementary
Figure
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postSCAT3 Symptom Severity Score in the concussed group. Standard error of the mean
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significantly
increased (F=9.7,
P=0.0001)
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from(A)
post-concussion
(SEM)
is represented
by vertical
bars.
The mean(P=0.0008),
SCAT3 Symptom
Score
by 3 (P=0.0007) and 6 (P=0.02) months.

significantly increased (F = 17.6, p < 0.0001) post-concussion (p < 0.0001), then

recovered from post-concussion by 3 (p < 0.0001) and 6 (p = 0.002) months. The mean
SCAT3 Symptom Severity Score (B) significantly increased (F = 9.7, p = 0.0001) postconcussion (p = 0.0008), then recovered from post-concussion by 3 (p = 0.0007) and 6 (p
= 0.02) months.
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Supplementary Figure 4.
Line graphs showing the mean concentration of Glutamine (Gln) and Glutamine/Creatine (Gln/Cr), and Fractional
Supplementary
2.4: Line
graphs
showing
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ofconsecutive
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Radial Diffusivity
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to the second off
season (P=0.03),
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from the
first off season to the second off season (P=0.02). Mean Gln/Cr levels (B) decreased (F=4.8, P=0.04) by 54% from the
Diffusivity
(RD) in the same non-concussed (N = 7) athletes playing two consecutive
first in season to the second off season (P=0.02), and from the first off season to the second off season (P=0.02). The
mean FA value (C) changed over time (F=6.4, P=0.02), with an increase between the first in season and second off
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(Except Gln/Cr, N = 8). Standard error of the mean (SEM) is represented by
season (P=0.006), and the mean RD value (D) changed over time (F=5.1, P=0.04), with a decrease between the first in
season andbars.
secondMean
off season
vertical
Gln(P=0.015).
levels (A) decreased (F = 4.7, p = 0.047) by 60% from the first

in-season to the second off-season (p = 0.03), and by 54% from the first off-season to the
second off-season (p = 0.02). Mean Gln/Cr levels (B) decreased (F = 4.8, p = 0.04) by
54% from the first in-season to the second off-season (p = 0.02), and from the first offseason to the second off-season (p = 0.02). The mean FA value (C) changed over time (F
= 6.4, p = 0.02), with an increase between the first in-season and second off-season (p =
0.006), and the mean RD value (D) changed over time (F=5.1, P=0.04), with a decrease
between the first in-season and second off-season (P=0.015).
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Supplementary Table
1. Rugby2.1:
Timeline
of Concussed
Athletes
Athlete 1
Season 1

Season 2

Season 3

Season 4

August
September
October
November
December
January
February
March
April
May
June
July
August
September
October
November
December
January
February
March
April
May
June
July
August
September
October
November
December
January
February
March
April
May
June
July
August
September
October
November
December
January
February
March
April

Athlete 2

In Season Concussion
Concussion

Athlete 3
In Season

Athlete 4
In Season

Athlete 5

Athlete 6

In Season

In Season

Off Season

Off Season

Athlete 7

Athlete 8

Athlete 9

Athlete 10

Athlete 11

Athlete 12

Athlete 13

Athlete 14

Athlete 15

3 Month
3 Month
Off Season
Off Season
6 Month
Concussion Concussion
In Season
Concussion
3 Month

Concussion

In Season In Season In Season
Concussion Concussion Concussion Concussion
3 Month

3 Month

3 Month

3 Month

3 Month

3 Month

6 Month

6 Month
6 Month

In Season

In Season

6 Month

6 Month

6 Month

6 Month

In Season

In Season
Concussion

Concussion
Concussion
3 Month
Concussion Concussion

3 Month

6 Month

3 Month
3 Month

Concussion
6 Month

Concussion Concussion
Concussion Concussion
3 Month
3 Month

3 Month
6 Month
6 Month

In Season, Off Season, Concussion, 3 Month, 6 Month ; Data used in analysis
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Chapter 3

3

Brain Metabolite Levels in Female Rugby Athletes differ
from Non-Contact Athletes and Sedentary Women
*Submitted July 18th, 2019 to the Journal of Neurotrauma

Amy Schranz, Gregory A. Dekaban, Lisa Fischer, Kevin Blackney, Christy Barreira,
Timothy J. Doherty, Douglas D. Fraser, Arthur Brown, Jeff Holmes, Ravi S. Menon, and
Robert Bartha
The objective of this study was to investigate in vivo brain metabolite level
differences between female varsity athletes engaged in contact and non-contact sports as
well as sedentary women. These groups were chosen to examine the effects of long-term
exercise and cumulative sub-concussive impacts on brain metabolites measured by proton
magnetic resonance spectroscopy (MRS).
Single voxel MRS was acquired from the prefrontal white matter at the beginning
(In-Season) and end (Off-Season) of season in contact (N=54) and non-contact (N=23)
athletes. Sedentary women (N=23) were scanned once at a time equivalent to the OffSeason time point.
Metabolite levels in non-contact athletes did not change over a season of play, or
differ from age matched sedentary women except that non-contact athletes had a slightly
lower myo-inositol level. The non-contact athletes had different levels of myo-inositol,
glutamate, and glutamine compared to levels previously found in contact athletes.
Importantly, glutamine levels were significantly higher in contact athletes compared to
the sedentary (p < 0.001) and non-contact (p < 0.0001) groups. Taken together, the
measures from non-contact athletes and sedentary women do not demonstrate long-term
exercise-induced changes in MRS measured metabolite levels. The differences in myoinositol levels may reflect altered glial profiles in athletes. Altered glutamine levels as
well as glutamate and myo-inositol between non-contact and contact athletes suggests
that repetitive sub concussive impacts due to physical contact in high impact sports can
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alter brain metabolite levels. This result underscores the need to use proper control
groups in studies of concussion in high-impact sports.

3.1 Introduction
Athletes participating in contact sports are at a high risk of sustaining not just a single
concussion, but multiple concussions, which can lead to structural and metabolic changes
in the brain.1 There is also growing concern that such injuries put athletes at an increased
risk of neurodegeneration later in life.2 These concerns may not be relevant in cases with
rapid symptom resolution (e.g. 7-10 days), but may be of greater importance in the subset
of athletes that develop post-concussion syndrome.2 Relevant to this point, studies have
shown that structural and functional brain changes persist beyond the time of symptom
resolution.3,4 However, the lack of correlation between existing clinical test scores and
quantitative brain changes underlies the complexity of interpreting imaging findings
related to sport concussion. Adding to this complexity are questions regarding the role of
sex differences, the influence of repeated sub-concussive impacts on brain function and
metabolism, and the use of proper control groups when evaluating the effects of
concussion.
Although many different non-invasive imaging modalities have been used to
study changes in the brain following concussion, magnetic resonance spectroscopy
(MRS) provides neurochemical information that can be directly related to the known
neurometabolic cascade.5 MRS can be used to quantify specific metabolites relevant to
concussion injury in a defined brain region of interest, including N-acetyl aspartate
(NAA; neuronal integrity), creatine (Cr; energy metabolism), choline (Cho; phospholipid
turnover and myelin), glutamate (Glu; neurotransmission and metabolism), glutamine
(Gln; involved in neurotransmission and metabolism), and myo-inositol (Myo; glial
marker).6,7
Numerous metabolite level changes have been reported in athletes following
concussion in several different brain regions, primarily examining males.8,9,18–20,10–17
Changes have been found, including reduced NAA in ex-boxers,8 reduced NAA/Cr and
Glu/Cr in concussed athletes (e.g. football players) compared to non-concussed 9,10 as

93

well as elevated Myo/Cr,10 exacerbated Glu declines in former concussed athletes,11 and
changes in Myo and Cho in hockey and football players.12 There have also been several
studies that examined male and female athletes together.21,22,31,23–30 Among these studies,
reported changes included mostly reductions in NAA/Cr and NAA/Cho in the white
matter of the frontal lobes,21–23 elevated GABA/Cr in the frontal lobes of males and
females,31 as well as reduced NAA/Cr and NAA/Cho in the genu of the corpus
callosum.26 However, relatively few studies on female athletes have been reported.4,32,33
In these studies, reduced Myo/Cr 32 and elevated Glx/Cr 33 (Glx = glutamate + glutamine)
were found. The previous study by our group in female varsity rugby players,4 found
reduced glutamine following concussion compared to non-concussed rugby players, and
decreased glutamine in the non-concussed players at the end of their season. However,
this study did not include a group to control for an exercise effect across seasons of play.
Several previous studies measured metabolite changes in athletes during their
athletic season, to investigate the effect of cumulative sub-concussive impacts.13,14,16,25,28–
30,34

In contact athletes, elevated Myo25 and reduced Glx14,25,34 have been reported, as

well as reduced Cho, and Cr.14,34 Moreover, elevated Glx/Cr,28 and reduced NAA16,29 has
been observed after a season of play.
The interpretation of changes detected in previous studies depends to some degree
on the control groups that are included. Many studies compare to an age-matched control
group that are not athletes21–23,27,35 or do not specify if they are athletes that participated
in contact or non-contact sports,9,10,26,31–33 leaving sub-concussive impacts as a potential
confound in their interpretations. Studies have also demonstrated that the brains of
athletes differ from sedentary controls, likely due to neuroanatomical adaptations and
plastic changes in response to long-term training.36,37 For example, a global increase in
brain nonoxidative metabolism of carbohydrate substrates, potentially leading to changes
in proton MRS findings, has been reported.38 Specifically, studies have found increased
lactate and Glx, as well as acute modulation of glutamate and GABA after vigorous
exercise.38,39 However, these studies investigated the acute effects of physical activity.
How these changes translate into long term metabolite changes, such as over the course
of a sports season, is not known. Perhaps closest to this paradigm is a study by Gonzales
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and colleagues40 who examined the effect of endurance training and found elevated
NAA/Cr and Cho/Cr in the endurance trained group compared to normal healthy
controls. However, this study included only athletes >40 years of age and did not report
the duration of endurance training. Therefore, the effects of long-term exercise on MRS
measured metabolites remains to be determined.
The main objective of the current study was to determine whether metabolite
levels differed in female varsity rugby players (contact athletes) compared to female
varsity rowers and swimmers (non-contact athletes) as well as sedentary females. The
comparison of these groups allowed us to examine the effect of exercise on metabolite
levels, as well as the effect of repetitive sub-concussive hits over the course of a season.
Based on the results of previous studies, we hypothesized that there would be differences
in NAA and Cho40 between sedentary individuals and varsity athletes, but no differences
in metabolite levels between athletes involved in non-contact sports (rowing and
swimming), and contact sports (rugby).

3.2 Material and Methods
3.2.1

Participants

Sedentary and athletic females were recruited from the same university across three
varsity sports teams, and studied at the same time during the beginning (In-Season) and
end of season (Off-Season) to minimize sample heterogeneity. This study was approved
by the University of Western Ontario’s Health Sciences Research Ethics Board. Informed
consent was obtained from each participant prior to the start of data collection. All
participants in this study were university level athletes or students (age 18-30 years old).
Athletes and sedentary recruits were required to be concussion free for at least 6 months
to be included in the study. Athletes were recruited from the women’s varsity rugby team
over the course of five seasons, and women’s varsity rowing and swim teams over a
single season (for more details on these participants see Chapter 2 and Manning et al.,
2019).4,41
Briefly, sports seasons began at the end of August and early September (including
tryouts). Rugby players had weekly contact practices in addition to weekly games until
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November, followed by non-contact training until off-season data collection. Rowers
trained six days a week with regular regatta competitions until November, and swimmers
trained six days a week with monthly swim meets until March. In-Season data were
acquired from the end of August to early September for all athletes, and Off-Season data
were acquired from the end of January through February for rugby players and rowers,
and in March for swimmers. Sedentary participants were scanned at a single time point
from the end of January to end of March, to match with the Off-Season timepoint in
athletes.

3.2.2

Clinical Measures

The SCAT3 (Sport Concussion Assessment Tool) was administered by a sports medicine
physician at the In- and Off-Season timepoints for all athletes, and results are reported
elsewhere.41
For the sedentary group, participants were recruited using the IPAQ (International
Physical Activity Questionnaire, October 2002), a self-administered questionnaire that
incorporates (1) job-related physical activity, (2) transportation physical activity, (3)
housework, house maintenance, and caring for family, and (4) recreation, sport, and
leisure-time physical activity, where each section is comprised of walking, moderate, and
vigorous activity levels. Participants were asked to fill out the questionnaire based on
their average routine over the course of the school semester (September 2018-January
2019), to match with the duration of the varsity sports seasons. This required participants
to record their average time spent per activity outlined in each of the four categories. The
raw time spent per activity was then weighted by its energy requirements defined in
METs (METabolic equivalent; ratio of work metabolic rate to a standard resting
metabolic rate) to yield a score of MET-minutes. A MET-minute is computed by
multiplying the MET score of an activity by the minutes performed. The MET score used
for walking, moderate, and vigorous activities were 3.3, 4.0, and 8.0 respectively.42
Additionally, for transportation by cycling a MET score of 6.0 was used.42 A threshold of
300043 MET minutes were used as the inclusion criteria for the sedentary group (A
typical week of training for contact athletes would yield a MET score of approximately
5000).
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3.2.3

Magnetic resonance imaging acquisition

Magnetic resonance spectroscopy data acquisition was identical to that reported
previously.4 Briefly, a Siemens 3T Magnetom Tim Trio and Prisma Fit MRI Scanners
(Erlangen, Germany), both using a 32-channel head coil, were used for data acquisition.
A rapid T2-weighted FLAIR image was acquired to guide the placement of a 6 cm3 (2 x 2
x 1.5 cm) voxel in the prefrontal WM region of the brain (Fig. 1A) for the acquisition of
the spectroscopy data (slices = 50, TR/TE = 15000/139 ms, slice thickness = 3 mm, turbo
factor = 38, matrix size 256 x 256, FOV = 256 mm, inversion time = 2850 ms). Water
suppressed (192 acquisitions) and unsuppressed (8 acquisitions) spectroscopy data were
acquired using the PRESS (point resolved spectroscopy) pulse sequence (TR/TE =
2000/135 ms, dwell time = 833 !s, number of points = 1024). A long echo-time was
chosen in the current study to reduce the metabolite measurement error associated with
the macromolecule baseline at shorter echo times.44 Anatomical images for the estimation
of voxel gray matter (GM), white matter (WM), and CSF volume were acquired using a
sagittal T1-weighted magnetization-prepared rapid acquisition gradient echo sequence
(TR/TE = 2300/2.94 ms, flip angle = 98, matrix size 256 x 256, FOV = 256 x 240 mm,
number of slices = 160, slice thickness = 1.22 mm).

3.2.4

Magnetic resonance spectroscopy

Spectra were processed and analyzed as previously described,4 with absolute metabolite
levels quantified using the approach described in Gasparovic and colleagues.45 Spectra
with a signal to noise ratio (SNR) <50 or water line width >12 Hz were not included in
the analysis. SNR was measured as the NAA peak height divided by the standard
deviation of the noise. Briefly, spectra were lineshape corrected by combined QUALITY
(Quantification improvement by converting lineshapes to the lorentzian type)
deconvolution and eddy current correction46 and fitted in the time domain using a
Levenberg–Marquardt minimization routine47 using prior knowledge of metabolite line
shapes (Fig. 1B). Analysis software created in our laboratory in the IDL (version 5.4
Research Systems Inc., Boulder, CO) programming language was used to model the
spectra using prior knowledge acquired from in vitro spectra obtained from aqueous
solutions of metabolites at pH 7.0 prior to the study.47 Absolute concentrations are
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reported using unsuppressed water from the MRS voxel as an internal standard as
previously described.47,48 This incorporates corrections to account for tissue partial
volume (GM, WM, CSF) using the segmented T1-weighted anatomical image, as well as
corrections for signal loss due to T1 and T2 relaxation. The relaxation time constants used
in this study are provided in Table 1. To eliminate the uncertainty associated with partial
volume correction, and to compare to the literature, metabolite ratios relative to creatine
(X/Cr) were also calculated.

3.2.5

Statistical Analysis
All statistical analyses were performed using GraphPad Prism Version 7.0 for

Mac OS X (GraphPad Software, San Diego, CA). For each metabolite, the ROUT
method was performed to remove outliers and the D’Agostino & Pearson normality test
was used to test for normality. A two-way ANOVA, followed by two-tailed Sidak’s
multiple comparisons tests, was used to test for differences between rowers and
swimmers at both measurement times, and to test for differences between contact (rugby)
and non-contact (rowers and swimmers) athletes. A one-way ANOVA, followed by twotailed Tukey’s multiple comparisons test, was used to test for differences across contact,
non-contact, and sedentary groups at the end of season. A p-value of 0.05 was used for all
statistical tests.
Table 3.1 3 T Relaxation Constants used in Absolute Quantification*
Table 1: 3 T Relaxation Constants used in Absolute Quantification*
Metabolite
# of Protons T1 (s)
N -acetyl aspartate
3
Choline
9
Creatine
3
Glutamine
5
Glutamate
5
Myo -inositol
6
Glucose
6
Water
2

Grey Matter
T2 (ms)
1.34
1.21
1.34
1.17
1.27
1.17
1.17
1.46

T1 (s)
318
246
158
134
167
221
117
95

White Matter
T2 (ms)
1.35
1.26
1.36
0.98
1.17
0.98
0.98
0.94

343
209
159
134
143
195
122
75

Cerebrospinal Fluid
T1 (s)
T2 (ms)
4.3
503

*Values used were aeraged from values reported in the literature:
Ethofer et al. (2003) MRM
Stanisz et al. (2005) MRM
Ganji et al. (2012) NMR Biomed
Traber et al. (2004) J MR Imaging
Harris et al. (2015) J Magn Reson. Imaging Wansapura et al. (1999) J Magn Reson. Imaging
Lu et al. (2005) J Magn Reson. Imaging
Wyss et al. (2018) MRM
Mlynarik et al. (2001) NMR Biomed
Zhang e al. (2016) MRM
Piechnik et al. (2009) MRM
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3.3 Results
3.3.1

Participants, Clinical Data, and Concussion History

Twenty-five participants were recruited to the sedentary group. Two participants were
eliminated because one suffered a head injury prior to their scan, and another had a total
MET-minutes >3000, leaving a total of N = 23 participants in the sedentary group. On
average, participants had mean (± standard deviation) MET-minutes of 1252 ± 952. Of
the 23 included participants, six reported having a previous concussion, 9.3 ±5.7 years
prior to the start of the study.
A total of 31 athletes were recruited into the non-contact group from the Western
varsity rowing and swim teams, with a total of 23 completing both scans at the In- and
Off-Season time points. Of these 23 athletes, three reported having a previous concussion
prior to the beginning of the study. For details on the 54 rugby athletes included in
comparisons and associated concussion histories, please see Schranz et al., 2018.4
Additionally, the results of the SCAT3 scores for the contact and non-contact teams are
reported in Manning et al., 201941 and Schranz et al., 2018.4

3.3.2

Quality assurance measures

All spectroscopy quality assurance measures calculated for the sedentary and non-contact
groups did not differ significantly from the measures previously reported in the contact
athletes.4 The spectroscopy voxel was placed in the prefrontal region with mean (±
standard deviation) tissue content in the sedentary group: GM 23±6%, WM 73±8%, CSF
3.5±2%, and non-contact group: GM 23±7%, WM 74±8%, CSF 2.7±2%. For all
spectra from the sedentary and non-contact groups, the average full-width at half
maximum of the water peak was 6.2 Hz and the average SNR was 92. All spectra and
residuals were visually inspected prior to statistical analyses for artefacts and no spectra
were eliminated from the analysis due to artefacts or insufficient quality (SNR <50 or
water linewidth >12 Hz). Cramer-Rao Lower Bounds (CRLB) were calculated for all
metabolites but not used to eliminate spectra to avoid bias selection.49 For all spectra
(n=184), the average CRLBs were 0.62% for N-acetyl aspartate, 1.5% for choline, 1.3%
for creatine, 56% for glutamine, 4.2% for glutamate, and 6.9% for myo-inositol.
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3.3.3

Magnetic Resonance Spectroscopy: Absolute Metabolite
Concentrations

3.3.3.1

Non-contact Compared to Contact Athletes over a Season
of Play

No significant metabolite level differences were found between the rowers and swimmers
at either time point, so these athletes were combined into a single non-contact athlete
group. No metabolite changes were detected over a season of play in this non-contact
group (Fig. 2). There were no significant differences between contact and non-contact
groups in levels of NAA (Fig. 2A; Two-way ANOVA, F(1,75) = 3.63, p = 0.06), choline
(Two-way ANOVA, F(1,75) = 0.99, p = 0.32, data not shown) or creatine (Two-way
ANOVA, F(1,74) = 1.9, p = 0.17, data not shown).
Mean glutamate concentrations were found to be significantly different between
contact and non-contact groups (Fig. 2B; Two-way ANOVA, F(1,73) = 11.67, p = 0.001).
Glutamate was lower in the contact group at the In-Season (Fig. 2B; Sidak’s, t146 = 3.36,
p = 0.002) and Off-Season (Fig. 2B; Sidak’s, t146 = 2.53 p = 0.025) time points, although
glutamate levels did not change between time points within either group. Additionally,
mean glutamine concentrations were also found to be significantly different between
contact and non-contact groups (Fig. 2C; Two-way ANOVA, F(1,75) = 33.06, p < 0.0001),
with higher concentrations in the contact group at the In- Season (Fig. 2C; Sidak’s, t150 =
5.6, p < 0.0001) and Off-Season (Fig. 2C; Sidak’s, t150 = 4.1, p = 0.0001) time points.
Mean myo-inositol concentrations were found to be significantly different
between contact and non-contact groups (Fig. 2D; Two-way ANOVA, F(1,69) = 36.78, p <
0.0001), with lower concentrations in the contact group at the In-Season (Fig. 2D;
Sidak’s, t138 = 6.14, p < 0.0001) and Off-Season (Fig. 2D; Sidak’s, t138 = 3.36, p = 0.002)
time points. Additionally, a significant interaction was found between groups (Fig. 3,
Two-way ANOVA, F(1,69) = 5.01, p = 0.028), where non-contact Myo levels tended to
decrease over a season, while contact Myo levels tended to increase.
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3.3.3.2

Off-Season Athletes compared to a Sedentary Group

A one-way ANOVA was used to compare the contact Off-Season, non-contact OffSeason, and Sedentary females. The ANOVA revealed no significant differences among
the three groups in NAA (Fig. 4A; F(2,96) = 2.91, p = 0.059) or choline (Fig. 4B; F(2,96) =
1.43, p = 0.24). However, significant differences were found in glutamate (Fig. 4C;
ANOVA, F(2,94) = 9.39, p = 0.0002), glutamine (Fig. 4D; ANOVA, F(2,96) = 15.5, p <
0.0001), creatine (Fig. 4E; ANOVA, F(2,95) = 6.92, p = 0.0016), and myo-inositol (Fig. 4F;
ANOVA, F(2,90) = 21.02, p < 0.0001) levels.
The contact group had significantly lower glutamate levels at the Off-Season
compared to non-contact (Tukey’s, q94 = 3.82, p = 0.022) and sedentary groups (Tukey’s,
q94 = 5.72, p = 0.0003), while glutamine levels were significantly elevated in the contact
group compared to non-contact (Tukey’s, q96 = 6.68, p < 0.0001) and sedentary groups
(Tukey’s, q96 = 5.95, p = 0.0002).
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Creatine levels were significantly lower in the contact group compared to the
sedentary group only (Tukey’s, q95 = 5.23, p = 0.001), while myo-inositol levels were
significantly lower in the contact group compared to the non-contact (Tukey’s, q90 = 4.75,
p = 0.0033) and sedentary groups (Tukey’s, q90 = 8.95, p < 0.0001). No differences were
found between the sedentary group and non-contact group, except for lower myo-inositol
levels (Fig. 4F; Tukey’s, q90 = 3.69, p = 0.028) in the contact group.
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3.3.3.3

Glutamine levels post-concussion: Group Comparisons

Due to the large differences in glutamine levels observed between contact and noncontact athletes in the current study, we chose to compare glutamine levels in the subset
of contact athletes that obtained a concussion. Specifically, N = 13 contact athletes
obtained a concussion, and seven of them had baseline scans (e.g. an In-Season scan prior
to their concussion). Glutamine levels from 24-72 hours after concussion in our contact
group and baseline levels (previously reported in Schranz et al., 20184 as significantly
reduced glutamine levels) were compared to the non-contact and sedentary groups (Fig.
5). A one-way ANOVA revealed significant differences across the 4 groups (F(3,61) =
15.22, p < 0.0001). First, concussed contact group glutamine baselines measures were
significantly higher than non-contact (Tukey’s, q61 = 8.87, p < 0.0001) and sedentary
groups (Tukey’s, q61 = 8.42, p < 0.0001). Second, 24-72 hours post-concussion glutamine
levels were significantly higher than non-contact levels (Tukey’s, q61 = 3.9, p = 0.037),
but significantly lower than contact baseline measures (Tukey’s, q61 = 5.28, p = 0.0023,
as previously reported). No significant differences were found between sedentary and
post-concussion glutamine levels (Tukey’s, q61 = 3.36, p = 0.092).
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3.3.4
3.3.4.1

Magnetic Resonance Spectroscopy: Amplitude Ratios
Non-contact versus Contact Athletes over a Season of Play

No metabolite ratio changes were found over a season of play in the non-contact group
(Supplementary Fig. 1). A two-way ANOVA found no significant differences between
contact and non-contact groups in NAA/Cr (Supplementary Fig. 1A; F(1,74) = 0.059, p =
0.8), while mean Cho/Cr was significantly different between athlete groups
(Supplementary Fig. 1B; F(1,73) = 10.05, p = 0.0022), with significantly higher Cho/Cr in
the contact group at the In-Season time point (Sidak’s, t146 = 3.38, p = 0.0019). Mean
Myo/Cr were found to be significantly different between contact and non-contact groups
(Supplementary Fig. 1C; F(1,71) = 14.19, p = 0.0003), with lower concentrations in the
contact group at the In-Season (Sidak’s, t142 = 3.82, p = 0.0004). Mean Glu/Cr was found
to be significantly different between contact and non-contact groups (Supplementary Fig.
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2D; F(1,74) = 10.7, p = 0.0016), with a lower ratio in the contact group at the In-Season
(Sidak’s, t148 = 3.43, p = 0.0016). Additionally, mean Gln/Cr were found to be
significantly different between contact and non-contact groups (Supplementary Fig. 2E;
F(1,74) = 41.87, p < 0.0001), with a higher ratio in the contact group at the In-Season
(Sidak’s, t148 = 6.18, p < 0.0001) and Off-Season (Sidak’s, t148 = 4.45, p < 0.0001).

3.3.4.2

Off-Season changes compared to a Sedentary Group

A one-way ANOVA revealed no significant differences among the three groups in
NAA/Cr (Supplementary Fig. 2A; F(2, 95) = 2.82, p = 0.065), Cho/Cr (Supplementary Fig.
2B; F(2, 95) = 2.94, p = 0.058), or Glu/Cr (Supplementary Fig. 2D; F(2, 95) = 2.099, p =
0.13). However, significant differences were found among Myo/Cr (Supplementary Fig.
2C; F(2, 94) = 10.29, p < 0.0001) and Gln/Cr (Supplementary Fig. 2E; F(2, 95) = 19.06, p <
0.0001).
The contact group had significantly elevated Gln/Cr compared to non-contact
(Tukey’s, q95 = 7.23, p < 0.0001) and sedentary groups (Tukey’s, q95 = 6.77, p < 0.0001),
while Myo/Cr was significantly lower in the contact group compared to the non-contact
(Tukey’s, q94 = 3.84, p = 0.021) and sedentary groups (Tukey’s, q94 = 6.04, p = 0.0001).
No differences were found between the sedentary group and non-contact group.

3.3.4.3

Glutamine/creatine changes post-concussion: Group
comparisons

Supplementary Fig. 3 shows the results of the one-way ANOVA across the 4 groups
(F(3,60) = 20.57, p < 0.0001). First, concussed contact Gln/Cr baselines measures were
significantly higher than non-contact (Tukey’s, q60 = 10.23, p < 0.0001) and sedentary
groups (Tukey’s, q60 = 9.95, p < 0.0001). Second, post-concussion Gln/Cr levels were
significantly higher than non-contact levels (Tukey’s, q60 = 4.33, p = 0.017) and
sedentary groups (Tukey’s, q60 = 3.98, p = 0.033), but significantly lower than baseline
measures (Tukey’s, q60 = 6.24, p = 0.0002).
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3.4 Discussion
The objective of this study was to investigate brain metabolite level differences between
female varsity athletes engaged in contact and non-contact sports as well as sedentary
individuals, to examine the long-term effects of exercise and sub-concussive impacts. We
found that myo-inositol, glutamate, and glutamine levels differ at both In-Season and OffSeason time points between contact and non-contact female varsity athletes. Furthermore,
metabolite levels did not differ between non-contact athletes and age matched sedentary
women, except that non-contact athletes had lower levels of myo-inositol. The current
study also demonstrates that contact athletes had higher baseline glutamine levels
compared to non-contact athletes and sedentary women. This unexpected finding
suggests that the interpretation of glutamine changes previously reported post-concussion
must be made carefully considering the control group used. For example, the glutamine
levels previously reported post-concussion4 were higher than that observed in noncontact athletes, but lower than baseline measures in the same athletes. This emphasizes
the need to include proper control groups in studies of concussion.

3.4.1

Non-contact versus Contact Teams over a Season of Play

No changes were measured from In- to Off-Season in non-contact athletes. This suggests
that previously reported reductions in glutamine and Gln/Cr observed in contact athletes
from In- to Off-Season4 is not the result of an exercise effect. Instead, it is more likely
that the previously reported reduction in glutamine and Gln/Cr is caused by the repetitive
impacts experienced by athletes throughout the season. To confirm that the contact
athletes were indeed receiving high impacts, a head impact sensor that measured linear
acceleration and rotational velocity was worn by a subset of players during a preseason
rugby game.41 During this single rugby game, a total of 151 impacts exceeding 15g were
recorded across 26 players. Therefore, on average, a single player received six impacts
>15g per practice, and two impacts >15g per game. For the detailed results on the impact
data, please see Manning et al., 2019.41 It is important to recognize that previous studies
reporting higher impact rates used a threshold of >10g,50,51 rather than the >15g used in
this cohort of athletes. Additionally, it has been shown that 45% of head impacts land
between 10-15g,52 meaning that there is a large portion of impacts not included in the

107

current analysis. Taken together, the female rugby athletes experience sub-concussive
impacts throughout their season, and these impacts likely contribute to the reduction in
glutamine and Gln/Cr, as well as the other major metabolite level differences observed in
comparison to the non-contact and sedentary groups, further discussed below.
A significant interaction in myo-inositol levels was observed between contact and
non-contact athletes. Even though myo-inositol levels are significantly lower in contact
athletes at the In- and Off-Season timepoints, it appears that myo-inositol tends to
increase over the season in contact athletes but decrease over the season in non-contact
athletes (although, not significantly). A recent study by Lefebvre et al (2018)25 examining
male and female athletes found increased myo-inositol in contact athletes (rugby and
soccer), compared to non-contact (swimming) and non-athletes in the motor cortex. This
is opposite to our finding of lower myo-inositol levels at In- and Off-Season on contact
athletes, but in line with our observed myo-inositol interaction between the groups.
Furthermore, studies of retired contact athletes, found higher myo-inositol levels in the
medial temporal lobe12 and in the posterior cingulate gyrus.18 This suggests that over
time, myo-inositol levels may continue to rise in athletes playing contact sports.

3.4.2

End of Season Changes Compared to a Sedentary Group:
Exercise versus Impacts

We found no metabolite differences in the prefrontal white matter between sedentary and
non-contact athletes, asides from a marginal reduction in myo-inositol in non-contact
athletes. However, there were many differences between the contact group and the
sedentary and non-contact groups. This further suggests that the contact nature of the
sport is having a cumulative effect on the brain, as described by others.16,25,53 Although
we saw no significant changes in NAA in the current study, trends towards reduced NAA
in the contact athletes were observed (p < 0.1). Other studies have reported reduced NAA
in male mixed martial arts fighters,16 and in female and male athletes without
concussion.24,29,33 Moreover, Chamard and colleagues24 found reduced NAA/Cr in female
athletes only, but with subsequent absolute quantification, found NAA to be reduced in
males and females.29 However, these NAA changes were found in the corpus callosum,
not in the prefrontal white matter. Another study that examined high school football
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players found metabolite differences at the beginning of season, with lower choline and
creatine levels during the season in a similar region of interest. These results are
consistent with the lower creatine levels observed at the off-season compared to our
sedentary group. Moreover, similar to the elevated glutamine levels in contact athletes
observed in the current study, a study by Bari and colleagues28 examining male football
and female soccer players found elevated Glx (glutamate + glutamine) levels in the motor
cortex in females. Furthermore, high school football players were found with elevated
Glx in a similar region of interest at the beginning of a sports season, and found those Glx
levels to drop during the season. Interestingly, this change in Glx follows the same
pattern as glutamine in our contact athletes.

3.4.3

Elevated Glutamine in Contact Athletes

In our previous study on concussion in female varsity rugby athletes, we measured
reduced glutamine levels after concussion compared to baseline measures.4 Moreover, we
demonstrated that the significance of this reduction is lost when (1) baseline measures are
not used and (2) when glutamate and glutamine are fitted together as Glx. Now, perhaps
of even greater interest, we demonstrate that if non-contact athletes or sedentary
individuals were used as a control group, the directionality of the glutamine change
would appear to be reversed. For example, by only having non-contact athletes as a
control group, it would seem that glutamine levels were elevated immediately after
concussion, while we know from comparison to same-subject baseline measures that
glutamine is actually decreasing. This highlights the need for proper baseline measures,
to correctly interpret metabolite changes following concussion.
We speculate that the increase in glutamine levels observed in contact athletes and
the decrease previously reported after concussion, are driven by glutamine synthetase
(GS) activity and expression. GS is the enzyme that converts glutamate to glutamine, and
is present in glial cells, including astrocytes and microglia.54 During neurotransmission,
glutamate is released into the synaptic cleft and is then taken up by astrocytes to be
converted to glutamine by GS.55 This process is part of the glutamate-glutamine cycle.
According to Giza and Hovda,5 the neurometabolic cascade of events that occur
immediately after a concussive injury includes altered ion flux and glutamate release.
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Moreover, elevated levels of extracellular glutamate can lead to excitotoxicity and tissue
injury.56 If we assume that glutamate release also occurs in association with subconcussive hits, but to a lesser extent than when associated with concussion, it is
conceivable that over time epigenetic changes could lead to increased GS expression and
activity to compensate for the elevated glutamate release. This compensation could
manifest as elevated glutamine levels as observed in our contact athletes. In more severe
head injuries, one of the most significant pathophysiological processes is the number of
free radicals, oxygen (ROS) and nitrogen species (NOS), that are created as a
consequence of glutamate efflux and calcium influx.56 Furthermore, studies have shown
reduced GS activity to be due to increased oxidative stress, and that this inhibition in GS
leads to reduced glutamine.54,57 Therefore, it is feasible that following a concussive
injury, if there is significant production of free radicals, GS inhibition would manifest as
reduced glutamine levels, as we previously reported post-concussion.4

3.4.4

Limitations, Strengths, and Future Work

There are several limitations to consider for this study. The MRS voxel was manually
placed by the MRI technician, which limits the reproducibility of the voxel placement
within subjects at follow up scans. However, given the diffuse nature of a concussive
injury, and the heterogeneity of sub-concussive hits, it is likely that the effected brain
tissue extends beyond our voxel. Moreover, having impact data from the contact athletes
would have allowed us to investigate associations between the number of hits and
glutamine levels. Such data were limited however, because the league did not allow
impact recording devices to be worn during games.
There are several important strengths to the current study. Our contact and noncontact athletes were recruited from three sports teams, ensuring similar training
schedules and matched activity levels, and we focused on only female athletes, as sex
differences have been observed.10,32 Additionally, we chose a longer echo time (TE = 135
ms) to remove any macromolecule signal, allowing more reproducible quantification of
the lower amplitude metabolites.
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3.4.5

Conclusions

The objective of this study was to compare metabolite levels in sedentary and athletic
females from the same university and varsity sports teams during the In- and Off-Season
at the same time of year. Metabolite levels in non-contact athletes did not differ from age
matched sedentary women except for a slightly lower myo-inositol level in the noncontact athletes, suggestive of no long-term exercise-induced change in MRS measured
metabolite levels. Comparing metabolite levels to a group of female contact athletes
previously reported, the non-contact athletes had different levels of myo-inositol,
glutamate, and glutamine compared to the contact athletes. Importantly, glutamine levels
were significantly higher in contact athletes compared to the sedentary and non-contact
groups, demonstrating that repetitive sub-concussive impacts due to physical contact in
high impact sports can alter metabolite levels. These data also demonstrate that the use of
a sedentary or non-contact control group, instead of a contact control group or same
subject baseline scans, can change the interpretation of the directionality of metabolite
changes, specifically glutamine, after concussion.
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Longitudinal brain metabolite changes in a murine
model of mild repetitive closed head injury
*In preparation for publication

Amy Schranz, BMSc, Patrick McCunn*, BSc, Kathy Xu, Arthur Brown, PhD, Robert
Bartha, PhD
*Patrick McCunn provided the data analysis, interpretation, and written sections on the
DTI portion of this study
The number and severity of impacts to the head triggers an unpredictable cascade of
neurometabolic events. The final outcome of a head injury depends in part on a complex
network of biochemical pathways, involving both oxidative metabolism and anaerobic
pathways. These immediate changes in brain neurochemistry following an impact may
precede microstructural changes. Previous studies in animal models of concussion have
normally examined brain metabolism after a single insult. However, this approach does
not replicate the environment of competitive contact sports, where athletes receive
repetitive sub-concussive impacts often daily for months prior to a concussion. The
purpose of this study was to investigate the changes and potential associations between
brain metabolite levels measured by magnetic resonance spectroscopy (MRS) and brain
microstructure measured by diffusion tensor imaging (DTI) in the mouse brain after a
repeated mild closed head injury paradigm.
Male mice were divided into five groups, control (n=12), 48 hours post-injury
(n=12), 1-week (n=12), 4 weeks (n=12), and 10 weeks post-injury (n=12). Mice received
a closed-head mild controlled cortical impact, with one impact per day for five days,
followed by in vivo MRS and DTI data acquisition.
In this study, we observed changes in DTI and NAA early on (48 hours and 1
week), that resolved by 4 and 10-weeks, indicating a mild injury that recovered with
time. However, small changes at 10-weeks in creatine, lactate, taurine, Glu/Cr and
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Gln/Cr, point towards a subtle shift in these biochemical pathways in order to re-establish
homeostasis. Moreover, the change in Gln/Cr is consistent with that observed in a
previous human study of female varsity rugby athletes in comparison to non-contact
athletes. We speculate that the five hits in five days paradigm used in the current study
may simulate the impact conditions that contact athletes experience over a season of play,
eventually causing elevated glutamine levels.

4.1 Introduction
Despite recent research efforts to understand the long-term effects of concussion,
identifying those at risk of post-concussion syndrome, and the development of effective
treatment methods remains elusive. Failure to make significant progress in this area is
largely due to the complexity of the underlying pathophysiology of concussion and the
inability of conventional CT and MRI contrasts to detect brain changes.1 As a result, over
the last two decades, there have been many studies dedicated to investigating the utility
of more specialized MRI techniques to detect subtle brain changes following concussion,
including magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI).1
DTI is a complementary MRI modality that provides sensitive measurements
related to tissue microstructure and structural connectivity, that can be associated with
pathological changes within the brain.2 Previous work applying DTI in humans after
sport concussion has shown changes in fractional anisotropy (FA), mean diffusivity
(MD), axial diffusivity (AD), and radial diffusivity (RD),3 and it has been suggested that
altered diffusion persists well after clinical assessment scores return to normal.4 For a
more comprehensive review on DTI in sports concussion see Chamard et al., 20183 and
Asken et al., 2017.5 Unfortunately, the measured changes in these metrics have been
inconsistent, and it is important to study them further in pre-clinical models to verify their
accuracy and suitability for diagnostic medicine. In line with the human literature,
increases and decreases in DTI metrics have been found in animal models. For example,
a study performed by Bennett et al. (2012)6 observed decreased FA in the corpus
callosum of mice after repeated closed-skull TBI, while Robinson et al. (2017)7 found
reduced AD in mice but no changes in FA within the corpus callosum. It is important to
note, that even though animal models have the benefit of reducing the heterogeneity in
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the injury, the model used and chosen parameters still vary from study to study making
comparisons challenging.
After an insult to the head, there is a cascade of neurometabolic events that
depends on factors including the number and severity of impacts.8–10 The final outcome
of a head injury is determined by the ability of the brain to modulate a complex network
of biochemical processes, including the TCA cycle and oxidative metabolism, as well as
anaerobic pathways. These immediate changes in brain neurochemistry as well as altered
neurotransmission from the secondary chemical cascade of ion flux that occurs after
receiving a hit to the head11 precede structural changes,12 and produce metabolite level
changes that can be detected and quantified by 1H MRS.
The effect of concussion on the brain has been largely studied by MRS in athletes
participating in various contact sports. These studies have observed changes in the levels
of several different metabolites. For example, altered N-acetyl aspartate (NAA),13,14
choline,15–17 myo-inositol,16,18,19 glutamate20 and glutamine21 have been reported in
WM4,16,22,23 and GM18,19,24 regions in the brain. The large variability in metabolite
findings across the literature is likely due to the heterogeneous nature of concussion (e.g.
impact site, force of impact, timing of imaging post impact, concussion history, sex, diet,
etc.).25 Animal models can be utilized to control many of these variables, allowing
exploration of the mechanisms and relevance of specific metabolite changes after
concussion.1 Numerous animal models exist, and studies to date have reported changes
including reduced NAA/Cr,26,27 Tau/Cr,8 creatine and glutamine,28 and myo-inositol,29 as
well as increased glutamine,10,30 lactate, myo-inositol, and choline31 after injury.
However, the majority of these studies used rather severe models, with craniotomies, that
are more representative of moderate to severe traumatic brain injury, not
concussion.10,27,29–31 Therefore, investigating concussion or the effects of repetitive
impacts with MRS in animal models, remains relatively unexplored. A synopsis of the
relevant literature in animal models is summarized in Table 1.4.
Few studies have examined the association of MRS and DTI metrics in
concussion. A recent study in rats by Li et al., (2017)9 did find a positive correlation

124

between FA and myo-inositol, which could indicate glial proliferation as the main cause
of increased FA post TBI. Additionally, we previously reported that changes in FA and
RD correlate with changes in the MRS measured metabolite, glutamine21 over a season of
play in female varsity rugby players. Moreover, we further found that these same female
contact athletes have elevated Gln/Cr and glutamine levels compared to non-contact
athletes and nonathletes,32 suggesting that repetitive sub-concussive impacts can
influence brain metabolism.
The force and direction of impact can vary greatly in different animal models of
concussion. The majority of studies utilizing MRS have examined the effects of
moderate and severe traumatic injuries using a fluid percussion injury,33–35 controlled
cortical impact,10,36–38 or a blast injury,28,29 rather than concussion (e.g. closed head
impact model, see Table 1.4). Additionally, for closed head impact (CHI) studies, MRS
has mainly been used to examine the effects of a single impact, rather than repetitive head
injury (See Table 1.4). The majority of single CHI have used a weight drop model of
450g8,31,39,40 with drop heights from 25-100 cm characterized as mild injuries, and >100
cm characterized as moderate to severe, with high mortality rates. Closed-head controlled
cortical impact models have also been used with 5mm diameter tips at 5-4 m/s at a depth
of 1 mm being characterized as mild.26,41,42
Investigating the effect of mild repetitive head impacts is critical to interpreting
the changes observed following sport induced concussion. We propose that the
metabolic response of the brain after a single concussive injury will be different to the
response observed after a similar impact delivered within the context of multiple subconcussive hits akin to what occurs in high impact sports. Understanding the metabolic
changes that occur following multiple light impacts is the first step in answering this
important question, which has immediate parallels to the effects of sub-concussive
impacts in contact sports. Therefore, the objective of this study was to investigate the
changes and potential associations between brain metabolite levels measured by MRS
and brain microstructure measured by DTI in the mouse brain after a repeated closed
head injury paradigm. Based on the results of previous studies,42,43 as well as our own
recent findings21,32 in humans, we hypothesized reduced NAA levels, as well as increases
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in glutamine, would be associated with altered tissue microstructure.

4.2 Methods
4.2.1

Study Design

Sixty C57BL/6J male mice (weight 22.5 ± 2.5 g) were divided into five groups, control
(n=12), 48 hours post-injury (n=12), 1-week (n=12), 4 weeks (n=12), and 10 weeks postinjury (n=12). In preparation for injury, mice were anaesthetized by induction with 4%
isoflurane followed by maintenance with 2% isoflurane. The animal was positioned under
a traumatic brain injury device (TBI 0310, Precision Systems and Instrumentation, LLC).
Following a 10 mm midline incision, the skin and fascia were reflected, and the animals
received a mild controlled cortical impact, centered at the sagittal suture, with a 5 mmdiameter, pliant, silicone tip. The device was programmed to impact at a depth 1.0 mm at
a 3.5 m/s velocity with a 500 ms dwell time. Animals received one impact per day for
five days. Imaging followed at 48-hours, 1 week, 4 weeks, or 10 weeks after the final
impact (different mice were studied at each time point). Control mice received no surgery
or impacts.

4.2.2

Data Acquisition

All imaging and spectroscopy were performed on an Agilent 9.4 Tesla small-bore MRI
scanner (Santa Clara, CA, U.S.A.) at the Robarts Research Institute using a Millipede
MP30, or MP40 radio frequency coil. The MP40 coil was used at the last timepoint due
to failure of the MP30 coil. Diffusion Tensor Imaging (DTI) was acquired using a spinecho acquisition sequence (TE=36 ms, TR=1s, max b-value=1085 s/mm2, 12 gradient
directions, FOV=18.75 mm, 128x128 matrix, 31 – 0.5 mm thick slices). A 2D fast spinecho anatomical image (TR/TE=4000/10ms; FOV=19.2x19.2 mm2; matrix=128x128;
slice thickness=0.5 mm) was acquired for tissue/CSF segmentation. Magnetic resonance
spectra were acquired from a 2 x 6 x 3 mm3 voxel encompassing both hippocampi
(Figure 4.1) using VAPOR water suppression44 and the localization by adiabatic selective
refocusing (LASER) pulse sequence (TR/TE=3250/18.9 ms; averages=128/8; HS2 R15
adiabatic full passage pulses; bandwidth=6000 Hz).45 Acquisition of a macromolecule
only spectra was interleaved with the acquisition of the full spectrum using a single-
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inversion recovery technique as previously described46 to remove the contribution of
macromolecules to the spectrum in post-processing.

B

A

Figure 4.1: Masks utilized for diffusion tensor imaging analysis of brain microstructure.
(A) Regions of interest were defined for white matter including Corpus Callosum (teal
binary mask), and hippocampus (yellow binary mask). (B) A typical voxel placement
(green outline) for 1H MRS in the mouse brain including both hippocampi (2 x 6 x 3
mm3).

4.2.3

Post-Processing and Statistical Analysis

DTI images were pre-processed using fMRI Software Library (FSL, v.5.0.10, Oxford,
UK). Images were first registered to a C57BL/6J atlas using a linear transformation
(FLIRT)47 followed by a non-linear registration (FNIRT)48 in FSL. The resulting
transformation matrices were then inverted and used to bring masks of the corpus
callosum and hippocampus back into the diffusion space of each subject, where mean
diffusion parameter values for each region were then extracted. Mean region of interest
(ROI) analysis was performed and focused on two relevant regions of interest: the corpus
callosum and the hippocampus (Figure 4.1). Within each ROI the mean fractional
anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity
(RD) values were extracted.
All spectra were lineshape and eddy current corrected using combined QUALITY
deconvolution (400 points) and eddy current correction.49 Macromolecules were then
fitted using a Hankel singular value decomposition (HSVD)50 and subtracted from the
metabolite spectrum. Using in-house analysis software, suppressed (post macromolecule
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subtraction) and unsuppressed spectra were fitted in the time domain using prior
knowledge produced by density matrix simulations51 incorporated into a LevenbergMarquardt minimization routine52 (Figure 4.2). Metabolites included in the prior
knowledge template included N-acetyl aspartate (NAA), alanine, $-aminobutyric acid
(GABA), aspartate, choline, glycerophosphorylcholine (GPC), phosphorylcholine
(PCho), creatine (Cr), glucose, glutamate (Glu), glutamine (Gln), glutathione, glycine,
myo-inositol (Myo), lactate, and taurine (See Table 4.1 and Figure 4.2).

5

4

3

2

1
Gly
Myo
tCr
tCho
Tau
GSH
Gln
Glu
Asp
Ala
Lac
NAA

5

4

3
Frequency (ppm)

2

1

Figure 4.2: A typical 1H spectrum after post-processing and macromolecule subtraction
(orange), with the fitted spectrum (green) superimposed. The residual after fitting (blue)
is shown above, and the individual prior knowledge components of the spectrum are
shown below in black. Gly, Glycine; Myo, Myo-inositol; tCr, total Creatine; tCho; total
Choline; Tau, Taurine; GSH; Glutathione; Gln, Glutamine; Glu, Glutamate; Asp,
Aspartate; Ala, Alanine; Lac, Lactate; NAA, N-acetyl asparate; ppm, parts per million.
(Note that GABA and glucose are not shown, as they fit to zero in this dataset)

128

Metabolite absolute concentrations and ratios relative to Cr were calculated in this
study. Absolute concentrations incorporated a correction to account for tissue partial
volume (Tissue and CSF) obtained by segmenting the 2D fast spin-echo anatomical
image. Absolute concentrations also account for T1 and T2 relaxation related signal loss
using the constants listed in Table 4.1. For spectra acquired from the MP40 coil, the
unsuppressed spectra were scaled to match the mean water signal obtained from MP30
coil. Metabolite ratios relative to Cr were also calculated, to eliminate the uncertainty
associated with partial volume and relaxation corrections from influencing the results.
Signal-to-noise ratio (SNR) was measured as the N-acetyl aspartate peak height
divided by the standard deviation of the noise. Spectra with an SNR <10 or water
linewidth >30 Hz were not included in the analysis. Metabolites with a coefficient of
variation >40% were excluded from the statistical analysis, except for glutamine
(CV>40%), which was left in due to the overall study hypothesis.
All statistical analyses were performed using GraphPad Prism Version 7.0
for Mac OS X (GraphPad Software, San Diego, CA). The ROUT method and D’Agostino
& Pearson normality test were performed on each metabolite in each group to remove
outliers and test for normality, respectively. A one-way ANOVA (or Kruskal-Wallis) was
used to assess statistical significance (%=0.05) across groups, using Tukey’s multiple
comparisons correction (or Dunn’s Test). The associations between metabolic changes
and metrics of tissue microstructural integrity were examined using two-tailed Spearman
correlations (%=0.05).
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Table 4.5.
Relaxation
Constants Constants
used to correct
1 and T2for
related
signal
loss
Table
4.1: Relaxation
usedfortoTcorrect
T1 and
T2 related
signal loss
Grey Matter
Metabolite Protons T 1 (s)
T 2 (ms)
NAA
NAAG
Alanine
GABA
Aspartate
Choline
GPC
PCho
Creatine
Glucose
Glutamate
Glutamine
Glutathione
Glycine
Myo
Scyllo
Lactate
Taurine
Water

3
3
4
6
3
9
9
9
3
6
5
5
7
2
5
6
3
4
2

1.67
1.67
1.37
1.37
1.37
1.35
1.35
1.35
1.04
1.37
1.50
1.50
1.37
1.37
1.37
1.37
1.37
2.33
2.16

294
294
148
105
148
441
441
441
128
104
89
116
106
148
148
148
148
93
44

White Matter
T 1 (s)
T 2 (ms)
1.67
1.67
1.37
1.37
1.37
1.35
1.35
1.35
1.04
1.37
1.50
1.50
1.37
1.37
1.37
1.37
1.37
2.33
2.16

294
294
148
105
148
441
441
441
128
104
89
116
106
148
148
148
148
93
44

T 1 (s)
4.29

CSF
T 2 (ms)
111

4.3 Results
4.3.1

Quality Assurance Measures

The spectroscopy voxel placed over the hippocampus was composed of (mean ±
standard deviation) 94 ± 3 % tissue and 6 ± 3 % CSF. For all data sets the average fullwidth at half maximum of the water peak was 20 ± 3 Hz and the average SNR was 14.7
± 4. All spectra were visually inspected prior to statistical analyses for artefacts. Four
spectra were eliminated due to insufficient data quality and SNR (<10), and outliers were
removed for each data set according to the ROUT test (including DTI data sets). CramérRao Lower Bounds (CRLB) were not used to eliminate metabolite measurements to
avoid bias selection,53 however, average CRLBs were 3% for NAA, 13% for lactate, 5%
for glutamate, 56% for glutamine, 9% for glutathione, 2% for creatine, 2% for taurine,
and 21% for choline.

4.3.2

Diffusion Tensor Imaging

DTI results of the hippocampus and corpus callosum are shown in Figure 4.3. Significant
differences were observed in FA (p < 0.0001) and RD (p = 0.0004) in the hippocampus,
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as well as in FA (p = 0.003) and RD (p = 0.0048) in the white matter (corpus callosum).
There was a statistically significant increase in FA in the hippocampus (Figure 4.3A) at
48 hours in comparison to the control group (p = 0.019), that persisted out to 1-week (p =
0.015). A similar increase in FA was observed in the white matter (Figure 4.3B; p =
0.037) but it did not persist at later time points (p > 0.05). This increase in FA was driven
by a significant reduction in RD. In the hippocampus (Figure 4.3C) RD was reduced at
48 hours in comparison to the 10-week group (p = 0.0027), and the decrease remained at
1-week (p = 0.0014) and 4-weeks (p = 0.043). In the white matter (Figure 4.3D) RD was
reduced at 48 hours in comparison to the control group (p = 0.0026), but by 4-weeks had
significantly increased (p = 0.036) back toward baseline levels. There were no
statistically significant changes in mean diffusivity (MD) or axial diffusivity (AD) at any
timepoints in either region.
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differences from 48 hours, and the symbol (&) indicates significant differences from the
10-week group

4.3.3

Magnetic Resonance Spectroscopy and Correlations

Gln/Cr was significantly different (Figure 4.4A; p = 0.033), with increased levels at 10
weeks compared to 48 hours (p = 0.045). Furthermore, examining absolute glutamine
levels, the ANOVA showed a significant difference (Figure 4.4B; p = 0.025) among
groups, but individual comparisons between groups were did not reach the level of
significance (p = 0.07). Additionally, negative correlations between glutamine and MD
(Figure 4.4C; p = 0.037, r2 = 0.4), and RD (Figure 4.4D; p = 0.046, r2 = 0.37) were
observed at 10 weeks in the white matter.
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NAA/Cr was also found to be different across groups (Kruskal-Wallis p = 0.04,
Figure not shown), but individual comparisons between groups did not reach significance
(Dunn’s test, p>0.05). Measurement of absolute metabolite levels revealed decreased
NAA (Figure 4.5A; p = 0.018) from 48 hours to the 1-week group (p = 0.018).
Additionally, creatine concentrations were significantly different (Figure 4.5B; p =
0.013), with reduced levels at 10 weeks in comparison to the control group (p = 0.011).
Furthermore, NAA concentrations were positively correlated with FA in the white matter
(Figure 4.5C; p = 0.011, r2 = 0.11). Examining individual time points, this correlation was
only significant at 48 hours (Supplementary Figure 4.1A; p = 0.0094, r2 = 0.54). A similar
positive correlation was observed between creatine and FA in the white matter (p =
0.015, r2 = 0.11, data not shown) and at 48 hours (Supplementary Figure 4.1B; p = 0.013,
r2 = 0.51).
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and (C) FA in the corpus callosum (p = 0.011, r2 = 0.11), and (D) Creatine levels (p<0.0001,
r2 = 0.27) are plotted with 95% confidence bands
Glu/Cr was also found to be different across groups (Figure 4.6A; p = 0.026),
with significantly higher levels at 10 weeks in comparison to control levels (p = 0.035)
and 1-week levels (p = 0.049). Measurement of absolute metabolite levels revealed
differences in glutamate (Figure 4.6B; p = 0.044), but the increase did not survive posthoc testing (p = 0.056). Additionally, a negative correlation was observed between
glutamate and FA in the hippocampus (Figure 4.6C; p = 0.0014, r2 = 0.18), which was
driven by an increase in RD (Figure 4.6D; p = 0.003, r2 = 0.16). A similar correlation
with FA (Figure 4.6E; p = 0.005, r2 = 0.15) and RD (Figure 4.6F; p = 0.036, r2 = 0.09)
was found in the white matter.

k

k
10

W
ee

k

r

Glutamate vs RD (Hippocampus)
0.0015

0.4

0.0010

FA

RD

0.6

0.0005

0.2

0.0

0

2

4

0.0000

6

0

2

F

Glutamate vs FA (Corpus Callosum)

6

Glutamate vs RD (Corpus Callosum)
0.0010

0.45

0.0009

0.40

0.0008

FA

RD

0.50

0.35

0.0007
0.0006

0.30
0.25

4

Glutamate

Glutamate

E

W
ee

on
tr

D

Glutamate vs FA (Hippocampus)

W
ee

k

ol

0

W
ee

k
4

10

W
ee

k

r

W
ee

ou
H

1

C

48

C

on
tr
ol

0.0

2

ou

0.5

4

H

1.0

1

1.5

6

48

*

Absolute Concentration (mM)

2.0

Glutamate

B

C

*

4

Glu/Cr

A

0

2

4

0.0005

6

0

2

4

6

Glutamate

Glutamate

Figure 4.6. (A-B) Bar graphs indicating the individual mouse and mean values for Glu/
Cr and Glutamate, with standard error of the mean. (A) Glu/Cr was found to be
Figure 4.6: (A-B)
Bar graphs
indicating
mouse
and mean
values fortoGlu/Cr
significant
(ANOVA,
p = 0.026)the
withindividual
increased levels
at 10weeks
in comparison
controls (p = 0.035) and 1week (p = 0.049). (B) Glutamate concentration was found to
and Glutamate,bewith
standard
errorpof= 0.044),
the mean.
(A) Glu/Cr
was
to testing
be significant
significant
(ANOVA,
no significance
held
pastfound
post-hoc
(p =
2
0.056). Correlations between Glutamate and (C) FA (p = 0.0014, r = 0.18) and (D) RD
(p = 0.003, r2 = 0.16) in the hippocampus, and between (E) FA (p = 0.005, r2 = 0.15),
and (F) RD (p = 0.036, r2 = 0.09) in the corpus callosum are plotted with 95%
confidence bands

134

(ANOVA, p = 0.026) with increased levels at 10weeks in comparison to controls (p = 0.035)
and 1week (p = 0.049). (B) Glutamate concentration was found to be significant (ANOVA, p
= 0.044), no significance held past post-hoc testing (p = 0.056). Correlations between
Glutamate and (C) FA (p = 0.0014, r2 = 0.18) and (D) RD (p = 0.003, r2 = 0.16) in the
hippocampus, and between (E) FA (p = 0.005, r2 = 0.15), and (F) RD (p = 0.036, r2 = 0.09) in
the corpus callosum are plotted with 95% confidence bands
No significant changes were observed in Tau/Cr, but absolute taurine levels
significantly changed (Figure 4.7A; p = 0.0011), with reduced levels compared to
controls observed at 48 hours (p = 0.0007), 1-week (p = 0.013), and 10 weeks (p =
0.027). No correlations were found between taurine and DTI metrics. Although Lac/Cr
did not significantly change, absolute lactate levels did (Figure 4.7B; p = 0.016), showing
increased levels at 48 hours in comparison to 10 weeks (p = 0.01). Additionally, a
positive correlation was observed between lactate and FA in the white matter (Figure
4.7C; p = 0.005, r2 = 0.14), which was driven by an increase in AD (Figure 4.7D; p =
0.001, r2 = 0.19). Examining individual time points, this FA correlation was only
significant at 48 hours (Figure 4.7E; p = 0.0019, r2 = 0.47). The same was true for AD
(Figure 4.7F; p = 0.015, r2 = 0.5). No other significant changes or correlations were
observed.
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was found to be significant (ANOVA, p = 0.016) with reduced levels at 10 weeks compared
to 48 hours (p = 0.01). Correlations between Lactate and (C) FA (p = 0.005, r2 = 0.14) and
(D) AD (p = 0.001, r2 = 0.19) in the corpus callosum, and between (E) FA (p = 0.0019, r2 =
0.47), and (F) AD (p = 0.015, r2 = 0.5) at 48 hours in the corpus callosum are plotted with
95% confidence bands

4.4 Discussion and Conclusion
The purpose of this study was to investigate the changes and potential associations
between brain metabolite levels measured by MRS and brain microstructure measured by
DTI in the mouse brain after a repeated mild closed head injury paradigm. We
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hypothesized reduced NAA levels, as well as increases in glutamine, would be associated
with altered tissue microstructure. Acutely, at 48 hours, we found elevated FA driven by
reduced RD in the hippocampus and white matter within the MRS voxel (corpus
callosum). We additionally observed elevated lactate at 48 hours, followed by reduced
NAA at 1 week. By 10 weeks we observed reduced Taurine levels and elevated Gln/Cr
and Glu/Cr which were driven by reduced creatine and elevated Gln and Glu (trends).
Moreover, several correlations were observed at various timepoints after injury. Most
importantly, glutamine was found inversely correlated with MD and RD at 10 weeks, and
NAA was positively correlated with FA.

4.4.1

Diffusion Tensor Imaging

In the current study, ROI analyses of the hippocampus and white matter revealed
transient increases in FA and decreases in RD. These results are consistent with several
previous studies of concussion. For example, Kikinis et al. (2017)54 found increased FA
in the corpus callosum, the fimbria of the hippocampus and in other regions of the injured
rat brain, using a weight drop model. Moreover, increases in FA in the corpus callosum
has been reported in mTBI studies in humans.55–58 These changes could be associated
with neuroinflammation as well as remyelination.59,60 Additionally, Li et al., (2017)9
speculated that astrocyte proliferation is the main cause of increased FA after TBI.
However, two previous studies of repeated head injury in mice found somewhat different
results. Bennett and colleagues (2012)6 reported no changes in DTI metrics at 24 hours
post-injury but found reduced AD and MD at 1-week post-injury in the corpus callosum.
The timeline of changes was similar to the current study, however the DTI metrics
observed to change were different. Bennett and colleagues (2012)6 used a 2-hit paradigm,
rather than the 5-hit paradigm used in the current study, as well as different impact
parameters including a larger impactor tip (9 versus 5 mm), greater depth (3.3 versus 1
mm) and velocity (5 versus 3.5 m/s). Another study by Yu and colleagues (2016)61 found
reduced AD at 3, 6, and 42 days post injury in the cerebral cortex, and reduced FA at 42
days in the corpus callosum. Interestingly, Yu et al., (2016)61 also used a 5-hit paradigm
and similar impact parameters (3 mm tip, 4 m/s, 1 mm depth), but followed a longitudinal
study design, rather than a cross-sectional design as implemented in the current study.
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The increased FA and reduced RD in the current study are also consistent with
our own previous findings in non-concussed contact sport athletes.21 Specifically, we
observed increased FA and reduced RD within the white matter of the MRS voxel in
female rugby players after a season of contact play. Interestingly, a correlation was
observed between the change in Gln/Cr and the change in FA and RD over the sports
season. We observed a similar correlation in the current study between glutamine and RD
at 10 weeks. The similarities observed here with non-concussed rugby players suggest
that the mild 5- hit paradigm may be a suitable model of repetitive sub-concussive
impacts.

4.4.2

1

H MRS: Glutamine

In a previous study by our group in female varsity rugby players, we observed a large
reduction in glutamine levels after concussion, as well as a smaller reduction after a
season of contact play in athletes with no diagnosed concussion.21 More recently, we
have shown that Gln/Cr and absolute glutamine levels are increased in these same female
varsity rugby players compared to varsity athletes involved in non-contact sports and
non-athletes.32 These previous studies provided the motivation to investigate the effects
of multiple light impacts over a short period of time in an animal model to determine
whether glutamine levels would increase in comparison to controls and to explore
potential associations with DTI metrics. Despite the large variability in the glutamine
measurements, the current study did find increased Gln/Cr at 10 weeks post injury
compared to the 48-hour time point in the hippocampus (and corpus callosum). There
was also a trend (p<0.1) toward higher absolute glutamine levels at 10 weeks compared
to 48 hours after injury. Therefore, the significant increase in Gln/Cr is likely due to a
small increase in glutamine, and a concomitant reduction in creatine. Interestingly, this
change in Gln/Cr level is consistent with that observed in the varsity rugby athletes in
comparison the non-contact athletes.32 We speculate that the five hits in five days
paradigm used in the current study may simulate the impact conditions that contact
athletes experience over a season of play, eventually causing elevated glutamine levels.
Although the reason for this glutamine increase is currently unknown, there are several
potential explanations that could be explored in future studies. For example, we speculate
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that elevated glutamine levels may be the results of a primed microglia profile62 in the
brain after repetitive impacts. Glutamine’s main role in the brain is its involvement in
neurotransmission by shuttling glutamate back to the neuron through astrocytes.63 The
conversion of glutamate to glutamine is performed by the enzyme, glutamine
synthetase.63 Microglia have also been shown to express this enzyme, although they
hardly convert glutamate into glutamine.62,63 However, studies have shown persistent
microglia activation after brain injury,62 and have shown that in this state microglia will
increase the metabolism of glutamate to glutamine, to prevent dangerous levels of
extracellular glutamate.63 It is possible that persistent microglia activation manifests as a
shift in the glutamate-glutamine equilibrium, resulting in elevated glutamine levels.
We also previously found changes in Gln/Cr and glutamine to negatively
correlate with changes in FA and positively correlate with changes in RD in female
contact athletes after a season of play.21 In the current study, we did observe negative
correlations between glutamine and MD as well as RD at the 10-week time point.
However, a direct comparison cannot be made as a cross sectional study design was used
in the current study, while our previous study in rugby players used longitudinal
measures.

4.4.3

1

H MRS: N-acetyl Aspartate and Glutamate

Reduced NAA concentrations were observed in the current study as we hypothesized, but
not until 1-week post-injury, compared to 48 hours. There was no change detected
compared to the control group, which may be in part due to the lack of a sham surgery.
For example, Lyons and colleagues (2018)26 used a block experimental design in mice
with a traditional sham set up (surgery without TBI/CHI), and found reductions in NAA
3 days post injury, in a similar voxel to this current study, in a closed head impact model
(See Table 1.4). Moreover, a recent study by Fidan et al., (2018)42 that incorporated a
repeated measures paradigm in male rats, observed reduced NAA/Cr in the hippocampus
compared to shams at 1-week post injury. Signoretti et al., (2010)40 also found reduced
NAA at 2 hours, 4 hours, 1 day and 2 days post injury, but by using high-performance
liquid chromatography on deproteinized whole brain extracts rather than in vivo MRS.
Furthermore, using a repeated measures paradigm might also have increased sensitivity to
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changes in NAA levels after injury. For example, a study by Vagnozzi and colleagues
(2005)43 using a 2 hits paradigm found reduced NAA in whole brain extracts 2 days postinjury using a weight drop model.
The NAA correlation with FA, and lack of correlation with glutamate, may
suggest altered oxidative metabolism that reflects impaired glutamatergic signaling. NAA
is synthesized in the neuronal mitochondria and is constantly transported along axons into
oligodendrocytes to be used in myelin synthesis and maintenance, and is also thought to
be an osmolyte.64 NAA and FA values have been found to correlate in other studies65
suggesting that changes in NAA and tissue microstructure are linked. Interestingly, NAA
levels were positively correlated with FA in the white matter in this study. Furthermore, a
study looking at normal aging in mice, showed that NAA levels and glutamate levels
correlated extremely well (r2=0.859), because both metabolites mainly reside in
neurons.66 However, no such correlation was found in the current study, suggesting
alteration from healthy aging. Additionally, in the same study of normal aging,66
reductions in glutamate were observed in the hippocampal region at 12, 18, and 24
months, when compared to 3 months. The current study found increased Glu/Cr over the
10-week period post-injury, with a trend towards increased glutamate, reflective of
altered oxidative metabolism or excitotoxicity. This is further supported by the elevated
Gln/Cr, discussed earlier. Alternatively, other studies in the literature tended to observe
decreases in glutamate,38,67 however both of these studies used 13C MRS ex vivo. Lama
and colleagues (2014)67 used a modified weight drop model of severe TBI, and observed
lower glutamate labeling 60 mins post TBI, while Robertson and colleagues (2013)38
used a controlled cortical impact model of TBI and found reduced glutamate labeling 24
hours post TBI.

4.4.4

1

H MRS: Other Metabolite Changes

A small decrease in creatine at 10 weeks post-injury compared to control, and a positive
correlation with FA was observed. Several other studies using mice, rats, and rabbits have
also observed decreases in creatine after head injuries.26,28,68 Although a small decrease in
creatine was observed, the magnitude is larger than the expected reductions in creatine
observed over 21 months in healthy mice.66 The creatine signal is composed of creatine
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and phosphocreatine, which are involved in tissue energy metabolism.69 It has been
suggested that phosphocreatine serves as an energy shuttle between mitochondria and
other sites in the brain.69 Interestingly, NAA and creatine levels were positively
correlated. Given that NAA is synthesized in the mitochondria where phosphocreatine
serves as an energy shuttle, mitochondrial energetics may explain why these metabolites
were correlated.
Lactate was also increased at 48 hours compared to 10-weeks. Interpreting this is
challenging without a significant difference from the control group, which again could be
due to the lack of a traditional sham group. Lactate is the end product of anaerobic
glycolysis,69 and has been shown to increase in more severe cases of TBI,31,67 due to the
presence of hypoxic/ischemic conditions. This result suggests a reduction in oxidative
metabolism in favour of anaerobic glycolysis 48 hours after the 5-hits paradigm, which
resolves by 10-weeks.
In addition to the lactate change, lower taurine levels were observed 10-weeks
post injury compared to all other time points. Singh et al., (2016)8 found reduced Tau/Cr
five days after a single mTBI, and suggested that the reduction may be due to taurine’s
role in cell volume regulation, where astrocytes re-establish normal volume after injury
by extrusion of ions and amino acids such a taurine.70 Additionally, it has been suggested
that taurine release may be driven by activation of glutamate receptors,71 however no
correlations were observed between taurine and glutamate. The subsequent decrease in
taurine and creatine likely explain why no change was observed in Tau/Cr, further
demonstrating the importance of quantifying absolute measures in addition to using the
ratio method.

4.4.5

Limitations and Future Work

There are several limitations to the current study. With regard to the animal model, we
studied repeated impacts at 24-hour intervals in male mice. The first limitation of this
work is that we did not examine differences between male and female animals. Since
differences have been reported between male and female mice,26 and our hypotheses
were mainly derived from our previous studies of female athletes, future work must
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include direct comparison of metabolite changes in male and female mice. Another
limitation is that we did not explore the effect of the number of hits delivered, or the
timing between hits, which was beyond the scope of the current work. A third limitation
is that the mice used in the current study did not undergo cognitive and behavioural
testing. A separate cohort of mice was used for this purpose limiting the examination of
direct associations between imaging and behavioral measures (5-choice reaction time and
paired discrimination), and will be reported elsewhere with the histology findings
(GFAP, Iba-1, silver staining, NeuN/APP, and cleaved casp3). Finally, relating to the
metabolite level measurements, the variance was high for many of the lower amplitude
metabolites, including glutamine, making interpretations challenging. Lower variability
may be achieved in the future with a larger sample size, the incorporation of a
longitudinal study design, and the use of spectral editing techniques to improve
measurement of glutamine specifically.72,73

4.4.6

Conclusions

The purpose of this study was to investigate the changes and potential associations
between brain metabolite levels measured by MRS and brain microstructure measured by
DTI in the mouse brain after a repeated mild closed head injury paradigm. In this study,
we observed changes in hippocampal and white matter FA and RD, as well as NAA, and
lactate at early time points (e.g 48 hours and 1 week) compared to baseline and later time
points. Additional changes in creatine, taurine, Glu/Cr and Gln/Cr later following injury
(e.g. 10 weeks), point towards a subtle shift in the biochemical pathways involving these
metabolites to re-establish homeostasis.

4.5 References
1.

Bolton-Hall, A.N., Hubbard, W.B., and Saatman, K.E. (2018). Experimental
Designs for Repeated Mild Traumatic Brain Injury: Challenges and
Considerations. J. Neurotrauma 19, 1–19.

2.

Alexander, A., Lee, J., Lazar, M., and Field, A. (2007). Diffusion Tensor Imaging
of the Brain. Neurotherapeutics 4, 316–329.

142

3.

Chamard, E., and Lichtenstein, J.D. (2018). A systematic review of neuroimaging
findings in children and adolescents with sports-related concussion. Brain Inj. 32,
816–831.

4.

Manning, K.Y., Schranz, A., Bartha, R., Dekaban, G.A., Barreira, C., Brown, A.,
Fischer, L., Asem, K., Doherty, T.J., Fraser, D.D., Holmes, J., and Menon, R.S.
(2017). Multiparametric MRI changes persist beyond recovery in concussed
adolescent hockey players. Neurology , 10.1212/WNL.0000000000004669.

5.

Asken, B.M., DeKosky, S.T., Clugston, J.R., Jaffee, M.S., and Bauer, R.M.
(2018). Diffusion tensor imaging (DTI) findings in adult civilian, military, and
sport-related mild traumatic brain injury (mTBI): a systematic critical review.
Brain Imaging Behav. 12, 585–612.

6.

Bennett, R.E., Mac Donald, C.L., and Brody, D.L. (2012). Diffusion tensor
imaging detects axonal injury in a mouse model of repetitive closed-skull
traumatic brain injury. Neurosci. Lett. 513, 160–165.

7.

Robinson, S., Berglass, J.B., Denson, J.L., Berkner, J., Anstine, C. V., Winer, J.L.,
Maxwell, J.R., Qiu, J., Yang, Y., Sillerud, L.O., Meehan, W.P., Mannix, R., and
Jantzie, L.L. (2017). Microstructural and microglial changes after repetitive mild
traumatic brain injury in mice. J. Neurosci. Res. 95, 1025–1035.

8.

Singh, K., Trivedi, R., Haridas, S., Manda, K., and Khushu, S. (2016). Study of
neurometabolic and behavioral alterations in rodent model of mild traumatic brain
injury: a pilot study. NMR Biomed. 29, 1748–1758.

9.

Li, J., Zhao, C., Rao, J.S., Yang, F.X., Wang, Z.J., Lei, J.F., Yang, Z.Y., and Li,
X.G. (2017). Structural and metabolic changes in the traumatically injured rat
brain: high-resolution in vivo proton magnetic resonance spectroscopy at 7 T.
Neuroradiology 59, 1203–1212.

10.

Harris, J.L., Yeh, H.W., Choi, I.Y., Lee, P., Berman, N.E., Swerdlow, R.H.,
Craciunas, S.C., and Brooks, W.M. (2012). Altered neurochemical profile after

143

traumatic brain injury: 1 H-MRS biomarkers of pathological mechanisms. J.
Cereb. Blood Flow Metab. 32, 2122–2134.
11.

Giza, C.C., and Hovda, D.A. (2014). The New Neurometabolic Cascade of
Concussion. Neurosurgery 75, S24–S33.

12.

Graham, R., Rivara, F., Ford, M., and Spicer, C. (2014). Sports-Related
Concussions in Youth: Improving the Science, Changing the Culture. 239 p.

13.

Vagnozzi, R., Signoretti, S., Floris, R., Marziali, S., Manara, M., Amorini, A.M.,
Belli, A., Di Pietro, V., D’Urso, S., Pastore, F.S., Lazzarino, G., and Tavazzi, B.
(2013). Decrease in N-acetylaspartate following concussion may be coupled to
decrease in creatine. J. Head Trauma Rehabil. 28, 284–292.

14.

Johnson, V.E., Stewart, W., and Smith, D.H. (2013). Axonal pathology in
traumatic brain injury. Exp. Neurol. 246, 35–43.

15.

Manning, K.Y., Schranz, A., Bartha, R., Dekaban, G.A., Barreira, C., Brown, A.,
Fischer, L., Asem, K., Doherty, T.J., Fraser, D.D., Holmes, J., and Menon, R.S.
(2017). Multiparametric MRI changes persist beyond recovery in concussed
adolescent hockey players.[Erratum appears in Neurology. 2018 May
29;90(22):1039; PMID: 29807924]. Neurology 89, 2157–2166.

16.

Tremblay, S., De Beaumont, L., Henry, L.C., Boulanger, Y., Evans, A.C.,
Bourgouin, P., Poirier, J., Théoret, H., and Lassonde, M. (2013). Sports
concussions and aging: a neuroimaging investigation. Cereb. Cortex 23, 1159–66.

17.

Lin, A.P., Ramadan, S., Stern, R.A., Box, H.C., Nowinski, C.J., Ross, B.D., and
Mountford, C.E. (2015). Changes in the neurochemistry of athletes with repetitive
brain trauma: preliminary results using localized correlated spectroscopy.
Alzheimers. Res. Ther. 7, 13.

18.

Henry, L.C., Tremblay, S., Leclerc, S., Khiat, A., Boulanger, Y., Ellemberg, D.,
and Lassonde, M. (2011). Metabolic changes in concussed American football
players during the acute and chronic post-injury phases. BMC Neurol. 11, 105.
144

19.

Chamard, E., Lassonde, M., Henry, L., Tremblay, J., Boulanger, Y., De Beaumont,
L., and Théoret, H. (2013). Neurometabolic and microstructural alterations
following a sports-related concussion in female athletes. Brain Inj. 27, 1038–1046.

20.

Henry, L.C., Tremblay, S., Boulanger, Y., Ellemberg, D., and Lassonde, M.
(2010). Neurometabolic Changes in the Acute Phase after Sports Concussions
Correlate with Symptom Severity. J. Neurotrauma 27, 65–76.

21.

Schranz, A.L., Manning, K.Y., Dekaban, G.A., Fischer, L., Jevremovic, T.,
Blackney, K., Barreira, C., Doherty, T.J., Fraser, D.D., Brown, A., Holmes, J.,
Menon, R.S., and Bartha, R. (2018). Reduced brain glutamine in female varsity
rugby athletes after concussion and in non-concussed athletes after a season of
play. Hum. Brain Mapp. 39, 1489–1499.

22.

Vagnozzi, R., Signoretti, S., Floris, R., Marziali, S., Manara, M., Amorini, A.M.,
Belli, A., Di Pietro, V., Dʼurso, S., Pastore, F.S., Lazzarino, G., and Tavazzi, B.
(2013). Decrease in N-acetylaspartate following concussion may be coupled to
decrease in creatine. J. Head Trauma Rehabil. 28, 284–92.

23.

Johnson, B., Gay, M., Zhang, K., Neuberger, T., Horovitz, S.G., Hallett, M.,
Sebastianelli, W., and Slobounov, S. (2012). The Use of Magnetic Resonance
Spectroscopy in the Subacute Evaluation of Athletes Recovering from Single and
Multiple Mild Traumatic Brain Injury. J. Neurotrauma 29, 2297–2304.

24.

Lin, A.P., Shic, F., Enriquez, C., and Ross, B.D. (2003). Reduced glutamate
neurotransmission in patients with Alzheimer’s disease -- an in vivo (13)C
magnetic resonance spectroscopy study. MAGMA 16, 29–42.

25.

Kenzie, E.S., Parks, E.L., Bigler, E.D., Lim, M.M., Chesnutt, J.C., and Wakeland,
W. (2017). Concussion as a multi-scale complex system: An interdisciplinary
synthesis of current knowledge. Front. Neurol. 8, 1–17.

26.

Lyons, D.N., Vekaria, H., Macheda, T., Bakshi, V., Powell, D.K., Gold, B.T., Lin,
A.-L., Sullivan, P.G., and Bachstetter, A.D. (2018). A Mild Traumatic Brain Injury

145

in Mice Produces Lasting Deficits in Brain Metabolism. J. Neurotrauma 35, 2435–
2447.
27.

Zhang, F., Wu, H., Jin, Y., and Zhang, X. (2018). Proton Magnetic Resonance
Spectroscopy (H1-MRS) Study of the Ketogenic Diet on Repetitive Mild
Traumatic Brain Injury in Adolescent Rats and Its Effect on Neurodegeneration.
World Neurosurg. 120, e1193–e1202.

28.

Tang, S., Xu, S., Fourney, W.L., Leiste, U.H., Proctor, J.L., Fiskum, G., and
Gullapalli, R.P. (2017). Central Nervous System Changes Induced by Underbody
Blast-Induced Hyperacceleration: An in Vivo Diffusion Tensor Imaging and
Magnetic Resonance Spectroscopy Study . J. Neurotrauma 34, 1972–1980.

29.

Zhuo, J., Keledjian, K., Xu, S., Pampori, A., Gerzanich, V., Simard, J.M., and
Gullapalli, R.P. (2015). Changes in diffusion kurtosis imaging and magnetic
resonance spectroscopy in a direct cranial blast traumatic brain injury (dc-bTBI)
model. PLoS One 10, 1–18.

30.

Fievisohn, E.M., Sajja, V.S.S.S., Vandevord, P.J., and Hardy, W.N. (2014).
Evaluation of impact-induced traumatic brain injury in the Göttingen Minipig
using two input modes. Traffic Inj. Prev. 15 Suppl 1, S81-7.

31.

Singh, K., Trivedi, R., Verma, A., D’souza, M.M., Koundal, S., Rana, P., Baishya,
B., and Khushu, S. (2017). Altered metabolites of the rat hippocampus after mild
and moderate traumatic brain injury – a combined in vivo and in vitro 1H–MRS
study. NMR Biomed. 30, 1–11.

32.

Schranz, A.L., Dekaban, G.A., Fischer, L., Blackney, K., Barreira, C., Doherty,
T.J., Fraser, D.D., Brown, A., Holmes, J., Menon, R.S., and Bartha, R. (2019).
Metabolite Levels Differ in Contact and Non-Contact Sport Female Varsity
Athletes., in: International Society for Magnetic Resonance in Medicine. Montreal.

33.

Viant, M.R., Lyeth, B.G., Miller, M.G., and Berman, R.F. (2005). An NMR
metabolomic investigation of early metabolic disturbances following traumatic

146

brain injury in a mammalian model. NMR Biomed. 18, 507–516.
34.

Immonen, R.J., Kharatishvili, I., Niskanen, J.P., Gröhn, H., Pitkänen, A., and
Gröhn, O.H.J. (2009). Distinct MRI pattern in lesional and perilesional area after
traumatic brain injury in rat - 11 months follow-up. Exp. Neurol. 215, 29–40.

35.

Lescot, T., Fulla-Oller, L., Po, C., Chen, X.R., Puybasset, L., Gillet, B., Plotkine,
M., Meric, P., and Marchand-Leroux, C. (2009). Temporal and Regional Changes
after Focal Traumatic Brain Injury. J. Neurotrauma 27, 85–94.

36.

Casey, P.A., McKenna, M.C., Fiskum, G., Saraswati, M., and Robertson, C.L.
(2008). Early and Sustained Alterations in Cerebral Metabolism after Traumatic
Brain Injury in Immature Rats. J. Neurotrauma 25, 603–614.

37.

Xu, S., Zhuo, J., Racz, J., Shi, D., Roys, S., Fiskum, G., and Gullapalli, R. (2011).
Early Microstructural and Metabolic Changes following Controlled Cortical
Impact Injury in Rat: A Magnetic Resonance Imaging and Spectroscopy Study. J.
Neurotrauma 28, 2091–2102.

38.

Robertson, C.L., Saraswati, M., Scafidi, S., Fiskum, G., Casey, P., and McKenna,
M.C. (2013). Cerebral Glucose Metabolism in an Immature Rat Model of Pediatric
Traumatic Brain Injury. J. Neurotrauma 30, 2066–2072.

39.

Pascual, J.M., Solivera, J., Prieto, R., Barrios, L., López-Larrubia, P., Cerdán, S.,
and Roda, J.M. (2007). Time Course of Early Metabolic Changes following
Diffuse Traumatic Brain Injury in Rats as Detected by 1 H NMR Spectroscopy . J.
Neurotrauma 24, 944–959.

40.

Signoretti, S., Di Pietro, V., Vagnozzi, R., Lazzarino, G., Amorini, A.M., Belli, A.,
D’Urso, S., and Tavazzi, B. (2010). Transient alterations of creatine, creatine
phosphate, N-acetylaspartate and high-energy phosphates after mild traumatic
brain injury in the rat. Mol. Cell. Biochem. 333, 269–277.

41.

Schneider, B.L., Ghoddoussi, F., Charlton, J.L., Kohler, R.J., Galloway, M.P.,
Perrine, S.A., and Conti, A.C. (2015). Increased Cortical Gamma-Aminobutyric
147

Acid Precedes Incomplete Extinction of Conditioned Fear and Increased
Hippocampal Excitatory Tone in a Mouse Model of Mild Traumatic Brain Injury.
J. Neurotrauma 33, 1614–1624.
42.

Fidan, E., Foley, L.M., New, L.A., Alexander, H., Kochanek, P.M., Hitchens,
T.K., and Bayır, H. (2018). Metabolic and Structural Imaging at 7 Tesla After
Repetitive Mild Traumatic Brain Injury in Immature Rats. ASN Neuro 10.

43.

Vagnozzi, R., Signoretti, S., Tavazzi, B., Cimatti, M., Amorini, A.M., Donzelli, S.,
Delfini, R., and Lazzarino, G. (2005). Hypothesis of the postconcussive vulnerable
brain: Experimental evidence of its metabolic occurrence. Neurosurgery 57, 164–
171.

44.

Tkác, I., Starcuk, Z., Choi, I.Y., and Gruetter, R. (1999). In vivo 1H NMR
spectroscopy of rat brain at 1 ms echo time. Magn. Reson. Med. 41, 649–56.

45.

Garwood, M., and DelaBarre, L. (2001). The return of the frequency sweep:
designing adiabatic pulses for contemporary NMR. J. Magn. Reson. 153, 155–77.

46.

Kassem, M.N.E., and Bartha, R. (2003). Quantitative proton short-echo-time
LASER spectroscopy of normal human white matter and hippocampus at 4 Tesla
incorporating macromolecule subtraction. Magn. Reson. Med. 49, 918–27.

47.

Jenkinson, M., Bannister, P., Brady, M., and Smith, S. (2002). Improved
optimization for the robust and accurate linear registration and motion correction
of brain images. Neuroimage 17, 825–41.

48.

Andersson, J., Jenkinson, M., and Smith, S. (2007). Non-linear registration, aka
spatial normalisation. FMRIB Technial Report TR07JA2. Oxford Cent. Funct.
Magn. Reson. Imaging Brain, Dep. Clin. Neurol. Oxford Univ. Oxford, UK , 22.

49.

Bartha, R., Drost, D.J., Menon, R.S., and Williamson, P.C. (2000). Spectroscopic
lineshape correction by QUECC: combined QUALITY deconvolution and eddy
current correction. Magn. Reson. Med. 44, 641–5.

148

50.

van den Boogaart, A., Ala-Korpela, M., Jokisaari, J., and Griffiths, J.R. (1994).
Time and frequency domain analysis of NMR data compared: an application to 1D
1H spectra of lipoproteins. Magn. Reson. Med. 31, 347–58.

51.

Wong, D., Schranz, A.L., and Bartha, R. (2018). Optimized in vivo brain
glutamate measurement using long-echo-time semi-LASER at 7 T. NMR Biomed.
31, 1–13.

52.

Bartha, R., Drost, D.J., and Williamson, P.C. (1999). Factors affecting the
quantification of short echo in-vivo1H MR spectra: Prior knowledge, peak
elimination, and filtering. NMR Biomed. 12, 205–216.

53.

Kreis, R. (2016). The trouble with quality filtering based on relative Cramér-Rao
lower bounds. Magn. Reson. Med. 75, 15–8.

54.

Kikinis, Z., Muehlmann, M., Pasternak, O., Peled, S., Kulkarni, P., Ferris, C.,
Bouix, S., Rathi, Y., Koerte, I.K., Pieper, S., Yarmarkovich, A., Porter, C.L.,
Kristal, B.S., and Shenton, M.E. (2017). Diffusion imaging of mild traumatic brain
injury in the impact accelerated rodent model: A pilot study. Brain Inj. 31, 1376–
1381.

55.

Bazarian, J.J., Zhong, J., Blyth, B., Zhu, T., Kavcic, V., and Peterson, D. (2007).
Diffusion Tensor Imaging Detects Clinically Important Axonal Damage after Mild
Traumatic Brain Injury: A Pilot Study. J. Neurotrauma 24, 1447–1459.

56.

Mayer, A.R., Bellgowan, P.S.F., and Hanlon, F.M. (2010). A prospective diffusion
tensor imaging study in mild traumatic brain injury. Neurology 74, 643–650.

57.

Hartikainen, K.M., Waljas, M., Isoviita, T., Dastidar, P., Liimatainen, S., Solbakk,
A.K., Ogawa, K.H., Soimakallio, S., Ylinen, A., and Öhman, J. (2010). Persistent
symptoms in mild to moderate traumatic brain injury associated with executive
dysfunction. J. Clin. Exp. Neuropsychol. 32, 767–774.

58.

Pasternak, O., Shenton, M., and Echlin, P. (2014). Erratum: Hockey Concussion
Education Project, Part 2. Microstructural white matter alterations in acutely
149

concussed ice hockey players: a longitudinal free-water MRI study. J. Neurosurg.
121, 498–500.
59.

Sasaki, T., Pasternak, O., Mayinger, M., Muehlmann, M., Savadjiev, P., Bouix, S.,
Kubicki, M., Fredman, E., Dahlben, B., Helmer, K.G., Johnson, A.M., Holmes,
J.D., Forwell, L.A., Skopelja, E.N., Shenton, M.E., Echlin, P.S., and Koerte, I.K.
(2014). Hockey Concussion Education Project, Part 3. White matter microstructure
in ice hockey players with a history of concussion: a diffusion tensor imaging
study. J. Neurosurg. 120, 882–90.

60.

Lipton, M.L., Kim, N., Park, Y.K., Hulkower, M.B., Gardin, T.M., Shifteh, K.,
Kim, M., Zimmerman, M.E., Lipton, R.B., and Branch, C.A. (2012). Robust
detection of traumatic axonal injury in individual mild traumatic brain injury
patients: intersubject variation, change over time and bidirectional changes in
anisotropy. Brain Imaging Behav. 6, 329–42.

61.

Yu, F., Shukla, D.K., Armstrong, R.C., Marion, C.M., Radomski, K.L., Selwyn,
R.G., and Dardzinski, B.J. (2016). Repetitive Model of Mild Traumatic Brain
Injury Produces Cortical Abnormalities Detectable by Magnetic Resonance
Diffusion Imaging, Histopathology, and Behavior. J. Neurotrauma 34, 1364–1381.

62.

Norden, D.M., Muccigrosso, M.M., and Godbout, J.P. (2015). Microglial priming
and enhanced reactivity to secondary insult in aging, and traumatic CNS injury,
and neurodegenerative disease. Neuropharmacology 96, 29–41.

63.

Nakajima, K., Kanamatsu, T., Takezawa, Y., and Kohsaka, S. (2015). Upregulation of glutamine synthesis in microglia activated with endotoxin. Neurosci.
Lett. 591, 99–104.

64.

Bittsansky, M., Vybohova, D., and Dobrota, D. (2012). Proton magnetic resonance
spectroscopy and its diagnostically important metabolites in the brain. Gen.
Physiol. Biophys. 31, 101–112.

65.

Goebell, E., Fiehler, J., Ding, X.Q., Paustenbach, S., Nietz, S., Heese, O.,

150

Kucinski, T., Hagel, C., Westphal, M., and Zeumer, H. (2006). Disarrangement of
fiber tracts and decline of neuronal density correlate in glioma patients - A
combined diffusion tensor imaging and1H-MR spectroscopy study. Am. J.
Neuroradiol. 27, 1426–1431.
66.

Duarte, J.M.N., Do, K.Q., and Gruetter, R. (2014). Longitudinal neurochemical
modifications in the aging mouse brain measured invivo by 1H magnetic
resonance spectroscopy. Neurobiol. Aging 35, 1660–1668.

67.

Lama, S., Auer, R.N., Tyson, R., Gallagher, C.N., Tomanek, B., and Sutherland,
G.R. (2014). Lactate storm marks cerebral metabolism following brain trauma. J.
Biol. Chem. 289, 20200–20208.

68.

Xiao, Y., Fu, Y., Zhou, Y., Xia, J., Wang, L., and Hu, C. (2017). Proton Magnetic
Resonance Spectroscopy (1H-MRS) Study of Early Traumatic Brain Injury in
Rabbits. Med. Sci. Monit. 23, 2365–2372.

69.

de Graaf, R.A. (2007). in vivo NMR Spectroscopy Principles and Techniques.

70.

Schousboe, A., and Pasantes-Morales, H. (1992). Role of taurine in neural cell
volume regulation. Can. J. Physiol. Pharmacol. 70, S356–S361.

71.

Menéndez, N., Herreras, O., Solis, J.M., Herranz, A.S., and del Río, R.M. (1989).
Extracellular taurine increase in rat hippocampus evoked by specific glutamate
receptor activation is related to the excitatory potency of glutamate agonists.
Neurosci. Lett. 102, 64–69.

72.

Harris, A.D., Saleh, M.G., and Edden, R.A.E. (2017). Edited 1 H magnetic
resonance spectroscopy in vivo: Methods and metabolites. Magn. Reson. Med. 77,
1377–1389.

73.

An, L., Araneta, M.F., Johnson, C., and Shen, J. (2018). Simultaneous
measurement of glutamate, glutamine, GABA, and glutathione by spectral editing
without subtraction. Magn. Reson. Med. 80, 1776–1786.

151

4.6 Supplementary Material
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Chapter 5

5

Summary and Future Work

5.1 Summary
Prior to the work contained within this thesis, previous research applying proton MRS to
study concussion had demonstrated that sex differences exist post-concussion1,2, and the
most consistent finding was reduced NAA ratios1,3–8, but the vast majority of studies
focused on male athletes, or chose not to explicitly differentiate between sex. Moreover,
studies across labs have examined different brain regions using different methods to
quantify absolute metabolite concentrations, making it difficult to compare MRS results
across sites. Furthermore, most studies have chosen a short echo time (TE<45ms), and
have not separately measured glutamate and glutamine, which are difficult to distinguish
due to signal overlap with each other and with less well-defined macromolecule signals9.
Therefore, proton MRS studies tend to report the sum of glutamate and glutamine as
GLX, or do not report these metabolites at all. However, it is important to quantify
glutamate and glutamine separately due to their involvement in neurotransmission within
the glutamate-glutamine cycle10. After a concussive injury, there is altered ion flux and
neurotransmitter release11, which could shift the glutamate-glutamine equilibrium.
The overall objective of this thesis was to first examine metabolite changes using
MRS in the prefrontal white matter of female contact athletes before and after
concussion, with the added goal of quantifying glutamate and glutamine separately. The
second objective was to replicate metabolite level changes in an animal model of
concussion, to position future studies to probe the reasons for these changes, and to
explore whether these changes represent potential therapeutic targets.

5.1.1

Reduced brain glutamine in female varsity rugby athletes
after concussion and in non-concussed athletes after a
season of play

Chapter two applied proton MRS to monitor changes in prefrontal white matter
metabolite levels in female rugby players with and without concussion, following athletes
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over multiple seasons of play, as well as up to 6 months post-concussion. Reduced
glutamine and Gln/Cr were found following concussion, and in the Off-Season in nonconcussed athletes. Specifically, a 52% reduction in glutamine was observed immediately
following concussion and persisted out to 3 months post-concussion, whereas a 21%
reduction in glutamine was observed at Off-Season in non-concussed athletes. These
changes could reflect a reduction in oxidative metabolism or a shift in the glutamateglutamine cycle of neurotransmission. Although the magnitude of the glutamine
reduction was larger after concussion, the directionality of the changes was similar in
both groups. However, the cause of these changes may be different in the concussed and
non-concussed athletes. A reduction in glutamine in non-concussed athletes may be due
to an exercise effect. Alternatively, the reduction in glutamine in the concussed athletes
may be the result of concussion, while the change in non-concussed athletes may be due
to the cumulative effect of sub-concussive impacts over the course of the season.
Examining the effect of exercise and metabolite levels in non-contact athletes was the
main motivation for the thesis Chapter that follows.
Additionally, within the MRS voxel, increased FA and reduced RD were found,
which could be interpreted as neuroinflammation or re-myelination. Furthermore, no
clinical correlations were found with the reduction in glutamine, which demonstrates the
insensitivity of current clinical measures to these persistent brain changes following
concussion.

5.1.2

Brain Metabolite Levels in Female Rugby Athletes are
different from Non-Contact athletes and Sedentary Women

Chapter three used proton MRS to determine whether metabolite levels were altered in
female varsity rugby players (contact athletes) compared to female varsity rowers and
swimmers (non-contact athletes) as well as sedentary females. The inclusion of these
groups allowed us to examine the effect of exercise on metabolite levels, as well as the
effect of repetitive sub-concussive hits over the course of a season. In this study we
showed that metabolite levels in non-contact athletes do not differ from age matched
sedentary women, except for a small difference in myo-inositol. We also demonstrated
that myo-inositol, glutamate, and glutamine levels differed between contact and non-
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contact athletes. Specifically, glutamine levels were significantly elevated in contact
athletes compared to sedentary and non-contact groups. Most importantly, these data
show that having a sedentary or non-contact control group, instead of baseline scans, can
change the interpretation of the directionality of a metabolite change, specifically
glutamine, after concussion.
We speculated that the changes in glutamine levels in contact athletes and
after concussion, are driven by glutamine synthetase (GS) activity and expression, the
enzyme that converts glutamate to glutamine12. During neurotransmission, glutamate is
released into the synaptic cleft and is then taken up by astrocytes to be converted to
glutamine by GS, as part of the glutamate-glutamine cycle. If we assume that glutamate
release also occurs in association with sub-concussive hits11,13, but to a lesser extent than
when associated with concussion, it is conceivable that over time GS expression and
activity would increase in order to compensate for the elevated glutamate release,
manifesting as elevated glutamine levels as observed in our contact athletes. In more
severe head injuries, one of the most significant pathophysiological processes is the
creation of free radicals as a consequence of glutamate efflux and calcium influx13.
Furthermore, studies have shown GS activity to be sensitive to oxidative stress, and that
this inhibition in GS leads to reduced glutamine12,14. Therefore, it is feasible that
following a concussive injury, if there is significant production of free radicals, GS
inhibition would manifest as reduced glutamine levels, as we observed post-concussion in
Chapter two.

5.1.3

1

H MRS Metabolite changes in a mouse model of repetitive
closed head injury

The purpose of Chapter four was to investigate metabolite level changes in the male
mouse brain in a model of multiple sub-concussive hits. The main goal with this 5-hit
paradigm was to replicate the elevated glutamine levels observed in the female rugby
athletes compared to non-contact and sedentary women as we observed in Chapter three.
Understanding the metabolic changes that occur following multiple light impacts in
animal models is the first step towards understanding the effects of sub-concussive
impacts in contact sports. In this study we observed changes in NAA early on (48 hours
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and 1 week), that resolved by 4 weeks, indicating a mild injury that was able to recover.
However, small changes at 10-weeks in creatine, lactate, taurine, Glu/Cr and Gln/Cr,
suggested a subtle shift in the biochemical pathways involving these metabolites to reestablish homeostasis.
Although the elevation in Gln/Cr was successfully replicated 10 weeks after mild
repetitive injury, quantification of glutamine levels in this mouse study was challenging
due to the complexity of the spectrum at a short echo time (TE = 18.9 ms). Lower
variability may be achieved in the future with a larger sample size, the incorporation of a
longitudinal study design, and the use of spectral editing techniques to improve
measurement of glutamine15,16.

5.1.4

1

H MRS and Imaging Concussion: Clinical Translation

Using MRS in the clinic as a diagnostic or prognostic tool for concussion is currently not
feasible. However, there are several ways to further advance MRS, that can bridge this
gap between concussion research and clinical translation, as discussed next, under future
work. As outlined earlier, along with MRS research, studies have also investigated
changes in blood flow (PET, ASL), neuroinflammation (PET), water diffusion and
tractography (DTI), and connectivity (rs-fMRI) after concussion, and changes have been
identified in all of these metrics, but clinical translation is still limited.
We are now at a point in concussion research where it is imperative that
we start using results from these different imaging metrics, together, to interpret and
understand what is happening after concussion, and why. With a better understanding of
these mechanisms, therapies can be optimized. For example, MRI provides many
different types of contrast fundamentally based on the density or diffusion of water
throughout the brain. However, these metrics are insensitive to the biochemical
mechanisms underlying pathophysiological changes, such as those present after
concussion. This is where MRS fits in, by providing a way to measure the chemical
content of MR-visible nuclei, allowing for evaluation of brain metabolism and the
biochemical pathways involved. Therefore, MRS can aid in the interpretation of changes
found with other MRI techniques. Moreover, as the medical field shifts towards

156

personalized medicine, there should be a parallel shift towards real-time patient specific
data analysis. In regards to MRI, it is feasible that this real time analysis could allow the
identification of abnormal brain regions, such as with DTI or rs-fMRI, to which the MRS
voxel could be localized for signal acquisition.

5.1.5

Conclusions

The first aim of this thesis was to use proton (1H) MRS to explore metabolite changes in
the prefrontal white matter of female contact athletes before and after concussion. In the
first 1H MRS study done at 3 Tesla (Chapter 2), reductions in glutamine were observed
after concussion at 24-72 hours and 3 months post-injury in female varsity rugby players.
In a second 1H MRS study at 3 Tesla (Chapter 3), it was realized that glutamine levels
were significantly elevated in the same rugby players (contact athletes) compared to noncontact varsity athletes and sedentary women. These studies taken together demonstrate
the importance of investigating metabolites that are implicated in neurotransmission
(glutamate and glutamine). Moreover, these data show that having a sedentary or noncontact control group, instead of baseline scans, can change the interpretation of the
directionality of a metabolite change, specifically glutamine, after concussion. To begin
to understand why these changes occur in contact athletes, we must develop an animal
model that can be used for intervention studies.
The second aim of this thesis was to replicate the human findings in an
animal model of repetitive mild head injury, to position future studies to probe the
reasons for these changes, and to investigate the effects of potential therapeutic targets. In
the final study, we used 1H MRS 9.4 Tesla in a mouse model of repeated head injury to
investigate metabolite level changes post-injury, with the hypothesis that similar changes
to the contact athletes (elevated glutamine) would be observed. Elevated Gln/Cr was
observed 10-weeks post-injury, suggesting that the model may be an appropriate model
of sub-concussive injury.
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5.2 Future Work
5.2.1

Human 1H MRS studies in Athletes and Sport Concussion
This thesis used single voxel 1H MRS in the prefrontal white matter of female

varsity athletes, and sedentary women. However, other brain regions are also of interest
and have been studied including the hippocampus17,18, motor cortex6,19, prefrontal
cortex20, corpus callosum8,21, and posterior cingulate22,23, to name a few. It would be
interesting to investigate a collection of these brain regions within the same cohort of
athletes, to see how metabolites, such as glutamine, may vary across the brain. This is
especially intriguing, considering that concussion is a diffuse injury, but how subconcussive impacts change brain metabolite levels in different brain regions is less clear.
Furthering the work from Chapter 3, it would also be useful to follow non-contact
athletes and sedentary women over multiple years, as was done with the contact athlete
group (female varsity rugby team), to observe how these metabolite differences between
groups evolve over time.
Another important aspect to consider when designing future 1H MRS
human studies, is the choice of acquisition parameters, TE (echo time) in particular. The
majority of sport concussion 1H MRS studies to date, use a TE < 45 ms, which increases
the overlap of glutamate and glutamine with macromolecule signals potentially
decreasing quantification precision9. In this thesis a long-echo time of TE = 135 ms was
chosen to minimize macromolecule contributions to the spectrum in an effort to increase
quantification precision of glutamate and glutamine. This change in acquisition
parameters speaks to the need for standardization of 1H MRS methodology across sites.
More importantly, reporting absolute quantification methods and constants, to enable the
reproducibility of results across MRI centres, is lacking in the 1H MRS literature. Public
databases with metabolite T1 and T2 relaxation constants, for example, would allow for
easy use in the quantification process and easy referencing for future studies. Moreover, a
step towards improved inter-site data quality standards, such as choosing to use CRLBs
to eliminate data, is needed to prevent data bias.
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5.2.2

Using 1H MRS in Animal Models of Concussion and SubConcussion

With the replication of elevated glutamine in a mouse model of repetitive sub-concussive
injury (Chapter four), the next questions to investigate include (1) why is glutamine
changing after repeated hits to the head, and (2) is this change protective or detrimental?
As eluded to in Chapters 3 and 4, the changes in glutamine may be manifesting from
changes in the activity level and expression of glutamine synthetase. Therefore, studies
examining the activity of this enzyme and expression levels in conjunction with 1H MRS
would aid in the interpretation of these data.
In parallel with the animal studies outlined above, it is also pertinent that
the acquisition of lower-level metabolites continues to be improved. Although the
elevation in Gln/Cr was successfully replicated, quantification of glutamine levels in this
study was challenging due to the complexity of the spectrum at a short echo time (TE =
18.9 ms). This includes not just glutamate and glutamine, but also glutathione and
GABA, which are all tightly regulated together in the GABA-glutamate-glutamine
cycle10. Spectral editing techniques with subtraction have become a popular choice,
especially for quantification of GABA, however even with editing, separating glutamate
and glutamine, as well as removal of macromolecules, remains challenging. Newer
spectral editing techniques that do not require subtraction16 should be considered in future
studies. Another possibility for future studies, includes 13C MRS, to explore glutamine
changes through glutamine labeling. In fact, studies using this technique have found
reductions in glutamine labeling after a fluid percussion injury24.
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